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Cardiac and circulatory dysfunction are leading causes of admission, cost, and mortality in the 
intensive care unit (ICU). However, choosing a suitable treatment is extremely difficult, as a 
wide range of complex and patient-specific dysfunction types are found. Furthermore, due to 
the limits and constraints on the currently obtainable data, a full, clear picture of patient state 
cannot be precisely delineated, which can result in misdiagnosis and incorrect treatment 
choices. 
To overcome this problem, cardiovascular parameters essential for correct diagnosis and 
treatment must be accurately estimated from clinically available measured data. Specifically, 
the volume of blood ejected from the heart per beat, known as stroke volume (SV), needs to be 
estimated from easily accessible measurements, such as blood pressure, as it is an important 
hemodynamic parameter for assessment of cardiovascular performance. This goal can be 
accomplished by “adding value” to existing clinical data using physiological models of the 
cardiovascular system.  
This research develops a novel aortic model and patient-specific hemodynamic parameter 
identification method for continuous and accurate estimation of SV using measurements 
commonly available in the ICU. Thus, SV can be acquired in a non-additionally invasive 
fashion. In addition, use of this SV measurement can enhance the diagnosis, treatment and 
therapeutic decision support of bedside clinicians. 
The aortic model developed in this thesis uses continuous aortic pressure waveform and pulse 
wave velocity (PWV) as inputs to estimate SV. The parameters within the aortic model are 
aortic characteristic impedance, aortic compliance, and systemic resistance, and are identified 
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beat-to-beat. These parameters are used to compute blood flow and thus to estimate SV for 
every heartbeat. 
The SV estimation method is validated with two series of pig experiments involving 
administration of dobutamine and inducing septic shock, where direct and invasive 
measurement of SV is obtained for a gold standard comparator. In addition, SV is significantly 
changed throughout the experiment by modifying preload using various levels of positive end-
expiratory pressure, as well as fluid administration. The method developed is also compared 
against the PiCCO system from PULSION, a commercially available pressure-based SV 
estimation device that is currently considered the most accurate in the critical care.  
The Bland-Altman results from the porcine study showed clinically acceptable accuracy within 
approximately ± 30% by the developed model. The PiCCO system also showed similar 
accuracy compared with the direct SV measurement. However, the PiCCO system required 
multiple calibrations during the pig study, while the developed method only required one. This 
result suggests that the developed model and methods are more accurate and clinically useful, 
particularly when hemodynamic instability is present. 
Overall, the model developed in this research shows great potential for improving patient care 
in the ICU. The model offers key hemodynamic parameters for optimizing cardiovascular 
treatment. In particular, accurate titration of fluid, inotropes, and vasoactive drugs to patient-
specific responses are now possible. The overall methods and model can be generalized to 
outpatient management. 
The overall outcome provide new opportunities to reduce the cost of care, while improving 
quality. Adding value to existing measurements has not previously been proven in circulartory 
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management. Hence, this research provides a template for further advances, particularly in the 
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Chapter 1:  Introduction and Motivation 
1.1 Motivation 
Cardiovascular disease, dysfunction, and cardiac surgery are major causes of intensive care 
unit (ICU) admissions, cost, and mortality in the western world (Mozaffarian et al., 2015). In 
New Zealand, these patients comprise more than 20% of all ICU admissions, accounting for 
approximately 2400 patients per year (ANZICS, 2015). The majority of these patients require 
therapeutic interventions to restore and maintain cardiovascular system function (Pearse and 
Rhodes, 2004). However, a number of different causes and dysfunctions may appear essentially 
the same in typical ICU measurements, which can lead to incorrect diagnosis and treatment 
(Perkins et al., 2003, Franklin and Mathew, 1994, Brun-Buisson, 2000).  
Many measurements can be taken from an ICU patient, such as blood pressures, 
electrocardiogram, and heart rate. These common measurements show the effects of the body’s 
response to the underlying problems, but do not identify the physiological changes responsible 
for these effects (Graham and Parke, 2005). For example, blood pressure can increase or 
decrease, and the cause can be in the heart, or in the circulation, or a combination of both 
(Lamia et al., 2005). With clinical measurements only revealing a part of the patient’s 
cardiovascular state, accurate diagnosis and treatment is not guaranteed (Asfar et al., 2014, 
Dubin et al., 2009, LeDoux et al., 2000). In addition, incorrect treatment can cover further 
negative effects and further mask the underlying problems, which could lead to further harm 
(Hayes et al., 1994). 
2 
 
To provide correct diagnosis and optimal treatment for patients with cardiovascular 
complications, blood pressure measurements along with physiological parameters directly 
related to cardiac and circulatory functions must be monitored (Marik et al., 2010). The key 
cardiac and circulatory parameters to monitor are the volume of blood ejected from the heart 
per beat, known as Stroke Volume (SV), and vascular properties affecting SV and peripheral 
circulation, such as vascular stiffness and resistance to blood flow (Antonelli et al., 2007). The 
combination of information from these physiological parameters provides a full and more 
complete picture of a patient’s cardiovascular state, and thus allows clinicians to differentiate 
dysfunction types (Vincent and De Backer, 2013). Moreover, typical cardiovascular and 
circulatory managements/treatments involving inotropes and vasopressors directly modify 
these physiological parameters (Overgaard and Dzavik, 2008). Hence, optimal treatment can 
be enabled by accurate evaluation of relevant patient-specific response to therapy, forming 
direct “dose-response” relationships not currently available. 
Measurement of SV provides rich information on the heart performance and also enables 
estimation of the level of oxygen delivered around the body (Tibby and Murdoch, 2003). SV 
also reveals the blood flow through the main arteries, and vascular properties can easily be 
determined through knowledge of blood pressure measurement combined with SV (Dart and 
Kingwell, 2001). Therefore, obtaining the value of SV in real-time and in response to care is 
crucial for improving ICU patient care. 
While measurement of SV is essential for accurate diagnosis and optimal treatment in cardiac 
and circulatory failure, direct measurement requires inserting invasive sensors directly into the 
heart, which is clearly not clinically feasible. In general, the use, number, and positioning of 
catheters containing sensors are determined by the perceived risk to benefit ratio (Bellomo and 
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Uchino, 2003). For these reasons, measurement of SV is often limited and only available for 
patients requiring significant treatment (Eisenberg et al., 1984, Antonelli et al., 2007).  
Currently, several methods for indirect estimation of SV are available (Marik, 2013). Accurate 
methods involving cardiac imaging, such as MRI and echocardiography can be conducted, but 
are very expensive (Oren-Grinberg et al., 2013) and often only provide static, intermittent SV 
values. These methods are also not feasible during rapid hemodynamic changes, which is the 
critical time they are most needed to inform and guide care, and often the case for 
cardiovascular complications.  
There are other methods and commercial devices available for continuous SV measurement 
(Marik, 2013). However, studies show most of these methods are unreliable during 
hemodynamic instability (Pugsley and Lerner, 2010), meaning these monitors cannot be used 
effectively when the SV data is most needed and useful (Bein et al., 2007). These significant 
limitations with current SV monitoring and estimation indicate the need for a cost-effective, 
accurate, and reliable continuous SV estimation method. 
This research aims to develop a novel continuous SV estimation method from typical ICU 
measurements. A specific goal is accurate SV estimation when hemodynamic properties are 
significantly altered. Such a method would enable SV monitoring for patients with 
cardiovascular dysfunctions without the need for additionally invasive measurements, and 
would thus be clinically practical and cost effective. Most importantly, estimated SV can 
greatly improve quality of cardiovascular treatment and patient care. 
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1.2 Cardiovascular Physiology 
This chapter first introduces the important aspects of cardiovascular physiology necessary for 
this research. It then describes the four main types of cardiovascular dysfunctions. The purpose 
is to provide a basis for the clinical importance of SV measurement in critical care and context 
for the precision and performance required. 
1.2.1 Cardiovascular System Overview 
The cardiovascular system is responsible for pumping blood around the body. The system 
consists of two key areas: the heart, which pumps the blood, and the circulation, which channels 
the blood to every part of the body. The blood represents approximately 7% of the body mass 
(Alberts, 2012), and is responsible for delivery and removal of nutrients, gases, hormones, and 
metabolic end product, which help to provide homeostasis and basic functions of human cells 
and organs. An overview of the anatomy of the cardiovascular system is shown in Figure 1.1. 
 




1.2.2 The Heart 
The heart is composed of two synchronised pumps, each comprising two chambers. The left 
ventricle pumps oxygenated blood to the body’s periphery via the systemic circulation. The 
right ventricle pumps blood to the lung to be re-oxygenated via the pulmonary circulation. Each 
ventricle has a preceding atrium chamber. The purpose of the atria is to store the blood 
returning to the heart while the ventricle is active, and to pump the stored blood into the 
ventricle when it is relaxing.  
The heart has four valves, control blood flow. The right atrium receives deoxygenated blood 
from the body and delivers it to the right ventricle through the tricuspid valve. This blood is 
then pumped to the pulmonary circulation through the pulmonary valve, preventing back flow 
while right ventricle relaxes. Oxygenated blood from the lungs is received by the left atrium 
and delivers it to the left ventricle through the mitral valve. This blood is then pumped to the 
systemic circulation through the aortic valve. A diagram of the heart showing all chambers and 
valves is illustrated on Figure 1.2.  
 
Figure 1.2 – Anatomical features of the heart and blood vessels connected to the heart. 
(Adapted under the Creative Commons Attribution-Share Alike 3.0 Unported License). 
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Figure 1.2 shows the valve positions when the ventricles are contracting, and this phase of the 
cardiac cycle is called systole. During systole, the tricuspid and mitral valves are closed to 
prevent back flow, and the pulmonary and aortic valves are both open to eject blood to the 
pulmonary and systemic circulation, respectively. All valve states are reversed when ventricles 
are relaxing and receiving blood, and this phase is called diastole.  
1.2.3 The Circulation 
The circulatory system consists of two main circuits. The pulmonary loop passes blood through 
the lungs to be oxygenated, and the systemic loop that supplies oxygenated blood to the organs 
of the body. Both circuits have three major parts: the arterial system, the capillary system and 
the venous system.  
1.2.3.1 Arterial system  
The arterial system comprises the blood vessels that transport blood away from the heart to the 
capillary system. The diameter of the arteries becomes successively smaller as they get further 
from the heart and branch to supply the peripheral tissues and organs. The arterial system has 
three main vessel types: 1) elastic arteries, 2) muscular arteries, and 3) arterioles with the elastic 
arteries being closest to the heart and arterials being furthest.   
The elastic arteries have low elasticity and can easily be stretched from changes in pressure. 
Due to the low elasticity of these vessels, some of the blood ejected from the ventricle is stored 
during systole and released during diastole. This buffering action of elastic arteries helps to 
provide more continuous flow in the peripheral arteries. 
There are two major elastic arteries connected to the heart, the aorta and the pulmonary artery. 
The aorta receives oxygenated blood ejected from the left ventricle and supplies the systemic 
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circulation. The pulmonary artery receives deoxygenated blood from the right ventricle and 
supplies the pulmonary circulation to re-oxygenate the blood.   
The elastic arteries branch to muscular arteries, where the vessel walls are thicker and these 
vessels thus have higher elasticity. The gradual change in the arterial stiffness from the heart 
to the periphery enables efficient dissipation of energy introduced from the heart, leading to 
efficient and relatively constant blood flow and pressure in the vital organs. The muscular 
arteries further branch to the arterioles, where they connect to the capillary system. 
1.2.3.2 Capillary System 
The capillaries are the smallest blood vessels and the walls are only one endothelial cell layer 
thick. The diameters of capillaries range from 5 to 10 µm, which in some places is smaller than 
a single red blood cell of approximately 8 µm. These micro-vessels allow the exchange of gases, 
nutrients, and other products between the blood and the tissues. Capillary vessels are distributed 
all around the body to reach every tissue cell to meet its demand.  
1.2.3.3 Venous System 
The venous system comprises the blood vessels that return blood back to the heart from the 
capillaries. The blood from the capillaries enters the venous system, starting with venules. After 
the blood has travelled through the venules, it then moves into the veins, where the walls get 
thicker and the diameter increases. The blood pressure in the venous system is much lower than 
in the arterial system. Due to lower blood pressure in the veins, there are several valves in these 
vessels to prevent the back flow of blood. The venous system has much lower wall elasticity 
than arterial system and contain the largest proportion of blood, approximately 64% of total 
blood volume (Tortora and Derrickson, 2008). 
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1.2.4 Mechanical Properties of the Heart 
Cardiac performance can be analysed through pressure-volume (PV) information in the 
ventricle. The PV relationship for a single cardiac cycle drawn on the pressure (y-axis), and 
volume (x-axis) diagram is called a PV loop. From the PV loop, many properties of the heart 
can be derived. An example of PV loop is shown in Figure 1.3. The general characteristics of 
the PV loop is the same for both left and right ventricles.  
 
Figure 1.3 – Example of ideal ventricular pressure-volume loop showing the four phases of 
the cardiac cycle (Stevenson, 2013). ES: end systole, SF: start filling, ED: end diastole, SE: 
start ejection, ESPVR: end systolic pressure volume relation, EDPVR: end diastolic pressure 
volume relation, ESV: end systolic volume, EDV: end diastolic volume. 
Three important metrics can be calculated from the PV-loop: SV; the end-systolic PV relation 
(ESPVR); and the end-diastolic PV relation (EDPVR), these metrics are all shown in Figure 
1.3. The SV is simply the difference in the volume before and after heart contraction. Hence, 
it is the end-diastolic volume (EDV) minus the end-systolic volume (ESV). The ESPVR and 
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EDPVR lines represent the ability of the heart muscle to contract and stretch for a given blood 
volume. These relationships also determine the approximate shape of the PV-loop from a given 
EDV and ESV. In addition, the area enclosed by PV-loop represents the external work done to 
the artery by the heart, known as stroke work. 
1.2.4.1 Cardiac Cycle 
The cardiac cycle consists of four phases that cycle anti-clockwise on the PV-loop, as shown 
in Figure 1.3. At the start of systole, the ventricular muscle contracts with a very small volume 
change, resulting in sharp increase in ventricular pressure. This phase is called isovolumetric 
contraction. When the ventricular pressure exceeds the pulmonary artery/aortic pressure, the 
corresponding valves open and the ejection phase begins. The blood in the ventricle ejects into 
the artery until the pressure in the ventricle decreases below the arterial pressure due to 
ventricular relaxation and flow ceases. This pressure decrease and loss of flow causes the 
aortic/pulmonary valves to close, and the isovolumetric relaxation phase starts. When the 
ventricular pressure becomes lower than the pressure in the atrium, the tricuspid/mitral valves 
open and blood from the venous system starts filling the ventricle. After the ventricles are filled 
to EDV, the cardiac cycle starts again with ventricular contraction.  
1.2.4.2 Frank-Starling Mechanism 
Frank-Starling mechanism describes the nonlinear relationship between the volume of blood 
filling the ventricle (EDV) and resulting force of contraction by the ventricular muscle (Frank, 
1895). Increased filling causes greater expansion of the ventricular muscle, and further 
stretched myocardium fibres can contract more forcefully to eject blood. This mechanism 
allows SV to be synchronised with the venous return, thus providing efficient control of the 
cardiovascular system without needing external regulation. Frank-Starling curve showing 




Figure 1.4 – Ideal Frank-Starling curve showing nonlinear relationship between end diastolic 




Preload is defined as all of the factors that contribute to passive ventricular wall stress at the 
end of diastole (Norton, 2001). It is thus a measure of the circulations ability to fill the ventricle. 
The most direct contributing factors include, the end-diastolic ventricular radius, the end-
diastolic filling pressure, and the heart muscle wall thickness. Ideally, all these metrics should 
be measured to determine accurate preload status of the heart. However, it is not practical or 
feasible to make frequent measurement of cardiac geometry in vivo. In clinical settings, the 
value of EDV and/or end-diastolic pressure are often used as surrogates to represent preload 
(Nahouraii and Rowell, 2010).  
Changes in preload have a crucial effect on SV. Increase in preload causes greater filling of the 
ventricle, and thus, EDV increases. This causes greater force of contraction by Frank-Starling 
mechanisms. The outcome is increased EDV and SV with wider PV loop. Figure 1.5 shows the 






Figure 1.5 – Effect of increased preload and end-diastolic volume on the pressure volume loop. 
The black line shows the control state and the red line shows the increased state (Revie, 2013). 
Clinically, EDV cannot be increased directly, and alternatively, factors influencing EDV are 
changed. Changing these factors generally occurs by modifying the vascular properties and/or 
total blood volume in the circulation. For example, the total amount of blood volume returning 
to the heart can be increased by increasing the venous wall stiffness. The veins contain the 
largest proportion of blood volume in the circulation and act as a blood reservoir. When venous 
wall stiffness is increased, the reserved blood is reduced, pushing a greater percentage of blood 
around the circulatory system, increasing blood pressure and flow. A similar condition can be 
induced by increasing the total amount of circulating blood as stiffness is dependent on the 
blood volume. Thus, EDV can also be changed from treatments such as fluid administration 




Afterload can be defined as all of the factors that contribute to ventricular wall stress during 
the ejection period (Norton, 2001). The main factors affecting afterload are the aortic properties 
such as its stiffness, and resistance to flow. These properties shape the aortic pressure 
waveform, which is the pressure load the ventricle must overcome to eject blood into the aorta. 
Hence, mean aortic pressure is a simple measure of ventricular afterload. However, strictly 
speaking, aortic pressure is determined by the interaction of both the arterial system and of the 
ventricular effort of the heart. Thus, the total aortic pressure value does not uniquely index or 
capture just arterial system properties (Burkoff, 2002). 
An increase in afterload reduces the amount of blood the heart can pump into the artery. This 
reduction results in increased ESV for the same EDV, as shown in Figure 1.6. The effect of 
afterload on SV is less significant than a change in preload, as there is no direct influence on 
the heart contractility from Frank-Starling law. For this reason, preload has a greater impact on 
SV than afterload. 
 
Figure 1.6 – Effect of increased afterload on the pressure volume loop. The black line shows 
the control state and the red line shows the increased state (Revie, 2013). 
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1.2.4.5 Heart Rate 
Heart rate is the number of cardiac cycles that occur within one minute. SV multiplied by heart 
rate is called cardiac output (CO), which estimates the average blood flow around the 
circulation per minute, and often used in clinical settings to approximate level of oxygen 
delivery around the body. Heart rate is controlled by the autonomic nervous system. 
Sympathetic stimulation, for example via inotropes, increases both the heart rate and the force 
of the heart contraction. In contrast, parasympathetic stimulation decreases heart rate without 
greatly decreasing the strength of contraction (Hall, 2011).  
The baroreflex is one of the negative feedback mechanisms responsible for the nervous 
stimulation of the heart (Cheryl, 1999), thus controlling heart rate. Sensory neurons called 
baroreceptors are located in the vascular wall to monitor pressure levels in arteries and the 
veins. Baroreceptor are excited by stretch of the blood vessel. Thus, changes in pressure within 
the vessel activates baroreceptors, which triggers the central nervous system responsible for 
the heart’s autonomic reflexes. Increases in blood pressure results in sympathetic activation, 
and parasympathetic inhabitation. Conversely, when blood pressure decreases, the opposite 
nervous stimulation occurs. Finally, drug therapies can add to sympathetic or parasympathetic 
stimulation to modify pressures in circulation and cardiac management. 
1.2.5 Mechanical Properties of the Blood Vessels  
Properties of the circulatory system play an important role in maintaining an efficient 
cardiovascular system, and therefore transport of gases, nutrient and waste. In particular, 
vascular stiffness and resistance to blood flow have significant influence on the preload and 
the afterload, and thus performance of the heart. The vascular properties can be assessed from 
blood pressure and flow information within the blood vessels, using a well-known physical law 
combined with simplified representation of vasculature. 
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1.2.5.1 Vascular Resistance 
The Hagen-Poiseuille equation describes a linear relationship between pressure drop and flow 
in a cylindrical pipe of constant cross section, and is analogous to Ohms law for electric circuit. 
The slope of the relationship is determined by the size of the pipe and the dynamic viscosity of 
the fluid, which captures the resistance to flow. The equation is written: 
∆ =                        (1.1) 
 = 	8	
 																																																																																																																																														(1.2) 
Where P, R, Q, µ, L, and r are pressure, resistance, flow, dynamic viscosity, length of pipe, and 
pipe radius, respectively.  
Using Equation (1.1) with the blood flow rate and blood pressure across the circulation, an 
estimate of vascular resistance can be computed. The main factor affecting the level of 
resistance is the blood vessel radius, as can be seen in Equation (1.2). Vessel radius is controlled 
by a range of homeostasis mechanisms that exist within the cardiovascular system (Ackermann, 
2004). By controlling vascular resistance, blood flow to the vital organs can be regulated, so 
that adequate tissue perfusion that is neither too high nor too low is maintained.  
With varying vascular resistance and blood flow, the amount of blood returning to the heart is 
influenced. An increase in vascular resistance could reflect low flow in the circulatory system, 
and thus reduced preload. Alternatively, an increase in vascular resistance could induce high 
pressure gradients across the capillary system with constant flow, and thus increased afterload. 
As Equation (1.1) requires two known variables to identify the third variable, knowledge of 
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one variable alone, such as a measured pressure value, is not enough to identify its unique 
condition. 
Another type of vascular resistance beside capillary/systemic resistance is aortic characteristic 
impedance. This parameter describes resistance of aorta from pressure and flow generated by 
the ventricular ejection (Murgo et al., 1980). The relationship between aortic pressure, flow, 
and aortic characteristic impedance is the same as Equation (1.1). However, aortic wall cannot 
be assumed rigid with constant cross-sectional area as aortic wall has low elasticity unlike 
peripheral arteries. For this reason, Hagen-Poiseuille equation is not suited, and thus, resistive 
phenomenon of aorta is defined using water hammer equation, where conservation of 
momentum is considered for flow through elastic tube (Khir et al., 2001). 
1.2.5.2 Vascular Stiffness 
Clinically, the most commonly used index for describing vascular wall stiffness is compliance. 
The value of compliance is calculated as the ratio of change in volume from a given change in 
pressure, and its value is the reciprocal of elastance. Compliance is defined: 
 = ∆∆																																																																																																																																																	(1.3) 
The value of vascular compliance represents the ability of a blood vessel to recoil toward its 
original dimension from an increased distending force, such as pulse pressure from the heart. 
Physiologically, the vessel radius is controlled by contraction of vascular smooth muscles, 
which directly alter its compliance. The blood vessels are narrowed when vascular compliance 
is reduced and this process is called vasoconstriction. The opposite process of increased 
vascular compliance with widening blood vessels is called vasodilation. The value of vascular 
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compliance, thus significantly influences vascular resistance, which subsequently has a 
significant impact on afterload and preload. 
1.2.6 Summary 
In a normal healthy cardiovascular system, preload, afterload, heart rate, vascular resistance, 
and vascular compliance are all continuously changing/modulating under the controls of both 
passive and active mechanisms to maintain adequate blood flow and to meet demand from 
tissues and organs in the body. Any significant change in these cardiac and circulatory 
parameters decreases the efficiency of the cardiovascular system, and could thus lead to life-
threatening medical situations. In such cases, blood pressure information alone is inadequate 
to uniquely identify the metrics responsible for the abnormality.  
To examine cardiac and circulatory performance, both pressure and volume information are 
required to uniquely ascertain this relationship (Bellomo and Uchino, 2003), which can then 
be converted into clinically useful physiological values. Mechanical properties of the heart are 
determined from PV loops of the ventricles, which are affected by the preload and the afterload. 
The loading conditions of the heart are thus affected by the vascular properties, which can be 
determined through pressure-volume relationships within the blood vessels. In addition, SV 
which is the amount of volume transferred from the heart to the circulation contains rich 
information, as SV provides volume information of both systems and its interactions. 
1.3 Cardiovascular Dysfunctions  
Cardiovascular dysfunction is a common condition in critical care, affecting approximately 
30% of patients in the ICU (Sakr et al., 2006). All cardiovascular dysfunction results in 
inadequate cellular oxygen utilization, due to insufficient oxygen delivery by the 
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cardiovascular system. The end results are severe cellular dysoxia and multiple organ failure, 
leading to death if not treated appropriately (Cecconi et al., 2014). 
There are many cardiovascular dysfunction types, but the causes can be categorized into four 
main pathophysiological mechanisms: 1) distributive; 2) cardiogenic; 3) hypovolemia; and 4) 
obstructive (Weil and Henning, 1979). Each mechanism reflects an abnormality in a different 
part/function of the cardiovascular system. The following sections detail each dysfunction.  
1.3.1 Distributive  
Distributive dysfunction is the most common form of cardiovascular dysfunction in the ICU 
and accounts for approximately two-third of patients with cardiovascular dysfunction. In 
particular, sepsis and septic shock, which is a form of distributive dysfunction, makes up most 
of these patients (Vincent and De Backer, 2013). Septic shock is a major problem in ICU today 
with reported case-fatality rates in the range of 40-50%, and reaching as high as 80% (Jawad 
et al., 2012). 
Distributive dysfunction can be characterised as a dysfunction in the capillary system and its 
regulatory functions. This dysfunction is most commonly caused by bacterial infection 
introducing toxins into the circulation (Elbers and Ince, 2006). High levels of toxins in the 
blood activates the inflammatory response, which in turn affects regulation of vascular 
properties, leading to abnormalities in the micro circulation (Werdan, 2001).  
The loss of vascular function due to distributive dysfunction causes a decrease in vascular 
stiffness and an increase in capillary leak, leading to low systemic vascular resistance and 
afterload as well as reducing exchange with the tissues (Ince, 2005). These effects decrease the 
ability of the systemic circulatory system to exchange nutrients and oxygen, and return blood 
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back to the heart. In untreated cases, reduced venous return and preload to the right ventricle 
causes a reduction in SV, when the body actually requires greater SV. The hemodynamic 
profile is generally modified by increasing circulatory blood volume with fluid resuscitation, 
where the CO is normalised or elevated due to low systemic resistance (Dellinger, 2003). This 
elevated CO is a unique feature of distributive dysfunction as the other three dysfunctions are 
all associated with low CO (Cavazzoni and Dellinger, 2006).  
1.3.2 Cardiogenic  
Cardiogenic dysfunction is defined as a state of reduced cardiac performance in the presence 
of adequate intravascular volume (Nieminen and Harjola, 2005). This dysfunction is the second 
largest cause of cardiovascular dysfunction in the ICU (Vincent and De Backer, 2013). A 
multinational observational study of patients hospitalized for an acute coronary syndrome 
showed in-hospital case-fatality rate of approximately 60% for patients who developed 
cardiogenic shock (Awad et al., 2012).  
The cause of cardiogenic dysfunction can be due to mechanical complications, such as 
ventricular septal rupture and valve regurgitation, myocardial ischemia from insufficient 
coronary perfusion, and secondary effects from other types of cardiovascular dysfunctions 
(Reynolds and Hochman, 2008). When cardiac function is depressed from cardiogenic 
dysfunction, myocardium contractility is compromised and SV is reduced. This reduction 
causes less blood delivery to the coronary artery and body’s periphery, leading to cellular hypo-
perfusion. The ischemia induced to the myocardium from reduced coronary blood flow can 
further decrease the cardiac function. The end result is progressive myocardial dysfunction, 
leading to a positive feedback loop and a downward spiral of cause and effect (Hollenberg et 
al., 1999).  
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1.3.3 Hypovolemia  
Hypovolemia is a state of decreased intravascular blood volume. This condition is often found 
in trauma patients suffering severe haemorrhages (Kelley, 2005). The loss of blood volume in 
the circulatory system decreases preload and SV. In cases where the blood loss is up to 
approximately 30%, baroreflexes can restore the blood pressure back to normal levels by 
vasoconstriction (Cheatham et al., 2008), masking this dysfunction and its diagnosis. However, 
the cardiovascular system is significantly compromised in severe cases and tissue perfusion in 
the vital organs is decreased. 
1.3.4 Obstructive  
Obstructive cardiovascular dysfunction is the least common of the four types of cardiovascular 
dysfunction found in the ICU (Vincent and De Backer, 2013). It is a cardiovascular system 
failure due to physical obstruction of blood flow into or out of the heart. The causes can be 
found in the pulmonary circulation, such as tension pneumothorax and pulmonary embolism, 
or in the systemic arterial system, such as in severe aortic stenosis (Morgan and Wheeler, 2013). 
Obstruction in the circulatory system leads to reduction in preload and an increase in afterload. 
The effects of these hemodynamic changes lead to reduced SV for both pulmonary and 
systemic cases as described in Section 1.2.4.3 and 1.2.4.4. The loss of blood flow from 
obstruction combined with decreased cardiac function results in inadequate oxygen delivery to 
the body, organ failure, and death if not treated. 
1.3.5 Summary 
Although each cardiovascular dysfunction originates from different parts of the cardiovascular 
system, the common consequence of all dysfunction types is the reduction in ability of the heart 
to pump a sufficient amount of blood to the tissues. Distributive dysfunction reduces SV via 
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less preload due to low systemic resistance and hypotension. Cardiogenic dysfunction 
depresses cardiac contractility, and thus the ability of the heart to eject blood out of the ventricle 
is decreased. The loss of blood volume/flow in hypovolemia and circulatory obstruction lessens 
SV from reduced preload and blood received by the heart. While each dysfunction type are 
discussed separately, comorbidities are common with patient with cardiovascular dysfunctions, 
and thus, induce greater loss of heart performance. 
Proper cardiac function relies on proper function of the circulatory system, and vice versa. Due 
to their interdependence, SV is affected directly or indirectly in all cases, which is the key 
parameter in determining the level of oxygen delivery around the body. For this reason, SV 
monitoring could play a key role in cardiovascular system management, resuscitation, and 
optimization. 
1.4 Clinical Significance of Stroke Volume 
Arterial pressure measurement is commonly used in patients suffering from cardiovascular 
dysfunction in the ICU. However, pressure changes can be driven by alteration in cardiac or 
circulatory functions, and when volume measurement, such as SV is not available, accurate 
diagnosis and treatment cannot be performed. ICU clinicians have access to other 
hemodynamic variables, such as central venous pressure and blood oxygen/carbon dioxide 
saturation levels. However, the addition of SV measurements would provide a much clearer 
picture of patient condition from large amounts of often contradictory numerical data. 
When both pressure and volume measurements are available, key physiological parameters, 
such as systemic resistance with the Poiseuille equation, and vascular stiffness from pressure-
volume ratio, can be obtained. These identified values directly relate to the mechanisms of each 
of the cardiovascular dysfunctions. Thus, precise diagnosis of dysfunction types become much 
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easier. In addition, response to therapeutic intervention can be effectively monitored as 
treatments involve reversing/normalizing these parameters. 
The goal of cardiovascular treatment is to maintain adequate oxygen delivery and tissue 
perfusion (Pearse and Rhodes, 2004). To achieve this goal, patients commonly receive one or 
a combination of three main treatments: 1) fluid therapy; 2) inotropic agents; and 3) vasoactive 
agents (Vadakel and Rizzolo, 2013). Fluid is administered in an attempt to increase SV through 
increasing intravascular volume and preload (Phillips and Brierley, 2015). Inotropic and 
vasoactive agents are used to increase cardiac and circulatory performance through sympathetic 
and parasympathetic activation/inhibition (Ellender and Skinner, 2008). Excess amount of 
fluid/doses can be harmful when desired outcome is not achieved (Phillips and Brierley, 2015, 
Overgaard and Dzavik, 2008), and thus titration is key to successful treatment. 
The combined information from pressure and SV enabling assessment of vascular resistance 
and stiffness can correctly guide treatments by measuring its direct response. Monitored SV 
can be used to titrate fluid and inotrope therapy in real-time. In addition, estimated vascular 
stiffness using the value of SV with measured pressure can be used to guide treatment using 
vasoactive agents.  
1.5 Goals for This Research 
The aim of this thesis is to investigate, develop, and validate methods for continuous and 
accurate beat-to-beat estimation of SV using non-additionally invasive and/or typical ICU 
measurements. Accurate SV data would provide a means to unmask the hidden dynamics and 
interactions in the pressure measurements, enabling clearer diagnosis of dysfunction and a 
much better understanding of “cause and effect”. The outcomes of this research would provide 
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ICU clinicians a stronger foundation for cardiovascular treatment, thus enhanced patient 
outcomes. 
In this research, SV estimation models are developed and examined with porcine experimental 
data, where hemodynamic parameters were modified using inotropes, and induced septic shock 
and fluids. Animal experiments allows direct, invasive measurement of SV by inserting a 
sensor into the heart, which enables the SV estimated by a model to be validated against a 
direct measurement. Significant hemodynamic variability induced in the experiment is used to 
assess model robustness and accuracy in the transient dynamic situations of clinical importance.   
1.6 Preface 
The remaining thesis chapters cover this topic as follows: 
Chapter 2 gives background information of the current methods and techniques available for 
estimating SV. 
Chapter 3 investigates the relationship between SV and PWV, a clinical surrogate of vascular 
elasticity, to evaluate the potential for monitoring SV using beat-to-beat changes in PWV. 
Chapter 4 presents three-element aortic model for interpreting aortic pressure contours. SV is 
estimated using calibrated/constant model parameters, and its accuracy is analysed.  
Chapter 5 extends the aortic model in chapter 4 by combining aortic pressure and PWV 
measurements. SV estimation error introduced from constant model parameter is decreased 
using dynamic model parameters calculated using water-hammer equation.  
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Chapter 6 compares accuracy of SV estimation method developed in chapter 5 with pressure 
contour method developed by Wesseling et al. (1993) and PiCCO system from PULSION.  
Chapter 7 analyses the relationship between contractility, mechanical efficiency of the heart 
and the output model parameter values of extended aortic model in chapter 5, to expand the 
clinical usefulness of developed model. 
Chapter 8 investigates the method of estimating PWV using ECG and a single aortic pressure 
measurement to improve clinical practicality of the model developed in chapter 5. 
Chapter 9 and 10 summarise the conclusions drawn from this thesis, and examine potential 
avenues for future work.
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Chapter 2: Current Hemodynamic 
Monitors for Stroke Volume 
This chapter gives a brief overview of the current methods available for estimating SV. It is 
intended to provide the background information needed to understand the advantages and 
limitations of each method.  
2.1 Aortic Flow Probes 
An aortic flow probe measures blood flow rate within the aorta, which can be integrated over 
the systolic period to estimate beat-to-beat SV. The ultrasound flow probe utilizes a property 
of sound waves propagating through fluid in motion. Sound waves travel faster in the direction 
of flow and slower against the flow. Using this principle, the time difference between the 
ultrasound emitter and the receiver placed upstream and downstream can be used to determine 
flow (Dean et al., 1996). A picture of the aortic flow probe (Transonic Scisense Inc., Ontario, 
Canada) used in the pig experiments described later in this work is shown in Figure 2.1. 
 
Figure 2.1 – Aortic flow probe by Transonic Scisense. The device is wrapped around the aortic 
vessel to measure blood flow rate (Transonic, 2015). 
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Flow measurement from the aortic flow probe is considered very accurate. The method has 
been validated in vivo using data from pig experiments, where aortic flow was controlled and 
varied by bypassing the pulmonary circulation with roller pump (Dean et al., 1996). The result 
showed that this technique is capable of capturing aortic flow with an accuracy of ±2%.  
Although aortic flow probes have the ability to produce accurate results in ideal conditions, 
quality of the measured signal can be reduced depending on the variation in the attenuation of 
the ultrasound signal and how the equipment is placed (Eren, 1998). For example, the transit 
time measured by the flow probe could vary when the angle of incidence of the ultrasound 
beam is changed. Thus, the absolute flow value measured by the device could over/under-
estimate the actual flow rate.  
The major limitation of measuring SV using an aortic flow probe is that it cannot easily be used 
in the ICU environment, as it is extremely invasive procedure. The flow probe is placed around 
the blood vessels, and thus requires direct access to the aorta. Currently, the use of aortic flow 
probes is mainly limited to experimental and conceptual work (Yang et al., 2013, Phillips et 
al., 2012).  
2.2 Admittance Catheters 
Admittance catheters uses the relationship between conductance changes within the ventricle 
from applied electric field and changes in ventricular blood volume for estimating SV. 
Admittance catheters commonly comprise excitation electrodes, voltage recording electrodes, 
and a pressure sensor for obtaining pressure volume information within the ventricle. The 
catheter is placed directly into the ventricle, and measures the changes in voltage at the 
recording electrodes from electric field produced by the excitation electrode. The voltage 
change occurs due to the changes in conductivity induced from fluctuating blood volume within 
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the ventricle, and also the shape of the cardiac muscle during a heartbeat. The influence from 
the myocardium in the measured admittance signal is removed using Wei’s equation (Wei et 
al., 2005), and the filtered signal containing only the changes due to conductivity of the blood 
is converted into a continuous volume measurement, thus SV can be calculated as EDV minus 
ESV. Mathematical details of the principles used for the admittance catheter can be found in 
the literature (Porterfield et al., 2009). A diagram of admittance catheter (Transonic Scisense 
Inc., Ontario, Canada) is shown in Figure 2.2. 
 
Figure 2.2 – Diagram showing an admittance catheter (Transonic Scisense Inc., Ontario, 
Canada), placed inside the left ventricle. The catheter comprises excitation electrodes, voltage 
recording electrodes and a pressure sensor (Transonic, 2013). 
The result from a study comparing SV derived from a admittance catheter and three 
dimensional echocardiography showed precision of approximately ±30% between the two 
methods (Kutty et al., 2013). Since there is no “gold-standard” measurement for SV (Pugsley 
and Lerner, 2010), it is difficult to determine the true accuracy of either method. However, both 
techniques measure volume “directly” with little post-processing of the obtained signal 
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required. Thus, minimal approximations are made for the derivation of SV, and its reliability 
is justified by the physics of the method (Taylor, 1966, Porterfield et al., 2009).  
The limitations of utilizing admittance catheters in the ICU are similar to those of the aortic 
flow probe. Placing a catheter within the heart chamber is highly invasive and could decrease 
the function of the heart by penetrating the ventricular-arterial valve, causing negative 
influence on blood flow within the ventricle (Evans et al., 2009). It could also increase the 
chance of blood stream infection (Cousins and O'Donnell, 2004). With the resulting high 
perceived risk to benefit ratio, the use of admittance catheters in the ICU is not clinically 
feasible. 
2.3 Indicator Dilution Methods 
The indicator dilution method estimates blood flow through the heart by measuring at an 
arterial site, a known quantity of substance or change in properties introduced into the venous 
system (Grodins, 1962). The “indicator” introduced into the circulation is diluted by the blood, 
and its level of dilution depends on the blood volume encountered. By measuring how fast the 
diluted indicator passes through the measurement site, blood flow can be estimated. This 
relationship between velocity of indicator, level of dilution, and blood flow is known as 
Stewart-Hamilton equation (Kinsman et al., 1929) and written: 
 = 	  	 																																																																																																																																										 (2.1) 




The principle given in Equation (2.1) assumes mass conservation, implying the total amount 
of fluid entering the system must eventually leave the system. Thus, resulting dilution 
represents the amount of blood volume diluted the indicator, and not the volume permeated/lost 
into the system. It also assumes no recirculation. Specifically, it is assumed the indicator 
concentration change only occurs due to dilution in the blood volume and is not influenced by 
any other external input to the system (Valentinuzzi et al., 1969). These conditions are difficult 
to achieve in cardiovascular system, where the blood does recirculate, and is constantly 
leaving/entering blood vessels and tissues.  
For example, continuous estimation of blood flow is mathematically possible by extracting the 
recirculated portion of the indicator (Zierler, 1962). However, the uncertainty involved with 
the amount of tissue perfusion creates a significant limitation. Thus, indicator dilution is most 
accurate when an impulse of the indicator is given, and generally limited to providing 
intermittent CO values (Schmid et al., 1999). 
The limitations of the indicator dilution methods arise from the assumptions made in Stewart-
Hamilton equation. However, this approach is less invasive compared with aortic flow probes 
or admittance catheters, as measurements can be made in the circulation and not directly from 
the heart. Currently, the most common indicator dilution method used in the ICU environment 
is thermodilution (Ganz et al., 1971).  
The thermodilution method uses blood temperature as an indicator for estimating flow. Cold 
saline of known temperature and quantity is administered in the vein and the “dilution” of blood 
temperature is measured in the artery. By applying the values of specific heat and weight of 
the blood to Stewart-Hamilton equation, temperature change/thermodilution from saline can 
be converted to volume of blood. There are currently two main techniques available for 
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measuring CO using the thermodilution method, the pulmonary arterial catheter (PAC) and 
transpulmonary thermodilution (Sakka et al., 2012). 
A PAC is introduced into the cardiovascular system via the venous system, then threaded 
through the right atrium, the right ventricle, and subsequently into the pulmonary artery. The 
PAC is equipped with a thermistor enabling the temperature of the pulmonary arterial blood to 
be measured. Cold saline is administered into the venous system and the resulting blood 
temperature in the pulmonary artery measures CO of the right heart, which must match that of 
the left heart to prevent blood accumulation in the pulmonary system. A typical path of PAC 
in the cardiovascular system is shown in Figure 2.3. 
 
Figure 2.3 – An illustration of pulmonary arterial catheter inserted into cardiovascular system 
from the vein, through the right heart, and into the pulmonary artery. (Adapted under the 
Creative Commons Attribution-Share Alike 4.0 International License). 
 
A PAC measures the degree of thermodilution without the indicator going through the capillary 
system. Therefore, mass is conserved and this approach satisfies the conditions necessary for 
use of Stewart-Hamilton equation. For this reason, the PAC is regarded as the most accurate 
indicator dilution method, and many of the modern SV monitoring devices use intermittent 
estimates from a PAC to validate their system (Pugsley and Lerner, 2010). However, PAC 
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based methods have precision error of greater than ±30% when compared against estimates 
from aortic flow probes (Yang et al., 2013). Hence, accuracy is significantly limited. 
The PAC also requires penetration of the right heart and may increase catheter related 
complications (Evans et al., 2009). To overcome this limitation, transpulmonary 
thermodilution was developed, where the indicator temperature is measured in a systemic 
artery instead of the pulmonary artery (Sakka et al., 2012). Two separate catheters are required 
for this method, one in the vein for fluid injection, and another in the artery for indicator 
detection. However, no equipment goes through the heart.  
Transpulmonary thermodilution is less invasive than using a PAC. However, the thermal 
indicator passes through the capillary system in the lungs and also travels longer distance to 
the measurement site. These influences on the thermal indicator add error to the estimation of 
flow, and produce slightly less accurate estimates of CO than using PAC (Sakka et al., 1999).  
Finally, both methods are intermittent. However, there is no guarantee the measures are taken 
when the patient is dynamic and changing, a limitation of any intermittent measure. Hence, 
along with calibration requirements, these approaches are less suitable for the level of 
monitoring required. 
2.4 Pressure Contour Analysis 
Pressure contour analysis utilizes measured arterial pressure, combined with pressure-volume 
conversion algorithms to estimate blood flow. This method enables continuous estimate of SV 
as continuous arterial pressure measurements are often accessible in the ICU. Currently, there 
are several commercial devices available, each using their own unique algorithms (Montenij et 
al., 2011, Romano and Pistolesi, 2002, Gödje et al., 2002). However, due to lack of published 
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details in these proprietary devices, accurately assessing the model advantages and limitations 
of each model is difficult (de Wilde et al., 2008). 
The foundation of all the algorithms used is based on the relationship between pressure, SV, 
compliance, and vascular resistance (Montenij et al., 2011). As discussed in Section 1.2.5, if 
compliance and/or vascular resistance of the artery can be identified, arterial flow and volume 
change can be calculated from the pressure, and thus, SV computed. The main difference 
between each algorithm can be found in the identification method for these vascular properties. 
There are three main types of identification methods used in these pressure contour analysis 
based commercial devices: 1) using intermittent CO values with indicator dilution (e.g. PiCCO 
system, PULSION); 2) from patient demographic and physical characteristic (e.g. FloTrac 
system, Edwards Lifesciences); and 3) using only the shape of the pressure waveform (e.g. 
MostCare system, Vyetech Health). Commercial devices such as PiCCO and FloTrac using the 
first and second methods combine the third method to track/determine dynamic changes in 
vascular properties. The indicator dilution values and/or patient characteristics are used for 
initial/discrete calibration of the system. 
The accuracy of commercial devices is validated against methods that are considered more 
accurate, such as the indicator dilution. In general, calibrated systems provide more accurate 
estimates than uncalibrated systems (Vincent et al., 2011). However, previous validation 
studies show that pressure contour algorithms become less reliable when there is changes in 
vasomotor tone (Yamashita et al., 2008, Yamashita et al., 2007, Monnet et al., 2010, Cecconi 
and Rhodes, 2010). This is a significant limitation of current pressure contour methods as the 
tone changes are inevitable in patients with dynamically evolving cardiovascular dysfunction 
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requiring circulatory treatment, especially once some circulatory resuscitation treatments seek 
to directly modify vasomotor tone.  
2.5 Minimal to Non Invasive Methods 
There are two well-known methods for minimal/non-invasively estimating SV, which are 
echocardiography and oesophageal Doppler. In contrast to the methods described in previous 
sections, these methods does not require breaking through body’s membrane by the equipment. 
Echocardiography can be performed on the surface of the body and oesophageal Doppler only 
requires insertion of transducer probe down the oesophagus. 
2.5.1 Echocardiography 
Echocardiography uses the Doppler principle to determine flow velocity and cross-sectional 
area of aorta (Anavekar and Oh, 2009), thus integrating product of these two variables over 
systole produces an estimate of SV. The precision of Doppler echocardiography against 
thermodilution reported in a systematic review paper (Wetterslev et al., 2016) showed a mean 
error of ±32%. 
The main advantage of echocardiography is that it is non-invasive and adds no further risks to 
the patient. However, this technique requires specialised device/personnel, and impractical to 
obtain continuous SV. Thus, echocardiography only provides intermittent SV and important 
transient data is missing when assessing/managing patient conditions. 
2.5.2 Oesophageal Doppler 
The oesophageal Doppler method uses same principle as echocardiography, except the Doppler 
probe is inserted into the oesophagus pointing towards the thoracic aorta. This method 
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overcomes the limitations of echocardiography by taking continuous estimate of SV without 
the operator by leaving the probe in place. However, this technique has a steep learning curve, 
and the accuracy of SV can be operator dependent (Marik, 2013). The probes are inserted 
blindly and the resulting waveform is highly dependent on its depth and its rotation (Lefrant et 
al., 1998). Studies found better accuracy is achieved when the operator was not blinded to the 
results of the CO obtained with a PAC (Valtier et al., 1998), suggesting correct positioning of 
the probe requires some reference measurements.  
2.6 Summary 
At present, there is no gold-standard measure for SV, despite several methods available with 
varying accuracies and invasiveness. SV estimates from aortic flow probes, admittance 
catheters, and PAC are considered most accurate as measurements are made closest/directly 
from the heart with well-accepted laws of physics, leading to minimal measurement error. 
However, these methods are impractical in the ICU environment due to their highly invasive 
nature. PAC provides the least invasive method out of the three, and its benefit may outweigh 
the risks involved, but only provides intermittent SV values.  
In contrast, transpulmonary indicator dilution and pressure contour methods provide a less 
invasive, more clinically feasible means to estimate SV. Despite increased convenience by 
these methods, expected accuracies are lower as more assumptions need to be made on the 
principles used to identify SV. In addition, assessment of currently available pressure contour 
commercial devices is extremely difficult due to limited details available on the algorithms 
used, and their limitations cannot be easily investigated. 
Minimal to non-invasive methods of estimating SV are possible with echocardiography and 
oesophageal Doppler. However, these methods require specialised personnel to operate and 
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can be cumbersome. Furthermore, echocardiography only provides intermittent SV values and 
estimates from oesophageal Doppler are ambiguous due to its results being highly operator 
dependent. 
Currently, highly invasive methods offer continuous and more accurate estimate of SV. On the 
other hand, the accuracy is decreased and/or measurements of SV are intermittent as the method 
becomes less invasive. Thus, development of continuous, accurate, and non-additionally 
invasive method for estimating SV has significant value.
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Chapter 3: Correlation between Stroke 
Volume and Pulse Wave Velocity 
This chapter investigates the relationship between SV and pulse wave velocity (PWV) to 
evaluate clinical applicability of estimating SV using the value of PWV. Non-invasive PWV 
measurements are relatively easy to obtain in a critical care environment, and thus, the 
relationship could potentially provide a practical solution for monitoring SV in a non-invasive 
or minimally invasive fashion. The strength of this relationship is tested in various 
hemodynamic states to examine expected accuracy and reliability of SV estimation from PWV. 
3.1 Introduction 
PWV is the velocity of the pulse wave propagating through the arterial system and an indicator 
of arterial stiffness (Mackenzie et al., 2002). In particular, a high PWV indicates low arterial 
compliance as waves travel faster in a stiffer medium. In contrast, a low PWV implies high 
arterial compliance.  
Several studies have established associations between high PWV and the incidence of 
cardiovascular disease (Blacher et al., 1999, Cecelja and Chowienczyk, 2012). For these 
reasons, PWV is generally used to assess cardiovascular risk of an individual (Ben-Shlomo et 
al., 2014). Currently, the gold standard method for measuring PWV is highly invasive, 
involving two pressure measurements at the carotid artery and the femoral artery (Laurent et 
al., 2006). However, non-invasive methods are also available (Yamashina et al., 2002, Horvath 
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et al., 2010) and the ease of obtaining these PWV measurements has led to many clinical 
applications using this parameter (Hirata et al., 2006).  
In the ICU, titrating hemodynamic support therapies, such as fluid replacement and 
inotrope/vasoactive drugs is challenging (Michard and Teboul, 2002, Bangash et al., 2012). In 
particular, studies show approximately half of all fluid interventions are effective with the rest 
potentially harmful from the extra fluid introduced (Phillips and Brierley, 2015). This poor, 
effectively random outcome is mainly from the interventions being made without information 
on SV. Without monitoring changes in patient-specific SV, the efficacy of hemodynamic 
support therapy cannot be correctly identified, particularly in highly dynamic and transient 
scenarios.  
Consequently, excessive fluid introduced to the patient may cause tissue oedema, and organ 
damage, and has been demonstrated to increase mortality during septic shock (Vincent et al., 
2006, Boyd et al., 2011). Although information on SV is important in making correct decisions, 
SV is difficult to measure even in the ICU and usually requires additionally invasive 
measurements (Gomez and Palazzo, 1998) and/or expensive specialised equipment (Mehta and 
Arora, 2014). 
This chapter analyses mathematical relationships between SV and PWV to investigate whether 
PWV could be used as an alternative index for capturing SV dynamics. Since PWV 
measurements are much easier to obtain than direct SV measurements, the relationship could 
provide minimally invasive and cost effective solutions for monitoring patient SV changes, and 
optimising hemodynamic treatment. In addition, the SV values obtained can be used to access 
key cardiovascular parameters through physiological models, providing further useful 




Moens and Korteweg first derived the equation relating the elastic properties of the artery to 





=  (3.1) 
Where E, h, r, and ρ are elastic modulus, thickness of arterial wall, radius of the artery, and 
blood density, respectively.  
Bramwell and Hill (Bramwell and Hill, 1922) reformulated Equation (3.1) to be more clinically 
applicable by relating PWV to “distensibility”, which is the rate of volume increase with 
pressure increase. This modification was achieved by introducing the relationship that small 
increases in pressure, P, will cause small increases in the radius of the artery, r, where, δr = 











=  (3.3) 
Where V is the blood volume within the section of artery at the end of diastole and D is the 
distensibility of the arterial wall.  
At present, the distensibility of the arterial wall is interpreted by assuming constant blood 
density and changes in the wave velocity result entirely from the elastic nature of the arterial 
wall. This latter assumption holds true only if the velocity of the blood carrying the pulse wave 
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does not vary with varying patient conditions, which it almost certainly does (SINGER et al., 
1991).  
Clinically measured PWV must be treated as the addition of a velocity of wave along the artery 
with no blood flow, and the velocity of the blood that carries the wave. Thus, a change in 
measured PWV does not necessarily come only from the elastic properties of the artery. For 
example, the magnitude of SV itself could influence the velocity of the blood without causing 
changes in the arterial distensibility. Thus, measured PWV is a function of distensibility and 
velocity effects: 
PWVmeasured = PWVdistensibility + PWVvelocity       (3.4) 
Although, it has been reported that PWV values can be different between individuals 
(Collaboration, 2010), it can be assumed that intra-subject variability of arterial wall 
distensibility is a lesser component of changes in PWV. If this assumption holds, the changes 
in PWV should reflect the changes in the flow condition inside the artery generated by SV. 
Thus, this chapter investigates strength of the relationship between SV and measured PWV in 
various hemodynamic conditions, to investigate its validity. 
3.2 Method 
3.2.1 Porcine Trials and Measurements 
This study uses data from experiments performed on pigs at the Centre Hospitalier 
Universitaire de Liege, Belgium. All experimental procedure, protocols and the use of data in 




Experiments were performed on 8 healthy, pure pietrain pigs weighing between (20 – 29)kg. 
The pigs were premedicated with ketamine (20mg/kg) and diazepam (1mg/kg). Anesthesia was 
induced and maintained by a continuous infusion of sufentanil (0.5µg/kg/hour) and sodium 
pentobarbital (3mg/kg). The pigs were intubated via tracheotomy and ventilated using a 
Draeger Evita2 ventilator (Draeger, Lubeck, Germany). 
Left ventricular pressures and volumes were directly measured using 7F micromanometer-
tipped admittance catheters (Transonic Scisense Inc., Ontario, Canada) inserted into the 
ventricles through the right carotid artery. Pressure waveform measurements were captured at 
the aortic arch and abdominal aorta with 7F pressure catheters (Transonic Scisense Inc., 
Ontario, Canada). Catheters for pressure waveform measurement were inserted into the aortic 
arch through the left carotid artery and into the abdominal aorta through the femoral artery, 
respectively. In addition, aortic root flow was measured using an ultrasound flow probe 
(Transonic Scisense Inc., Ontario, Canada) for Pigs 7 and 8. All cardiovascular and respiratory 
data were sampled at 250 Hz. 
3.2.2 Hemodynamic Modification 
During the experiments, each pig underwent several step-wise positive end Expiratory pressure 
(PEEP) recruitment manoeuvres (RM). Increases in PEEP reduce systemic venous return to 
the right heart and increase pulmonary resistance. As a consequence, left ventricular preload 
decreases, causing a reduction in SV (Luecke and Pelosi, 2005). RM induced SV variations are 
similar to those made by volume expansion; as both of them modify SV as a result of changes 
in preload.  
Each RM involved increasing PEEP with 5 cmH2O steps to a maximum of (20-25) cmH2O 
then reducing PEEP back to the original level in a step-wise manner for Pigs 1-6, and sudden 
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drop from maximum PEEP to original PEEP for Pigs 7 and 8. An example of the relationship 
between SV and PEEP from one of the RM period are shown in Figure 3.1, where SV was 
measured directly by the left ventricle volume catheter. 
 
Figure 3.1 – Example of relationship between directly measured SV and PEEP from an 
experiment. Top Panel: Measured SV from left ventricular admittance signal. Bottom Panel: 
Measured airway pressure from mechanical ventilator. 
The experiment also included multiple administrations of fluid boluses throughout the 
experiment. However, SV changes made by fluid boluses were insignificant and did not 
produce preload changes desired, likely due to the pigs being otherwise healthy. On the other 
hand, the RMs produced significant changes in preload with noticeable effect on SV. For this 
reason, this analysis uses data from RM period only, covering a wider range of preload changes 
than those expected from volume expansion. 
The experiment also involved administering continuous dobutamine infusions to modulate 
contractility for Pigs 1 to 6. Dobutamine increases contractility of the heart and acts as a 
vasodilator (Ruffolo Jr, 1987), providing additional data for this study in modified 












































For Pigs 7 and 8, a single infusion of endotoxin (lipopolysaccharide from E. Coli, 0.5 mg/kg 
injected over 30 minutes) was administered to induce septic shock. Endotoxin causes capillary 
leak and significantly reduces the systemic resistance and afterload condition of the heart 
(Werdan, 2001). The effect provides further data to assess the relationship between PWV and 
SV in different hemodynamic conditions. 
In summary, the data set for this analysis includes two RM periods: 1) baseline period where 
pigs received no intervention (dobutamine/Endotoxin); and 2) a period where the pig’s 
condition was changed using dobutamine (Pigs 1-6) or endotoxin induced sepsis (Pigs 7-8). 
There was no baseline period for Pig 1 as dobutamine was administered at the beginning of the 
experiment due to a change in experimental protocol after the first experiment. 
3.2.3 Pulse Wave Velocity Measurements 
Pulse wave velocity can be measured by identifying the time taken for a pressure wave to travel 






=                            (3.5) 
Where ∆x is the distance travelled by the pressure wave and ∆t is the time taken for pressure 
wave to travel the distance (transit time).  
In this analysis, the PWV was obtained using experimentally measured aortic arch pressure 
and abdominal aortic pressure waveforms. The distance between the two catheters were 
measured on the body’s surface by approximating the catheter locations. This method requiring 
estimation of distance may introduce small errors in the absolute value of PWV. However, as 
the catheters did not move within a given pig during the experiment, PWV trends were 
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estimated to be unaffected. The measured distance between catheter locations were 
approximately 40cm in all pigs and this value was used as ∆x.  
Transit time was determined by locating the ‘foot’ of the systolic rise on both aortic arch and 
descending aortic pressure waveform (Millasseau et al., 2005). In this analysis, the ‘foot’ of 
the pressure was identified as the intersection of the tangent line along the maximum systolic 
pressure gradient and the horizontal line along the minimum pressure, as shown in Figure 3.2. 
 
Figure 3.2 – Example of measured aortic arch pressure (solid black line) and abdominal aortic 
pressure (dashed red line) waveforms. Dotted thin lines represent maximum systolic gradient 
and minimum pressure line for aortic (dotted black) and descending aortic pressures (dotted 
red). Solid black dots represent identified ‘foot’ of the pressure waveforms at time t1 and t2 
respectively. 
3.2.4 Signal Processing 
The raw volumetric and flow signals recorded by the admittance and ultrasound flow probe 
were filtered to remove the measurement noise. These signals contained high frequency 
components that are physiologically unrealistic. An example of the raw volumetric/flow 














Figure 3.3 – Top Panel: Raw volume signal recorded by admittance catheter. Second Panel: 
Frequency spectrum of the volume signal. Third Panel: Raw flow signal recorded by 
electromagnetic flow probe. Bottom Panel: Frequency spectrum of the flow signal. Noise can 
be seen in both of the signal as pointed out in second and third panel. 
Noise was removed by applying finite impulse response (FIR) filter. A 50th order low pass filter 
with cutoff frequency at 10 Hz, which is approximately 5 - 10 times the heart rate, were used 
based on the assumption that any changes in the signal beyond this frequency are 
unphysiological. Signals were filtered on MATLAB using the command ‘fir1’ (hamming 
window). The frequency response of the filter and filtered signals are shown in Figures 3.4 and 
3.5, respectively. 
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Figure 3.4 – Frequency response of the FIR filter used for admittance and ultrasound flow 
probe signals. 
 
Figure 3.5 – An example of FIR filtered signal (blue line). Top Panel: Filtered volume signal 
from admittance catheter. Bottom panel: Filtered flow signal from ultrasound aortic flow probe. 
Stroke volume calculated from the signals are shown in each signal. 
In the data pre-processing stage, measurements having obvious error due to equipment or 




































pressure, and left ventricular volume waveform data were split into individual heart beats for 
the analysis of beat-to-beat changes in PWV and SV. For each beat, PWV was calculated using 
Equation (3.5) with aortic and abdominal aortic pressure waveforms. SV was calculated as the 
difference between maximum and minimum left ventricular volumes from admittance signals 
for Pigs 1 - 6. For Pig 7 and 8 the SV was measured using the integral of aortic flow rate per 
beat, as shown in Figure 3.5.  
3.3 Results 
3.3.1 Investigated Physiological Range 
Table 3.1 shows the range of aortic arch pressure (Paoa), abdominal aortic pressure (Pabao), heart 
rate (HR), SV, and PWV investigated in this study. It can be seen that wide ranges of induced 
hemodynamic changes are analysed, which should provide a robust estimate of the validity of 
any relation between SV and PWV. Dobutamine increased HR significantly in all pigs and had 
a different impact on SV depending on the subject, as expected. Aortic arch and abdominal 
aortic pressure varied as might be expected with dobutamine infusion and administration of 
endotoxin. Overall, a wide, clinically and physiologically relevant range was obtained. 
There was large inter-subject variability in all physiological variables, even at baseline RM 
period, where no interventions were made. The average aortic pressures in Pig 2 were 
approximately four times larger than Pig 6 and 8. The value of PWV for Pigs 3 and 5 was 




Table 3.1 - Investigated range of physiological parameters Paoa, Pabao, SV and PWV across 
Recruitment Manoeuvre (RM) period for each pig. Data are presented as the median [5 – 95th 
percentiles]. 
Baseline RM 
Subject Paoa (mmHg) Pabao (mmHg) HR (min-1) SV (ml) PWV (ms-1) 
Pig 1 - - - - - 
Pig 2 155 [145 – 161] 168 [151 – 180] 63 [61 – 65] 32.9 [30.9 – 34.6] 5.8 [5.4 – 6.1] 
Pig 3 119 [111 – 123] 118 [109 – 123] 80 [76 – 81] 18.3 [17.0 – 19.9] 7.0 [6.7 – 7.3] 
Pig 4 118 [69 – 154] 115 [67 – 150] 93 [80 – 99] 30.1 [27.3 – 34.5] 5.6 [5.0 – 6.3] 
Pig 5 116 [104 – 125] 120 [110 – 129] 77 [70 – 82] 31.2 [26.3 – 37.7] 8.9 [8.5 – 9.2] 
Pig 6 44 [38 – 49] 48 [42 – 52] 73 [71 – 74] 27.0 [22.4 – 33.3] 3.8 [3.5 – 4.0] 
Pig 7 62 [51 – 72] 73 [60 – 82]  77[76 – 79] 56.3 [47.0 – 67.6] 5.1 [4.8 – 5.4] 
Pig 8 47 [38 – 50] 43 [35 – 46]  74[72 – 75] 23.3 [18.6 – 28.0] 5.1 [4.6 – 5.3] 
Dobutamine RM 
Subject Paoa (mmHg) Pabao (mmHg) HR (min-1) SV (ml) PWV (ms-1) 
Pig 1 79 [72 – 105] 81 [73 – 106] 136 [120 – 143] 38.0 [33.5 – 46.9] 4.7 [4.3 – 5.3] 
Pig 2 153 [124 – 170] 166 [129 – 199] 104 [90 – 108] 28.3 [24.4 – 34.3] 6.2 [5.9 – 7.0] 
Pig 3 61 [44 – 91] 60 [45 – 89] 145 [136 – 146] 19.1 [13.6 – 26.4] 5.9 [5.1 – 6.6] 
Pig 4 66 [55 – 98] 67 [55 – 99] 193 [190 – 197] 17.4 [12.7 – 24.9] 5.3 [4.8 – 5.9] 
Pig 5 104 [90 – 91] 108 [94 – 119] 100 [90 – 110] 25.3 [23.1 – 27.5] 8.9 [8.5 – 9.3] 
Pig 6 68 [50 – 91] 70 [53 – 94] 144 [141 – 151] 24.0 [18.4 – 27.0] 5.4 [4.8 – 6.1] 
Endotoxin RM 
Pig 7 58 [49– 64] 67 [58 – 73] 71 [69 – 73] 59.2 [50.1 – 71.9] 4.8 [4.7 – 5.0] 
Pig 8 45 [44– 46] 42 [41 – 43] 66 [65 – 67] 26.9 [25.1 – 29.2] 4.8 [4.6 – 5.0] 
 
3.3.2 Correlation of Absolute Values 
Correlation plots between absolute values of measured SV and PWV for each pig are presented 
in Figure 3.6. The analysis involved approximately 600 to 2000 heartbeats per pig and a total 
of more than 9500 heartbeats. The calculated correlation coefficients in each RM period and 
for each pig are shown in Table 3.2. 
The correlation coefficient between SV and PWV showed higher values in the dobutamine RM 
period than the baseline RM period in most pigs. This might be due to the effect of increasing 
the inotropic state of the heart and preload responsiveness inducing higher SV changes from 
PEEP changes. This additional discrepancy in the data caused by the effect of dobutamine have 





Figure 3.6 – Correlation plots between absolute value of SV and PWV for each pig. Baseline 
RM period are shown with blue dots and dobutamine/sepsis RM period are shown with red 
dots. 
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Table 3.2 – Correlation coefficient (R) between PWV and SV in each RM period and in 
individual pig. 
SV-PWV (correlation coefficient) 
Subject Baseline RM Dobutamine/Endotoxin RM  Overall  
Pig 1 - 0.86 0.86 
Pig 2 0.24 0.63 0.23 
Pig 3 0.15 0.73 0.19 
Pig 4 0.70 0.43 0.58 
Pig 5 0.25 0.46 0.18 
Pig 6 0.67 0.70 -0.11 
Pig 7 0.87 0.69 0.47 
Pig 8 0.12 0.32 0.02 
 
3.3.3 Correlation of PEEP Dependent Trend Values 
It can be seen from Figure 3.6 and Table 3.2 that the overall relationships between absolute 
values of SV and PWV were poor across the hemodynamic modifications induced by 
administration of dobutamine/sepsis. However, relatively high correlation coefficient values 
were achieved between SV and PWV when SV varied only due to RM. 
The next analysis looks at the relationship between trend values of SV changes and trend values 
of PWV induced by PEEP.  To determine the trend relationships, data from each RM were 
separately analysed by subtracting the mean value of SV and PWV from the absolute SV and 
PWV values for the RM period, yielding ‘SV – mean (SV)’ and ‘PWV – mean (PWV)’. This 
calculation removes the hemodynamic effect from dobutamine/endotoxin, and allows analysis 
of the SV and PWV relationship for SV changes due only to PEEP variations (preload). The 
correlation plots for each individual pig and all pigs combined are presented in Figures 3.7 and 
Figure 3.8, respectively. Pearson correlation coefficients (R) for each individual pig and the 





Figure 3.7 - Correlation plots between trend value ‘SV – mean SV’ and ‘PWV – mean PWV’ 
for each pig. Baseline RM period are shown with blue dots and dobutamine/sepsis RM period 
are shown with red dots. Regression line for each RM periods are also shown with 
corresponding colour. (Note: gradient of sepsis regression line for Pig 7 was same as baseline 
and very close to zero for Pig8, hence the line is not so visible). 














































PWV - mean PWV (ms
-1
)











Table 3.3 – Correlation coefficient (R) between PWV and SV for ‘SV – mean SV’ and ‘PWV 
– mean PWV’ in individual pig. Correlation coefficient represents data including both baseline 
and dobutamine/endotoxin RM. 
SV-PWV (trend relationship) 
Subject Baseline RM 
regression gradient 
Dobutamine/Endotoxin 
RM regression gradient 
 Correlation coefficient (R) 
Pig 1 - 13.85 0.86 
Pig 2 3.06 6.45 0.61 
Pig 3 1.40 6.82 0.66 
Pig 4 4.33 5.03 0.51 
Pig 5 4.87 3.46 0.31 
Pig 6 14.93 5.00 0.66 
Pig 7 32.84 33.03 0.77 
Pig 8 10.28 0.07 0.57 














Figure 3.8 – Correlation plots and regression line across all pigs for trend values ‘SV – mean 
SV’ and ‘PWV – mean PWV’. Baseline RM and dobutamine/endotoxin RM are shown with 




3.4.1 Relationship between PWV and SV 
The results from Figure 3.6 shows the effect of changes in PWV from dobutamine and 
endotoxin. Dobutamine increases the contractility of the heart, HR, and reduces the arterial 
stiffness (Ruffolo Jr, 1987). Endotoxin significantly reduces the systemic resistance via 
capillary leak and vasodilation (Merx and Weber, 2007). Figure 3.6 displays these effects as 
the relationship between the absolute value of SV and PWV are altered with the intervention, 
seen in the difference between the blue dots and the red dots. Both dobutamine and endotoxin 
modify both distensibility and flow velocity, affecting PWV through changes in the arterial 
wall properties and systemic resistance. More specifically, with changes in distensibility 
independent of changes in flow conditions due to dobutamine and endotoxin, sum of these two 
factors could give constant measured PWV even when SV is changed or vice versa. Under 
these significant influences on hemodynamic conditions, the relationships between the absolute 
value of SV and PWV were weaker than expected.     
Figure 3.7 analyses the relationship between ‘SV-mean SV’ and ‘PWV – mean PWV’ to assess  
normalized changes in SV and PWV, where SV were predominantly varied by alteration of 
preload conditions from PEEP variation (Pinsky, 1984) in the RM.  Mean values of SV and 
PWV were subtracted from the absolute value of SV and PWV in each RM period to remove 
the effect of dobutamine/endotoxin. The figure shows a clear positive relationship between SV 
and PWV, not evident in Figure 3.6.  
Table 3.3 shows good agreement between ‘SV – mean SV’ and ‘PWV – mean PWV’ with 
correlation coefficients above R=0.5 for all pigs, except for Pig 5. With only the variation in 
preload, changes in PWV from flow velocity and distensibility are thought to be both in the 
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same direction. Reduction in SV from increased PEEP decreased flow velocity, and with the 
reduction in amount of volume entering the artery, distensibility is also decreased. In such 
condition, where changes in flow condition is the main cause of changes in distensibility, and 
thus PWV, PWV correlated well with the changes in SV.  
Figure 3.8 shows correlation plots for ‘SV – mean SV’ and ‘PWV – mean PWV’ for all pigs 
combined, and the correlation coefficient was R = 0.56. Although significant variation exists 
about the regressed line, the relationship suggests that the PWV could be used to determine 
trends of SV if hemodynamic conditions were changed only due to preload, such as fluid 
replacement (Monnet and Teboul, 2013). The wide variation of slopes in Table 3.3 and Figure 
3.7 show why the variability in Figure 3.8 can be large. While relationships are stronger for 
each individual pig, it is clear that the relationship can be very different between pigs. This 
result provides the possibility of reducing the need for additionally invasive measures or 
expensive devices to help optimise fluid administration rates.  
3.4.2 The Relationship in Assessment of Preload Responsiveness 
It is common in cases of cardiovascular failure to assess patient preload responsiveness 
(Michard and Teboul, 2002). Clinical studies show that only 50% of patients with 
cardiovascular failure are fluid responsive and will benefit from volume expansion (Marik et 
al., 2009). In the case where a patient is not fluid responsive and volume expansion does not 
increase SV, the continuation of fluid therapy may result in worsening patient’s condition 
(Roch et al., 2011). Thus, an improvement to the method for estimating preload responsiveness 
would provide significant benefits to care and patient outcome. 
The assessment of preload responsiveness involves changing preload while monitoring SV 
(Mohsenin, 2015). The former can be achieved relatively easily by performing a fluid challenge, 
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passive leg raising, or changing airway pressure (Marik et al., 2010). However, evaluating the 
impact on SV from altered preload condition is very difficult due to lack of available 
information on SV. Currently, there are several methods available for monitoring SV, varying 
from non-invasive procedures such as echocardiography to highly invasive methods such as 
thermodilution (Alhashemi et al., 2011). However, all these methods require additionally 
invasive measurements and/or expensive equipment (Lavdaniti, 2008). Thus, the positive 
relationship and trend correlations found from this analysis can be used to identify SV trends 
from PWV, improving the accuracy of fluid responsiveness assessment in a minimally invasive 
and cost effective manner.      
3.4.3 Limitations  
3.4.3.1 Identifying Absolute Values of SV from the Relationship 
The inter-subject variability of arterial wall properties and varying impact on vascular 
properties from dobutamine and endotoxin prevents use of the relationship between SV and 
PWV to estimate the exact impact on SV. Figure 3.7 and Table 3.3 show consistent positive 
relationships between SV and PWV. However, the slope of the relationship between each 
subject before and after the interventions can be very different. This difference in the slope 
prevents estimation of the degree of impact on SV, specifically the amount of change in ml, if 
there are significant hemodynamic modifications. 
In addition, in the dobutamine/endotoxin modified RM period for Pig 6 and Pig 7, the 
relationships are shown to be nonlinear, making identification of the absolute value of SV from 
PWV even more difficult. This nonlinearity might be due to nonlinearity of the arterial wall 
property producing smaller or larger distensibility changes from the volumetric input into the 
artery from aorta (Langewouters et al., 1984). Another explanation is the nonlinearity of the 
Frank-Starling mechanism (Fukuda et al., 2009) producing different contractility level for a 
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given amount of SV. Different contractility would change the velocity of the blood as well as 
changing SV, and thus, producing nonlinear changes in the PWV. 
3.4.3.2 Analysed Data and Equipment 
A limitation of this study is that experiments were done on healthy pigs and pigs did not have 
valve regurgitation, aneurysm, and/or any arterial defect. Blood flow conditions in such cases 
are more complex than those examined in this study and may not follow the positive SV and 
PWV relationships identified in this analysis. Further validation and analysis must be done 
covering a wider range of cardiovascular systems and hemodynamic conditions to ensure the 
accuracy, strength and applicability of SV-PWV relationships found in this chapter.  
Another limitation of this study is that signals from the admittance catheter can be sensitive 
depending on the location within the ventricle (Wei et al., 2014). This sensitivity could produce 
errors in the measurement of absolute value of SV and may provide slightly higher or lower 
SV values from the true SV. However, for a single pig, the admittance catheter locations were 
fixed and the SV trend values were accurately captured, except for Pig 4 where the admittance 
catheter was recalibrated, relocated, and replaced during the experiment. However, the overall 
SV-PWV trend relationship identified in this chapter is still valid. In addition, SV for Pigs 7 
and 8 were measured from aortic flow probes and the relationships showed similar results 
providing additional validation of the admittance data from Pigs 1-6, and thus for the 
relationships found. 
3.5 Summary 
The relationship between SV and PWV can be drawn only when PWV increase or decrease 
reflect the changes in flow condition inside the artery generated by SV.  Inter-subject variability 
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of arterial properties will produce different PWV values for the same amount of SV, and thus, 
the value of PWV alone is unreliable for capturing the absolute value of SV. In addition, the 
changes in afterload condition induced by dobutamine/endotoxin administration produces 
PWV changes from the arterial wall, as well as flow components. Hence, when both effects are 
present, the relationship between the values of SV and PWV are weaker, and thus less useful. 
Despite its limitations, the relationships found can be used to estimate the overall trend of SV 
from measured PWV, when SV changes mainly due to changes in preload. The relationship 
could be used to support clinical decisions such as fluid replacement, where the main 
hemodynamic changes arise from preload changes. The value of PWV can be obtained from 
pressure measurements, and thus has the potential, in these titrations, to provide a non-
additionally invasive and cost effective solution for monitoring patient SV. The relationship 
identified in this chapter thus has the ability to improve current cardiac and circulatory 
treatment, especially in fluid responsiveness assessment. In addition, the relationship could be 




Chapter 4: Stroke Volume Estimation 
using Aortic Pressure Waveform 
This chapter presents a method for continuously estimating SV from the aortic pressure 
measurements using a three element Windkessel model combined with the reservoir-excess 
hypothesis proposed by Wang et al. (2003). Continuous Beat-to-beat SV is estimated using 
patient-specific Windkessel model parameters calibrated from initial measurement of SV. The 
accuracy of the method is analysed and benefits/limitations of this approach are discussed. 
4.1 Introduction 
Methods for estimating flow from arterial properties have been extensively studied to assist 
clinical diagnosis and treatment (Shi et al., 2011). More realistic and complex models 
consisting of many physiological parameters (Steinman, 2002) can simulate precise flow 
conditions within the artery. However, identification of the model parameters for these 
complex models is much more difficult, and is usually not practical with the common 
measurements available in the ICU.  
In contrast, simpler models require less information to identify model parameters. However, 
they can produce inaccurate results due to the assumptions being made and fewer number of 
model parameters available to capture the dynamics in the measured data (Westerhof et al., 
2009). For a model to be useful and practical in the ICU, the complexity of the model must be 
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adjusted according to the available clinical measurements, as well as able to capture the 
clinically relevant observed dynamics   
Aortic pressure measurements are clinically available in the ICU and converting aortic pressure 
to aortic flow allows absolute values of SV to be determined. The continuous waveform signal 
of the pressure measurements enables beat-to-beat estimation of SV, and thus, offers an 
advantage over conventional, discrete estimates of CO from indicator-dilution methods 
(Cousins and O'Donnell, 2004) or echocardiography (Slifka and Whitton, 2000). Identifying 
SV continuously provides more detailed SV dynamics, particularly in transient cases showing 
the effect of evolving patient condition and/or response to clinical interventions. 
One of the most frequently used models in relating arterial pressure to flow is the three element 
Windkessel model introduced by Westerhof et al. (2000). The model consists of characteristic 
impedance, systemic resistance, and compliance of the artery. In many current applications, 
the model parameters are calibrated using discrete estimates of CO combined with area under 
the systolic pressure curve (Rivers et al., 2001) or from physical/demographic information 
(Marik, 2013). These methods calculate characteristic impedance, which is then used to 
continuously estimate the total amount of flow within the artery.  
Despite the model having three elements, commercial devices often use characteristic 
impedance as the calibration parameter (Butlin, 2008, Metafratzi et al., 2002), and systemic 
resistance and compliance are then the model output. This approach is used because all three 
elements contribute to the shape and magnitude of the systolic pressure curve (Parker et al., 
2012), and unless the magnitude of the pressure components corresponding to each parameter 
are known, the model parameters cannot be calibrated correctly. With the analogy of three 
element Windkessel model alone, separating the pressure due to each model parameter 
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component requires extra information on vascular properties in addition to pressure, and as a 
result, the method becomes less practical in the ICU. 
The aortic model combining a three element Windkessel model and the reservoir-excess 
hypothesis proposed by Wang et al. (2003) provides the ability to decompose the aortic 
pressure waveform into two components: 1) reservoir pressure representing the energy 
stored/released by the compliance; and 2) excess pressure representing the excess amount of 
work provided by the ventricle to accelerate blood. This decomposition is done using the 
information obtained from the diastolic pressure decay curve, and does not require extra 
information in addition to the measured pressure waveform. Thus, the combined model is 
suitable for clinical use and allows parameters, such as resistance and compliance, to be 
calibrated for the beat-to-beat estimation of SV.    
This chapter analyses this combined aortic model to estimate SV from the aortic pressure 
waveform by calibrating and fixing different Windkessel parameters. First, the aortic model 
and the method involved in separating the aortic pressure waveform into reservoir and excess 
pressure are presented. Second, the equations relating SV, the reservoir/excess pressure 
component, and the Windkessel model parameters are described. Finally, the accuracy of SV 
estimated using different calibration parameters is investigated and compared to the traditional 
characteristic impedance method. Bland-Altman plots are presented for each case to assess 




4.2.1 Aortic Model 
The reservoir-excess pressure theory was used to analyse measured aortic pressure. The theory 
interprets the measured pressure as the sum of two pressure components, reservoir pressure, 
Pres, and excess pressure, Pex, as shown in Equation 4.1. 
Pao(t) = Pres(t) + Pex(t) (4.1) 
Reservoir pressure represents the pressure components generated from compliance of the artery, 
and by this definition, the time dependent reservoir pressure, Pres(t), can be expressed as a 
function of volumetric compliance, Cv (= dV/dPres), and changes in aortic compartment volume, 
(dV/dt), yielding: 
() = 	()  = 1 	 () −	"#$()%																																																																			(4.2) 
Where Qin(t) and Qout(t) are flow entering the aortic compartment from the left ventricle and 
flow leaving the aortic compartment, respectively.  
Wang et al also validated proportionality between each pressure component, flow dynamics in 
the aorta, and Windkessel model parameters (Tyberg et al., 2014, Wang et al., 2003):  
() −	'() = "#$()         (4.3) 
*() = +," ()                      (4.4) 
Where R, Zao and Pcvp are systemic resistance, aortic characteristic impedance and central 
venous pressure, respectively.  
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In this analysis, Pcvp was assumed 8mmHg for all pigs representing a typical population value 
(Westerhof et al., 2015b). In addition, central venous pressures were measured in pigs 
administered endotoxin to induce sepsis and the average measured pressure were 
approximately 8mmHg. Substituting these relationships into Equation (4.2), the differential 
equation relating Pres, Pex, and the three element Windkessel model parameters, R, Zao, Cv, can 
be written:  
() = 	*()+," 	− 	() −	'() 																																																																																											(4.5)	 
Applying the initial condition Pres(0)= Pao(0) at the beginning of a heartbeat, Equation (4.5) 
can be solved for Pres(t) over one cardiac cycle (Kamoi et al., 2014): 
() = 	 ./(012)$ 34.(012)$5$6 7,"(8) 9 :'()%8 9	,"(0)<																																				(4.6) 
Where α=1/ ZaoCv and β=1/RCv.  





Qout   Zao 
R 
C
Figure 4.1 – Electrical analogy of the aortic model used in this study. The currents represents 
the blood flow through the artery (Qin and Qout). The node voltage represents different pressure 
components (Pao, Pres, and Pcvp). The electrical components represents the Windkessel elements 
(R, Zao, and Cv). In this case, the ground/reference voltage represents atmospheric pressure. 
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4.2.2 Reservoir-Excess Separation 
The separation method involves analysing the pressure decay in the diastolic period of the 
aortic pressure waveform. In diastole, the pressure decay is assumed to result only from the 
release of energy stored by aortic compliance during systole. Thus, the measured aortic 
pressure waveform in diastole represents the reservoir pressure. This condition is defined: 
Pres(td<t<tf) = Pao(td<t<tf) (4.7) 
Where td and tf are the aortic valve closure time and total time for one cardiac cycle, respectively. 
Applying this diastolic condition to Equation (4.5) and solving the ODE for diastole, a 










))(()(  (4.8) 
In this form, the only unknown parameter in the equation is 1/RCv, which is β in Equation (4.6). 
Performing regression between the measured aortic pressure decay and pressure decay 
calculated using Equation (4.8), the parameter value for 1/RCv can be identified. Once the 
parameter value 1/RCv (or β) has been identified for a given heartbeat, this value is substituted 
into Equation (4.6) to solve Pres for the entire heartbeat.  
For the identification of 1/ZaoCv, another physiological condition was applied. At end systole 
(td), ventricular hydraulic force equals aortic reservoir force pushing against the ventricle. This 
equilibrium of force initiates aortic valve closure. Hence, maximum reservoir pressure will not 
exceed measured pressure at td. This condition is defined: 
Max(Pres) ≤ Pao(td) (4.9) 
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Using constraints in Equation (4.8) and (4.9) with the identified parameter, 1/RCv, the 
parameter value 1/ZaoCv can be identified by regression between Equation (4.6) and measured 
diastolic decay. An example of the resulting separated pressures, Pres and Pex, obtained from a 
measured aortic pressure waveform using this method is shown in Figure 4.2. 
 
Figure 4.2 – Example of separated aortic pressure waveform. Calculated reservoir pressure 
Pres (red line), excess pressure Pex (shaded grey area), and measured Pao (black line). End 
systolic point, or duration systole, td, is indicated by blue plus mark. 
 
4.2.3 Detection of End Systolic Point 
Identification of the end systolic point (ESP) illustrated in Figure 4.2, is required for reservoir-
excess separation. In this analysis, the ESP was identified as the maximum negative gradient 
point on the aortic pressure waveform (Abel, 1981). However, this condition alone was not 
enough to reliably detect ESP for typically measured aortic pressure waveforms, which can 
have multiple inflection points, and thus, multiple minima in the dP/dt waveform. An example 




Figure 4.3 – Detected minimum gradient point (blue +) and detected end systolic point using 
the modified function (red x) on a single beat pressure waveform. Top Panel: measured 
pressure waveform having multiple descending inflection points. Second Panel: pressure 
gradient dPmeasured / dt and detected global minimum, shown as blue cross. Third Panel: Weight 
function WF(t) applied to dPmeasured / dt. Bottom Panel: Modified function showing product of 




Figure 4.3 shows local and global minimum gradient points. In this specific case, the correct 
location of the ESP would be the second maximum negative gradient point in the pressure 
curve, and not the global minimum of dP/dt point. To avoid false detection of the ESP, a generic 
weight function (WF) was applied to the gradient of the pressure curve, as shown in the third 
panel of Figure 4.3, and defined: 
>?() = @0.5	 − A0.5 −	B ∗ 60 AD
E 																																																																																												(4.10) 
FG = 	HIJ @K,#L >?()D																																																																																														(4.11) 
Where HR is the heart rate, and t is time in seconds.  
This WF applies a greater weighting to points near the midpoint of the cardiac cycle and thus, 
enhances minima in the expected ESP location. This procedure is illustrated in lower two 
panels of Figure 4.3. The identified ESP using the method as illustrated in Figure 4.3 is used 
for parameter identification of 1/RCv and 1/ZaoCv. 
4.2.4 Stroke Volume Estimation 
To estimate aortic flow from the separated pressure components, Pres and Pex, one of the 
Windkessel model parameter must be calibrated or fixed using a discrete measurement of SV 
or estimated from physical characteristics. In this analysis, the first 10 beats of experimentally 
measured left-ventricular SV values for each pig were used to calculate a pig-specific value of 
R, Cv, and Zao. The calculated parameter values for each beat were then averaged. The 
calculation of these parameter values for each of the Windkessel model elements are defined: 
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RQ < 10S 																																																																										(4.12) 
 (,',M 	= 	U∑ WX	YZX[\]^XOX\[ (_̀ \a($)/_bcd)L$^O^PQ6RQ e 10f 																																																																																					(4.13) 




RQ < 10S 																																																																																							(4.14) 
The subscript cal refers to calibrated parameter. Equations (4.12) and (4.14) can be obtained 
by rearranging Equation (4.3) and (4.4), respectively, and taking the integral of the flow, which 
is SV. Equation (4.13) can be obtained by combining Equation (4.12) with the identified 
parameter 1/RCv from Equation (4.8).  
Using these calibrated parameters, three different estimations of SV can be calculated per 
heartbeat, each representing estimated SV using one of the calibration parameters above. The 
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The analysis examines the accuracy of each of SV estimates, and thus investigates if some of 
the calibration parameters perform better than the others depending on the cardiovascular 
conditions and/or clinical interventions. More specifically, is there a better or best choice of 
which of the three calibration parameters of equations (4.12) – (4.14) to use in general for given 
clinical scenarios. 
4.2.5 Traditional Characteristic Impedance Method 
The traditional method calibrates characteristic impedance using the entire (unseparated) area 
under the pressure curve (Butlin, 2008). The equation for parameter calibration with this 
method: 




RQ < 10S 																																																																													(4.18) 
In this traditional method, the entire pressure component is assumed to represent the ventricular 
flow instead of only the excess component.  The difference in interpretation of the systolic 
aortic pressure is still inconclusive (Murgo et al., 1980, Hughes et al., 2012). However, the 
theory of Wang et al allows estimation of changes in pressure components from aortic 
compliance, and provides the possibility of improving the estimation of SV. In this study, Wang 
et al work is assumed to be correct and compares the accuracy to the SV estimation with entire 
systolic pressure as a flow component. 
Given the calculated pig-specific impedance value using Equation (4.18), the traditional 














                                                                                              (4.19) 
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4.2.6 Data Analysis 
In this analysis, porcine experimental data from Chapter 3 were used, as detailed in Section 
3.2.1 and 3.2.2. However, Pig 1 and Pig 4 were excluded from the analysis because Pig 1 did 
not have baseline measurements and Pig 4 had multiple catheter disturbances/failures during 
the experiment. For all other pigs, continuous experimental data was used to estimate SV, and 
analyse its accuracy to the admittance catheter direct measurements. 
For the dobutamine pigs, the experiment involved administration of five rapid saline boluses 
of 180ml up to a total of 900ml, except for Pig 6 where a total of 720ml of saline solution was 
given. After fluid admistration, the pigs received a continuous infusion of dobutamine at a rate 
of either 2.5 or 5µg/kg/min. In Pigs 5 and 6, further administration of a 180ml rapid bolus was 
given while continuing the dobutamine infusion. 
For the induced sepsis pigs, the experiment involved slow infusion of 400ml saline solution, 
then a single infusion of endotoxin (lipopolysaccharide from E. Coli, 0.5 mg/kg) injected over 
30 minutes. For Pig 7, a further administration of 400ml saline solution were given and for Pig 
8, 400ml saline solution was given twice to total 800ml. 
For all of pigs, RM were performed between each intervention. The summary of interventions 
made for each pig is given in Table 4.1. The overall experiment ensures a wide range of 
hemodynamic conditions, and thus a wide range of SVs might be expected.  
As described in Section 3.2.1, two aortic pressure measurements were made in the porcine 
experiments, which are aortic arch and abdominal aortic pressure waveforms. In this analysis, 
a measured continuous abdominal aortic pressure waveforms, Pabao, was used for reservoir-
excess separation. The continuous waveforms were first split into individual heart beats for the 
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beat-to-beat pressure contour analysis. For each beat, a reservoir-wave separation was applied 
and each pressure components were identified. Calibration parameters were then calculated 
using Equations (4.12) – (4.14) for the aortic model and Equation (4.18) for the traditional 
method. Finally, the resulting four estimations of SV per beat are made using Equations (4.15) 
– (4.17), and (4.19). 
Table 4.1 - Summary of interventions made for each pig in the experiment. 
Pig 
No 








 180ml 360ml 540ml 720ml 900ml 2.5 5 180ml 
2      ×  × 
3      ×  × 
5     ×  ×  
6      ×   
Sepsis Pigs 
 400ml 0.5 400ml 800ml 
7    × 
8     
4.3 Results 
4.3.1 Identified Parameters and Investigated Range of Windkessel 
Parameters  
The identified parameters RCv and ZaoCv from Equation (4.6), and the number of heart beats 
analysed for each pig are presented in Table 4.2. Table 4.3 shows the range of Windkessel 
model parameters obtained for each pig by forward simulating Equations (4.15) – (4.17) and 
(4.19), and using the measured left ventricular SV value. It can be seen that vasodilatory effect 
of dobutamine decreased systemic resistance, R, in all pigs and increased aortic compliance, 
Cv, in 3 of the pigs. The characteristic impedance, Zao, derived by the traditional method and 
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by using the excess pressure approach had the same trend of decreased values for dobutamine 
and increased value for the endotoxin cases. 
Table 4.2 – Summary of identified parameters RCv, ZaoCv, and number of heart beats analysed 
for each pig. Data are presented as the median [5th – 95th percentiles]. 
Pre-dobutamine/Sepsis period 
Pig No RCv (s) ZaoCv (s) No Heart Beats 
Pig 2 2.75 [2.30 – 3.32] 0.16 [0.13 – 0.21] 1944 
Pig 3 1.22 [0.99 – 1.46] 0.10 [0.09 – 0.12] 3920 
Pig 5 1.77 [1.39 – 2.29] 0.11 [0.09 – 0.17] 2427 
Pig 6 1.11 [0.58 – 1.34] 0.21 [0.08 – 0.24] 1723 
Pig 7 1.65 [1.25 – 2.06] 0.22 [0.15 – 0.25] 762 
Pig 8 0.96 [0.82 – 1.30] 0.21 [0.18 – 0.25] 762 
Dobutamine RM 
Pig 2 2.30 [1.69 – 3.30] 0.13 [0.10 – 0.17] 1012 
Pig 3 0.89 [0.74 – 1.04] 0.12 [0.10 – 0.14] 1025 
Pig 5 1.82 [1.45 – 2.21] 0.12 [0.10 – 0.14] 630 
Pig 6 0.57 [0.40 – 0.75] 0.11 [0.06 – 0.15] 728 
Endotoxin RM 
Pig 7 1.22 [1.03 – 1.63] 0.24 [0.18 – 0.28] 663 
Pig 8 1.20 [0.95 – 1.94] 0.21 [0.15 – 0.34] 808 
 
Table 4.3 – Investigated range of Windkessel parameters R, Cv, Zao, and Zao(trad) for each pig. 
Data are presented as the median [5th – 95th percentiles]. 
Pre-dobutamine/Sepsis period 
Pig No R (mmHg.s/ml) Cv (ml/mmHg) Zao (mmHg.s/ml) Zao(trad) (mmHg.s/ml) 
Pig 2 3.87 [3.27 – 5.08] 0.70 [0.54 – 0.89] 0.24 [0.15 – 0.36] 2.08 [1.54 – 2.83] 
Pig 3 3.77 [2.70 – 5.15] 0.31 [0.24 – 0.46] 0.31 [0.22 – 0.47] 2.41 [1.53 – 3.49] 
Pig 5 2.44 [1.95 – 2.95] 0.73 [0.59 – 0.90] 0.16 [0.12 – 0.21] 2.06 [1.47 – 2.82] 
Pig 6 1.25 [1.02 – 1.51] 0.95 [0.76 – 1.17] 0.23 [0.19 – 0.28] 0.95 [0.80 – 1.15] 
Pig 7 0.67 [0.55 – 0.78] 2.39 [1.90 – 2.83] 0.09 [0.07 – 0.10] 0.43 [0.38 – 0.49] 
Pig 8 0.89 [0.79 – 1.27] 1.11 [0.93 – 1.34] 0.19 [0.17 – 0.24] 0.74 [0.68 – 1.08] 
Dobutamine RM 
Pig 2 3.03 [2.56 – 4.63] 0.72 [0.48 – 1.06] 0.16 [0.13 – 0.34] 1.52 [1.24 – 2.83] 
Pig 3 1.25 [1.53 – 3.49] 0.72 [0.48 – 0.97] 0.17 [0.12 – 0.22] 0.86 [0.70 – 1.26] 
Pig 5 2.06 [1.47 – 2.82] 0.87 [0.52 – 1.34] 0.13 [0.09 – 0.21] 1.15 [0.74 – 1.71] 
Pig 6 0.95 [0.79 – 1.25] 0.62 [0.47 – 0.78] 0.18 [0.10 – 0.26] 0.95 [0.70 – 1.42] 
Endotoxin RM 
Pig 7 0.64 [0.56 – 0.74] 1.82 [1.63 – 2.20] 0.13 [0.11 – 0.15] 0.52 [0.47 – 0.58] 




4.3.2 Calibrated Parameter Values 
Table 4.4 shows the pig-specific calibrated parameters calculated from Equations (4.12) – 
(4.14) and (4.18), using the first 10 measured SV values. It can be seen that calibrated 
parameters varied widely between subjects, for all of the parameters. This inter-subject 
variability suggests that using a generic population and/or demographic value could produce 
large errors in the estimation of SV for any specific subject, although relative trends might be 
unaffected. 
Table 4.4 – Calibrated parameters R, Cv, Zao, and Zao(trad) used for the estimation of SV in each 
pig. 
Pig No R (mmHg.s/ml) Cv (ml/mmHg) Zao (mmHg.s/ml) Zao(trad) (mmHg.s/ml) 
Pig 2 3.32 0.67 0.28 2.02 
Pig 3 2.82 0.31 0.30 1.99 
Pig 5 1.66 0.78 0.17 1.06 
Pig 6 1.02 1.01 0.21 0.85 
Pig 7 0.55 2.39 0.08 0.38 
Pig 8 0.89 1.00 0.20 0.74 
 
4.3.3 Bland-Altman Results  
The accuracy of SV estimated from Equations (4.15) – (4.17) and (4.19) using each of the 
calibrated parameters in Table 4.4 were analysed with Bland-Altman plots. Figure 4.4 displays 
four Bland-Altman plots for each pig showing the accuracy of each calibration method. 
Summary results showing the bias, and the 95% interval, as well as the average 95% range for 
all pigs are presented in Table 4.5. It is clear that there are significant differences in error for 
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Figure 4.4 – Bland Altman plots showing agreement between measured and estimated SV for different calibration parameter. Pre-
dobutamine/sepsis periods are shown with blue dots, and Post-dobutamine/endotoxin are shown with red dots. black dashed line showing the bias 



















































































Table 4.5 – Summary of Bland-Altman analysis showing bias, 95% interval, and average 95% 
range for each parameter. Data are presented as the bias [2.5-97.5th percentiles]. The calibration 
parameter having the best 95% range accuracy is shown in red. 
 Calibration Parameter (ml) 
Pig No R (mmHg.s/ml) Cv (ml/mmHg) Zao (mmHg.s/ml) Zao(trad) (mmHg.s/ml) 
Pig 2 -4.8[-16.2 – 5.7] -1.3[-13.2 – 10.6] 6.6[-9.6 – 16.5] 2.0[-11.5 – 11.0] 
Pig 3 -5.5[-13.1 – 13.1] 0.5[-5.5 – 13.4] 1.0[-8.7 – 11.4] -1.8[-11.1 – 13.9] 
Pig 5 -13.5[-22.9 – 0.9] -1.8[-11.2 – 10.2] 1.6[-10.5 – 10.7] -6.8[-19.3 – 6.0] 
Pig 6 -5.9[-14.5 – 1.4] -14.7[-37.7 – 0.6] -0.3[-8.0 – 11.2] 0.0[-8.5 – 6.5] 
Pig 7 -14.6[-26.4 – 3.3] -14.8[-35.0 – 11.8] -14.7[-46.9 – 10.4] -15.9[-30.9 – 0.0] 
Pig 8 -7.3[-12.1 – 0.5] -1.6[-8.7 – 5.9] -0.1[-6.0 – 3.5] -4.6[-10.7 – 1.9] 
 Average 95% range (ml) 
 20.60 27.31 25.55 21.89 
 
4.3.4 Effect of Dobutamine and Sepsis on Aortic Pressure  
The Bland-Altman analysis showed different accuracy for each of the calibration parameters. 
However, the optimal calibration parameter needs to be selected from clinically available 
surrogates.  To analyse the relationship between the optimal parameter and observable data, 
changes in identified parameters RCv, ZaoCv, and lower abdominal pressure, Pabao, from 
dobutamine/sepsis are shown in Table 4.6. The relative changes were calculated by mean (pre-
dobutamine/endotoxin) minus mean (post-dobutamine/endotoxin) divided by mean (pre-
dobutamine/endotoxin). 
Table 4.6 – Effect of dobutamine and sepsis on clinical measurements. Relative change in Pabao, 
RCv, and ZaoCv are shown. 
Pig No ∆Pabao (mmHg) ∆RCv (s) ∆ZaoCv (s) 
Pig 2 -0.01  -0.16 -0.18 
Pig 3 -0.49 -0.26 0.19 
Pig 5 -0.10 0.02 0.06 
Pig 6  0.46 -0.48 -0.48 
Pig 7 -0.08 -0.26 0.10 




4.4.1 Accuracy of Different Calibration Parameter 
Table 4.5 and Figure 4.4 show optimal calibration parameters for estimating SV can be 
different for each pig. Pigs 2 and 7 had the best accuracy with R, Pig 3 was with Cv, Pigs 5 and 
8 were Zao, and Pig 6 was best with the traditional method. This variability is due to dobutamine 
and endotoxin having different effects for each pig, even while the overall effect was broadly 
the same. Such inter-subject variability in response to care and/or dysfunction is typical. 
As can be seen in Table 4.2, the degree of changes in Windkessel parameters depends on the 
individual response to intervention. The calibration parameter having the least changes 
produced greater accuracy for SV estimation. Overall, calibrating R with reservoir pressure 
showed the best overall 95% range accuracy, as R was the most stable parameter compared to 
other Windkessel parameters within these data. 
Table 4.6 shows the impact on the abdominal pressure waveform and its characteristics, Pabao, 
RCv, and ZaoCv, from dobutamine and endotoxin. The changes in Windkessel parameter values 
cannot be identified without SV, and thus, optimal calibration parameters must be selected 
from observable data. Pigs having relatively low changes in Pabao before and after 
dobutamine/endotoxin had better accuracy calibrating with R or Zao. Within the pigs having 
low Pabao changes, calibrating R had higher accuracy when Pabao and RCv had the same trend, 
and Zao when relative changes in ZaoCv was low. Pigs 3 and 6 having large variations in Pabao 
showed better results with compliance and traditional method, respectively.  
There were potential relationships between measurable parameters Pabao, RCv, ZaoCv, and 
optimal calibration parameters. However, data from six pigs was not enough to identify strong 
patterns, and the physiological reasons behind these relations cannot be revealed until the 
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tendency shown in Tables 4.5 and 4.6 can be confirmed with larger sets of data. Further 
investigation is thus required to identify the relationships between different aortic pressure 
contours and stability of Windkessel parameters. 
4.4.2 Comparison with the Traditional Method 
Bland-Altman analysis in Figure 4.4 showed SV estimation from aortic pressure waveform can 
be improved using the method described in this chapter. Five out of six pigs had higher 
accuracy than the traditional method. However, when sub-optimal parameters were chosen, 
accuracy can be significantly worse as it can be seen in Pig 6 using Cv and Pig 7 using Zao and 
Cv. 
The traditional method of analysing the entire systolic pressure may work better under normal 
homeostasis. All three Windkessel model parameters contribute to the shape of systolic 
pressure curve, and baroreceptor regulation changes these parameters to maintain mean arterial 
pressure (Kougias et al., 2010). In such cases, SV stays relatively constant with the combination 
of parameter changes, and fixing one of the Windkessel parameter worsens the accuracy of SV 
estimation. On the other hand, errors are minimised when using one variable to represent the 
entire systolic pressure. 
In the ICU, patients suffer from a diverse range of cardiovascular dysfunctions (Goldhaber and 
Elliott, 2003a, Goldhaber and Elliott, 2003b, Gowda et al., 2008, Landgarten et al., 2000), and 
abnormal homeostasis (Thames et al., 1993, La Rovere et al., 2008), all of which can vary 
significantly over time. Patient-specific arterial properties are constantly fluctuating from these 
conditions, and by providing a method that can be adjusted according to the given conditions, 
the approach presented can adopt and provide better results. The method can also be improved 
by combining known mechanisms of action of drugs used (Overgaard and Dzavik, 2008, 
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Scholz, 1984) via a pharmacokinetics/dynamics model, and/or the known impact on vascular 
properties from various dysfunctions (Bonate and Steimer, 2006).  
The SV estimation method described in this chapter requires further analysis detailing the 
identification method for optimal calibration. Although the R calibration showed the best 
overall accuracy, the result may change with more data and thus conclusions cannot be drawn 
with the current data. However, the method shows the possibility and means of improving the 
accuracy of SV estimation and enhances the current understanding of arterial mechanics. 
4.4.3 Limitations 
The clinical applicability of the presented method is limited to patients having aortic pressure 
measurements. In most cases, radial arterial catheters are used for ICU patients requiring 
continuous blood pressure monitoring and aortic catheters are rarely used. However, arterial 
catheterization sites are determined by the perceived risk-to-benefit ratio. Thus, increasing the 
benefit from using aortic pressure waveforms may reverse this trend, turning potential risk into 
benefits (Cousins and O'Donnell, 2004). Additionally, models for estimating aortic pressure 
from radial arterial pressure may be developed in future, which would enhance the clinical 
applicability of this approach.  
Another limitation is the inability of the method to capture Windkessel model parameter 
dynamics. Information on systemic resistance, compliance, and impedance are clinically 
important for diagnosis and treatment. Alterations in these parameters help clinicians unmask 
hidden dynamics and interactions in evolving patient condition (Dart and Kingwell, 2001). 
Despite its usefulness, the aortic model is structurally non-identifiable without the value of SV, 
and consequently, all of the model parameters cannot be uniquely identified using information 
from single pressure waveform alone, which led to the fixed calibration parameter approach 
78 
 
presented. To overcome this limitation, an extended aortic model is conceptualized and 
validated in Chapter 5.   
4.5 Summary 
The aortic model and reservoir-excess pressure separation method presented in this chapter 
allowed systemic resistance R and compliance Cv in the three element Windkessel to be 
calibrated for the estimation of SV using aortic pressure waveform. The method showed higher 
SV estimation accuracy can be achieved compared to the traditional method when optimal 
calibration parameters can be used. In addition, information from clinical data could potentially 
be used to identify the optimal calibration parameter for a specific condition, but with the 
limited number of pigs analysed, the strength of the relation could not be assessed in this study.  
The presented method needs to be improved with more clinical data, covering various 
cardiovascular conditions. With larger data sets, a robust identification method can be formed 
for optimizing calibration. Thus, the model has the potential for improving SV monitoring 
system and diagnosis/treatment of cardiovascular dysfunctions in the ICU.
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Chapter 5: Stroke Volume Estimation 
using Aortic Pressure Waveform and Pulse 
Wave Velocity 
This chapter extends the aortic model presented in Chapter 4 by incorporating PWV 
measurement to improve continuous SV estimation. The subject-specific aortic dimension is 
calibrated instead of initially calibrating and fixing one of the Windkessel model parameters. 
This approach enables changes in systemic resistance, aortic compliance, and impedance to be 
determined. The water-hammer equation, with a physiological relationship identified between 
ventricular ejection time and aortic area, is used to calculate beat-to-beat characteristic 
impedance. Continuous SV is then estimated using the identified value of characteristic 
impedance with the excess component of the aortic pressure waveform. The accuracy of 
identified physiological parameters and estimated SV values are analysed, in comparison to 
directly measured values. 
5.1 Introduction 
The aortic model presented in Chapter 4 calibrates and fixes one of three specific Windkessel 
model parameter values to estimate SV. This approach prevents changes in one of systemic 
resistance, aortic compliance, and impedance from being captured. However, as seen in 
Chapter 4, all three parameters are clinically important and equally necessary to minimize the 
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SV estimation error. In particular, in the ICU, changes in the hemodynamic state are expected 
and assuming constant hemodynamic parameters may not be suitable for patients undergoing 
significant physiological changes (Bein et al., 2007, Bendjelid, 2009). Inaccurate surrogate 
measures of SV and/or its trends in response to care and condition could lead to misdiagnosis, 
incorrect clinical treatment/decisions, and/or misinterpretation of patient response to therapy. 
Therefore, there is a need for accurate and robust methods of estimating SV that are reliable, 
even when hemodynamic properties are evolving rapidly. 
This chapter presents a method for estimating dynamic Windkessel parameter values using 
measurements of aortic pressure and PWV, thus eliminating the limitation of requiring a 
constant Windkessel model parameter in Chapter 4. The value of PWV and calibrated aortic 
dimension are used to identify beat-to-beat aortic characteristic impedance with the water-
hammer equation. The identified time-varying impedance value is then used to estimate SV 
with the excess pressure component. The distinct difference between this approach and the 
method used in many commercial SV monitors (Gödje et al., 2002, Porhomayon et al., 2012b) 
is that PWV measurements are used to improve the capacity of pressure contour analysis. 
Pressure contour analysis has traditionally been purely based on the geometry of the pressure 
waveform alone (Esper and Pinsky, 2014). Consequently, the weaknesses associated with 
monitoring SV were always found during hemodynamic instability (Camporota and Beale, 
2010). However, it is hemodynamic instability that is the exact point where monitoring SV 
becomes essential to patients.  
To overcome the limited information available solely from pressure measurements, the method 
presented in this chapter couples pressure and PWV measurements to improve the analysis of 
the circulatory system. To investigate the accuracy of the method, Bland-Altman analyses are 
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performed between measured and estimated SV. In addition, correlation coefficients between 
identified Windkessel model parameter values and calculated parameter values using measured 
SV values are analysed to assess trend accuracy. 
5.2 Method 
Porcine experimental data from Chapter 4 was used for this analysis. A measured continuous 
abdominal pressure waveform, Pabao, was used as aortic pressure, and first split into individual 
heart beats for beat-to-beat pressure contour analysis. For each beat, a reservoir-excess 
separation was applied with the new parameter identification method utilising the PWV 
measurement. Aortic characteristic impedance was then calculated by solving the water-
hammer equation. Finally, the excess component of the pressure is used with this calculated 
value of aortic characteristic impedance to estimate beat-to-beat SV. 
5.2.1 Extended Aortic Model   
With the additional information from PWV measurements, the ODE described in Chapter 4 
(Equation 4.5) can be rearranged to include aortic compartment length. The ODE for the 
combined reservoir-excess and three element aortic model is defined: 
() = 	*()+," 	− 	() −	'() 																																																																																											(5.1)	 
Equation (5.1) can be modified using Equation (3.2), derived by Bramwell-Hill, and the water-
hammer equation by relating PWV and ZaoCv (Hughes and Parker, 2009). Aortic volumetric 
compliance, Cv, can be written in the form, Cv=CALao, and thus distensibility is written, D = 
CA/Aao, where CA, Lao, and Aao are compliance per unit length of aorta, aortic length, and aortic 
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cross-sectional area, respectively. The Bramwell-Hill and water-hammer equations can then be 
combined to give: 
ghHi.jj − BIjj:			>E = 	 l,"mn 																																																																																																(5.2) 
 	
ih. − ℎhHH.:		> =	+,"l,"m 																																																																																											 (5.3) 
>	," =	 1+," 																																																																																																																																			(5.4) 
Both the Bramwell-Hill and the water hammer equations are derived from conservation of 
momentum for flow within an elastic tube (Butlin, 2008). The equations are derived by 
assuming insignificant change in cross-sectional area and without any reflection of the 
propagating wave. These assumptions may not be true for aorta as cross-sectional area can be 
changed to accommodate approximately 50% of SV (Metafratzi et al., 2002), and aortic 
impedance can vary as the wave propagate away from the ventricle with aorta gradually 
stiffening (Westerhof et al., 2015b). However, obtaining continuous information on changes in 
aortic cross-sectional area and the reflected wave are clinically difficult. Thus, given the 
limitations on clinically available metrics, the relationships given by the Bramwell-Hill and the 
water hammer equations are assumed to be valid for aorta in this work. The relationship given 
in Equation (5.4) can be substituted into Equation (5.1) where the ODE can now be rewritten 
as: 
() = 	>	," *() 	− 	() −	'() 																																																																													(5.5)	 
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The differential equation now includes the value of PWV which can be used to identify the 
subject-specific aortic characteristic length instead of, ZaoCv. This allows a more accurate 
estimation of relative changes in reservoir pressure as aortic length is a constant physical 
parameter. Solving Equation (5.4) with the initial condition of, Pres(0)= Pao(0), at the beginning 
of a heartbeat yields: 
() = 	 ./(012)$ 34.(012)$5$6 7,"(8) 9 :'()%8 9	,"(0)<																																				(5.6) 
Where, α = PWV/Lao, and β = 1/RCv, respectively. 
5.2.2 Parameter Identification 
Parameter values, Lao and β, were identified from the measured pressure waveform, Pao. The 
diastolic condition given in Equation (4.7) with the value of PWV were used to identify both 
parameters. By performing a grid search for, Lao and β, the discrepancy between Equation (5.6) 
and measured diastolic pressure decay was minimized. An example of the error surface 
produced from a grid search for a single beat is shown in Figure 5.1. 
 
Figure 5.1 – Error surface showing the discrepancy between diastolic Pabao(td<t<tf) and 
calculated Pres with Equation (5.5) using different values of Lao and β. The red line represents 
optimal parameter Lao for a given β. 
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It can be seen in Figure 5.1 that the surface is convex so an optimal value of Lao could be 
identified for each value of β. To identify the most suitable set of parameters, Lao and β, from 
the sets of optimal parameters identified by grid search, further weights were added to the ESP 
to improve practical identifiability (Pironet et al., 2016). The constraints given in Equation 
(4.9) were modified to suit parameter identification for Equation (5.6). At ESP and the aortic 
valve closure time, the blood flow entering the aorta from the ventricle is zero, and 
consequently, the excess pressure at this point must be zero. Implementing this condition, the 
discrepancy between calculated end systolic pressure using the identified optimal sets of 
parameters, and measured end systolic pressure were minimized to select an optimal set of 
parameters, Lao and β, for a given pressure waveform. An example error curve for this 
optimization process is shown in Figure 5.2 
 
Figure 5.2 – The error curve showing the discrepancy between Pabao at ESP and calculated Pres 
at ESP using optimal sets of Lao and β identified by grid search. The red circle shows the 
identified optimal parameter Lao for a given pressure waveform. 
The parameter identification process described above was used for the first 10 beats of the 
experiment for each pig. Once 10 values of Lao were identified for each pig, the values were 
averaged to give a representative Lao for each pig over the rest of the experiment. Lao was held 




















Using this fixed, subject-specific representative value of Lao, β was optimized using the 
condition defined in Equation (4.7) for each heart beat and pressure waveform. The calculated 
Pres for each pressure waveform were then used to determine Pex and, subsequently, used to 
calculate aortic flow and SV. 
5.2.3 Aortic Characteristic Impedance Estimation 
5.2.3.1 Calibration of Aortic Area 
For this analysis, the first 10 beats of measured left ventricular SV values from the admittance 
catheter were used to calibrate Aao for each pig. Identified Pex and measured, SV =   $[6 , 
were substituted into Equation (4.4) to calculate Zao. Using these Zao values, Aao were 
determined from Equation (5.4) using a measured value of PWV. In this analysis the density 
of blood was assumed constant at 1050 kg/m3 (Trudnowski and Rico, 1974). The average value 
of Aao for the first 10 beats was used as a subject-specific representative value and to estimate 
aortic characteristic impedance, Zao, for the rest of the experiment. 
5.2.3.2 Relationship between Model derived Aortic Area and Ejection Time 
A previous study identified a relationship between ejection time and PWV (Salvi et al., 2013). 
It showed PWV, influenced by variation in ejection time, may provide inaccurate 
representation of aortic distensibility. Consequently, the changes in aortic characteristic 
impedance, Zao, calculated using PWV and Aao from Equation (5.3) can be effected by this 
factor. To minimize the error in PWV from changes in ejection time, the relationship between 
model derived aortic area, Aao, and ejection time were examined. 
To capture the effect of ejection time on PWV over the course of an experiment, the 
relationship between Aao calculated from Equation (5.3) using the measured SV and ventricular 
ejection time identified from the pressure waveform were analysed. The duration of systole is 
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used as the ejection time in this analysis. Figure 5.3 shows the regression line minimizing the 
geometric mean deviation between relative changes in Aao and the inverse of ejection time for 
all pigs as a percentage change in relation to initial part of the experiment. Regression using 
geometric mean deviation was applied as both parameters were expected to have measurement 
error (Brace, 1977). 
 
Figure 5.3 – Correlation plot showing relationship between relative change in aortic area, Aao, 
and inverse of ejection time. 
The relationship revealed a positive linear correlation between model derived aortic area, Aao, 
and the inverse of ejection time. Assuming Aao is a relatively constant physiological parameter, 
the effect of inverse of ejection time on aortic area, Aao, showed a nearly 1:1 ratio. This 
relationship was applied to calibrate Aao to identify more accurate values of Zao, yielding. 
l,"l,",6 = 	Fp.IqJ	rIH.6Fp.IqJ	rIH. 																																																																																																														(5.7) 



















Where the subscript zero refers to the calibrated value. The calculated aortic characteristic 
impedance, Zao, from Equation (5.8) and Pex from Equations (4.1) and (5.6) were then used to 
estimate SV. 
5.2.3 Stroke Volume and Windkessel Parameter Estimation 
The identified value of Zao from Equation (5.4) and Pex from the measured pressure waveform 
can now be used to estimate beat-to-beat SV for the entire experiment.  




The benefit of the method described in this chapter is that changes in aortic model parameters 
can also be tracked. The identified parameters RCv and ZaoCv for each heart beat combined with 
the estimated values of aortic characteristic impedance from Equation (5.4) allow all model 
parameters to be determined on a beat-to-beat basis. Aortic compliance was identified by, 
Cv=ZaoCv/Zao, and resistance was identified by, R= RCv/Cv.  
The aortic model can now reveal main cardiovascular dynamics responsible for changes seen 
in aortic blood pressure measurements. This ability is very important for correct diagnosis and 
optimizing treatment. Monitoring of the model outputs allow precise titration of fluid, inotropes, 
and vasoactive drugs by providing ‘direct’ physiological response. 
The estimated SV is compared against directly measured SV from the admittance catheter using 
Bland-Altman plots. In addition, the estimated parameter values were compared against 
calculated values from Equations (4.12) – (4.14) using the measured SV. A schematic of 
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Figure 5.4 - Schematic of SV 
estimation processes showing key 
steps involved in the pressure 
contour method. The equations used 
and corresponding equation number 
is presented 





The identified values of Lao and Aao,0 for each pig are shown in Table 5.1. Table 5.2 summarizes 
the correlation coefficients (R) between estimated Windkessel model parameters and those 
directly calculated using the measured SV value, analysing trend accuracy. Bland-Altman plots 
comparing SV estimated using Equation (5.9) and SV measured from the admittance catheter 
are presented in Figure 5.4. The summary of bias, the 95% interval, and precision accuracy 
calculated as 95% range divided by mean SV for each pig are shown in Table 5.3. In addition, 
time series showing measured and estimated SV in the last RM period, the most distant point 
from calibration and thus a potential worst case, for each pig, are shown in Figure 5.5.  
 
Table 5.1 – Summary of identified parameters, Lao and Aao,0, for all pigs. 
 Pig 2 Pig 3 Pig 5 Pig 6 Pig 7 Pig 8 
Lao (m) 0.88 0.41 0.89 0.91 0.73 0.68 
Aao,0 (mm^2) 201 269 473 163 436 207 
 
Table 5.2 – Summary correlation coefficients (R) between estimated and directly calculated 
Windkessel model parameters. 
Pig No R (mmHg.s/ml) Cv (ml/mmHg) Zao (mmHg.s/ml) 
Pig 2 0.54 0.74 0.62 
Pig 3 0.95 0.93 0.91 
Pig 5 0.76 0.81 0.70 
Pig 6 0.76 0.65 0.51 
Pig 7 0.17 0.58 0.58 



























































































Table 5.3 – Summary of Bland-Altman analysis for each pig. Data are presented as bias [95th percent interval]. 
Pig No Bland-Altman results (ml) Precision (%) 
Pig 2 -6.8 [-17.7 – 2.2] +27, -34 
Pig 3 1.7 [-1.3 – 4.9] +21, -18 
Pig 5 -3.3 [-9.2 – 2.2]  +22, -23 
Pig 6 -2.7 [-11.4 – 3.9] +22, -31 
Pig 7 -8.5 [-22.4 – 13.2] +33, -21 
Pig 8 -0.0 [-2.7 – 6.7] +33, -14 
Figure 5.5 - Bland Altman plots showing agreements between measured and estimated SV for each pig. Pre-dobutamine/sepsis periods are shown 
with blue dots, and post-dobutamine/endotoxin are shown with red dots. Black dashed line showing the bias, 95th percent interval and right panel 























































































































































































Figure 5.6 – Time series plot 
showing measured and estimated 
SV in the last RM period of the 
experiment for each pig. Top 
Panel: Measured SV from 
admittance catheter (black line) 
and estimated SV using equation 
(13) (red line). Bottom Panel: 
simultaneously measured airway 
pressure showing PEEP changes 
during recruitment manoeuvers 




5.4.1 Accuracy of Windkessel Parameters and SV estimation 
The correlation coefficients shown in Table 5.2 represent the similarity of estimated and 
calculated Windkessel parameter trends using direct SV measurement. The results showed all 
Windkessel parameters can be captured accurately with correlation coefficients above R=0.5 
for all pigs except for systemic resistance, R, in Pig 7. The ability of the method to capture 
aortic characteristic impedance, systemic resistance, and compliance provides great potential 
for not only monitoring SV, but capturing the underlying physiological change that caused 
modification in SV, and thus, improving treatment decisions in critical care. 
The Bland-Altman results in Figure 5.5 and Table 5.3 demonstrate the capability of the method 
to capture the absolute value of SV. Despite all the significant hemodynamic changes made by 
dobutamine and endotoxin, the 95% range was within approximately ±30% for all pigs. Thus, 
these results demonstrate that this method is capable of estimating clinically acceptable 
absolute SV values according to criteria from Critchely and Critchely (1999). 
Trends in response to care and condition may be more important, clinically. The ability of the 
method to capture SV trends is shown in Figure 5.6. The figure shows the last RM period of 
the experiment where one would expect to find the largest difference in the hemodynamic 
conditions as it is furthest in time and condition from any calibration.  It can be seen that PEEP 
induced SV trends were correctly captured in most cases. The method was able to capture both 
‘affected’ and ‘unaffected’ (Pig 3) cases, which has clinical importance in preload assessment 
(Monnet and Teboul, 2013). In addition, SV variability induced from individual breath 
(Shekerdemian and Bohn, 1999) was correctly captured. 
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It can be noted that the method over-estimated the trend for Pig 6, had a large off-set for Pig 7, 
and made incorrect estimation for Pig 2 during PEEP reduction. Pig 6 had an extremely low 
blood pressure, of approximately 45 mmHg at the beginning of the experiment, where the 
method was calibrated and had the biggest change, almost a twofold increase, in the mean 
pressure during the experiment, which can be seen in Table 3.1. In such a case, the method was 
not able to capture the dramatic change in aortic dimension, and thus, deviated from true SV 
value. In Pig 7, the changes in SV from PEEP were accurately captured. However, the 
significant increases in aortic characteristic impedance from endotoxin were incorrectly 
captured. In this case, SV was reduced with the introduction of endotoxin with little 
modification to PWV or ejection time. This effect produced little to no change in model derived 
aortic characteristic impedance, and consequently, created the SV off-set seen in Figure 5.6. 
The error seen in Pig 2 during PEEP reduction was not able to be resolved as the value of 
measured SV remained at a reduced value, while all physiological parameters returned to pre-
RM values. A possible reason for this could be that the SV reduction cause by PEEP changes 
shifted the location of admittance catheter within the ventricle, resulting in measurement error 
of SV. Despite these errors and offsets, the overall SV trends were captured in most of the RM 
period. 
The method described in this chapter still requires improvement in accurately estimating the 
aortic characteristic impedance to minimise some of the errors in these results. Further 
investigations are necessary to determine the sources of error, and thus, appropriate corrections 
can be made to the model. Despite these limitations, the model presented in this chapter showed 
significant improvement compared to the Bland-Altman result shown in Figure 4.4, especially 
in Pigs 3, 5, and 8. In addition, the method overcame the inability to capture time-varying 




5.4.2 Pressure Contour Analysis 
There are several methods currently available for estimating continuous SV by pressure 
contour analysis (Montenij et al., 2011). In general, Windkessel models are used and 
parameters involved in the model are identified from the single pressure waveform and/or 
patients’ demographic/physical characteristics (Thiele and Durieux, 2011). The significant 
improvement of the method presented over conventional methods is that PWV measurements 
are integrated into pressure contour analysis to accurately capture the dynamics of time-varying 
model parameters, which are needed to obtain SV more reliably. 
PWV measurements are related to arterial distensibility (Bramwell and Hill, 1922) and relative 
changes within a subject provide additional information on the cause of changes in the 
characteristics of the pressure waveform. A combination of changes in the value of PWV and 
changes in the shape of diastolic pressure decay for a given aortic dimension gives a better 
approximation of the time-varying arterial reservoir function. The reservoir pressure waveform 
estimates the minimum pressure that ventricle must provide to induce flow in to the artery 
(Parker et al., 2012) and is closely related to arterial impedance (Milnor, 1975). By assigning 
the correct components of the pressure waveform to each of the Windkessel parameters, and 
with added data inputs, the method is capable of capturing accurate physiological conditions 
and their changes. 
5.4.3 Estimation of Aortic Dimension 
In this work, the aortic dimension was estimated by assuming the aorta behaved as a simple 
cylindrical tube having uniform properties and pressure along it. In reality, the properties are 
non-uniform and each segment of aorta has different pressure contours. However, to obtain 
such a large amount of information in a clinical setting is impractical, if not impossible. These 
assumptions thus produce error in the estimation of SV, but are necessary in developing a 
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method based on clinically accessible and reasonable measurements.  In the ICU, measurement 
of aortic area could be obtained using echocardiography (Robson et al., 1988) without 
additionally invasive procedures, and its value could be used to calibrate the model without SV 
measurements.  
The identified values of Lao and calibrated values of Aao,0 for each pig are shown in Table 5.1. 
These values represent an estimate of aortic dimensions for a given value of pressure contour 
and PWV. It is largely affected by the absolute value of PWV and SV values used to calibrate 
the method. Since even the reference values are expected to have error of approximately ±20% 
(Peyton and Chong, 2010), the identified values of aortic dimension may not be entirely 
realistic. However, given the large errors of reference values, the resulting values are of use, as 
are the resulting SV values. 
The important part of this calibration is to give an estimate of the dimension under given 
conditions and to use the relative changes in the measurements to track the trends of 
hemodynamic parameters. In a clinical environment, the absolute value of SV is often not of 
great importance. However, the relative changes in SV for different patient conditions and in 
response to therapy is of major clinical significance (Marik, 2013). From this point of view, 
the method has shown the ability to sufficiently track the trends of SV (Fig 5.6) under the 
assumptions made. 
5.4.4 Relationship between Model Derived Aortic Area and Ejection Time 
The identified relationship shown in Figure 5.3 uses Aao derived from Equation (5.2) with aortic 
characteristic impedance calculated using the measured value of SV. In the experiment, true 
aortic diameter was not measured and consequently, the exact rationale behind the relationship 
between aortic area and systolic period was not able to be determined. This limitation is due to 
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the possibility that the relationship may represent correlation between systolic periods with 
other physiological variables. 
Previous studies have identified the relationship between heart rate/ejection time and aortic 
PWV (Lantelme et al., 2002). The relationship can be explained by stiffening of the aortic wall 
due to viscoelastic properties (Salvi et al., 2013). The water hammer equation does not have 
terms to describe the energy loss due to hysteresis of the aorta, and thus could produce incorrect 
values of Zao, in turn affecting estimated SV. 
To identify the exact source of the relationship presented in Figure 5.3, accurate measurements 
of time-varying aortic area are required. Such measurements will produce a stress-strain 
relationship explaining the time-dependent mechanisms associated with arterial 
distensibility/stiffness. However, whether the relationship is due to the viscoelastic properties 
or not, the relationship was still useful in providing an accurate estimation of SV with the 
hemodynamic conditions changed by dobutamine/endotoxin, and thus, it was used for the 
method presented until better data are available in subsequent experiments. 
5.4.5 Limitations 
The experimental data used here involved highly invasive methods to obtain PWV, requiring 
two pressure measurements along the aorta, which is currently uncommon in the critical care 
environment. However, the results from this analysis demonstrates the possibilities for more 
accurate estimation of SV if PWV can be estimated by this approach or a different one. In 
addition, a specially designed double-lumen catheter having two pressure sensor (Harley et al., 
1969) could be used obtain accurate aortic PWV in a non-additionally invasive fashion, 
rendering it more clinically feasible. The aortic arch pressure measurement was used only for 
the purpose of identifying the transit time and the information from its contour was not used. 
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Therefore, this measurement can be replaced with less invasive measurements such as ECG to 
detect another pulse location (Loukogeorgakis et al., 2002). Previous studies show evidence 
for a strong relationship between invasive and non-invasive PWV measurements (Horvath et 
al., 2010), and thus the method is expected to have negligible influence from use of alternative 
PWV measurements. Chapter 8 further discusses and investigates the accuracy of estimating 
PWV using ECG measurements, improving the clinical applicability of the method. 
5.5 Summary 
The method presented in this chapter accurately estimates and tracks SV trends even when 
hemodynamic properties are significantly altered. PWV measurements, which are usually 
available in ICU or can easily be obtained in a non-additionally invasive way, were integrated 
into pressure contour analysis to overcome weaknesses associated with conventional methods 
for estimating SV. The additional information gained by PWV allowed precise estimation of 
Windkessel parameters and thus, accurate estimation of SV. The Bland-Altman plots showed 
SV error of within approximately ±30% between estimated SV and the reference SV across all 
pigs, demonstrating the clinical applicability of the method. In addition, the method requires 
only one calibration per subject offering less workload for beside clinicians and nurses. The 
method presented can track accurate and clinically important changes in patients’ 





Chapter 6: Comparison of SV Accuracy 
with PiCCO and Wesseling Models  
This chapter compares the accuracy of SV estimation between the aortic model presented in 
Chapter 5, a nonlinear three-element model developed by Wesseling et al (Wesseling et al., 
1993), and the PiCCO system from PULSION (Oren-Grinberg, 2010). Parameters involved in 
the nonlinear three-element model were identified by minimizing squared error between SV 
values from the admittance catheter/flow probe and the nonlinear model output. SV 
measurements from the PiCCO device were obtained every 12 seconds. In addition, PiCCO 
device was calibrated with thermodilution measurements in between clinical interventions. 
Accuracy of the three techniques is compared using Bland-Altman analysis and estimated SV 
trends from each techniques is discussed. 
6.1 Introduction 
There are many commercial devices available for continuously estimating SV using the 
pressure contour method (Porhomayon et al., 2012a). The most commonly used commercial 
devices are the: PiCCO system (Pulsion, Munich, Germany) (Oren-Grinberg, 2010); LiDCO 
system (LiDCO, Cambridge, UK) (Sundar and Panzica, 2010, Rhodes and Sunderland, 2005); 
and FloTrac system (Edwards Lifesciences, Irvine, CA) (Mayer et al., 2009). PiCCO and 
LiDCO both use indicator dilution measurements to calibrate the model for pressure contour 
analysis. FloTrac on the other hand uses demographic and physical characteristics of a patient 
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to identify values for the model. In general, indicator dilution calibrated systems have greater 
SV accuracy than non-calibrated systems (Hadian et al., 2010). A calibrated system has the 
advantage of correcting the model when estimated SV deviates from indicator dilution 
measurements due to hemodynamic instability or use of inotrope/vasoactive drugs, both of 
which are common in the ICU for patients with poor circulatory function.  
The accuracy of continuously estimating SV with commercial devices has been validated 
against gold standard SV measurements (Bein et al., 2004). However, previous studies show 
contradicting results, varying from good accuracy achieved (Button et al., 2007, Della Rocca 
et al., 2003) to low accuracy when hemodynamic instability is present (Camporota and Beale, 
2010, Bendjelid, 2009). For the calibrated systems, the necessity of frequent calibration during 
(unpredictable) instability suggests clinical impracticality and inaccuracy in continuously 
estimating SV from the arterial pressure waveform (Gruenewald et al., 2011). 
Another widely known pressure contour method is the nonlinear three-element model 
developed by Wesseling et al (Wesseling et al., 1993). The accuracy of the model has been 
assessed in number of papers (Jansen et al., 1990, Jansen et al., 2001, Jellema et al., 1999, 
HARMS et al., 1999) and compared against different methods (De Wilde et al., 2007). Unlike 
the PiCCO and FloTrac systems, the underlying algorithms involved in the pressure contour 
method are fully described in the paper.  
The PiCCO SV measurements were made in Pigs 5 and 6 from the dobutamine experiments 
and Pigs 7 and 8 from the endotoxin experiments. These data allow comparison of accuracy of 
SV estimation using different pressure contour methods. This chapter analyses the accuracy of 
three pressure contour methods, the: 1) PiCCO system; 2) Wesseling model; and 3) aortic 
pressure model developed in Chapter 5. They are compared to the admittance catheter/flow 
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probe direct measurements. Bland-Altman analysis between SV values estimated from three 
methods and measured SV assesses accuracy. Time-series plots demonstrate the trend accuracy 
of each method. 
6.2 Method 
6.2.1 PiCCO Measurement 
Abdominal aortic pressure measurements for the PiCCO device were made by inserting a 
catheter from the femoral artery. The catheter location for the PiCCO was adjusted so that the 
pressure value was similar to that being measured with the other catheter in the abdominal 
aortic pressure. Central venous pressure measurement for the PiCCO system was made by 
inserting a pressure catheter from the jugular vein into the superior vena cava. Saline solution 
for thermodilution calibration measurements were also injected from the central venous 
catheter. 
The PiCCO system was initially calibrated at the start of each experiment after all catheters 
had been placed. Re-calibrations of the PiCCO system were made between each of the clinical 
interventions shown in Table 4.1, ensuring optimal SV accuracy made by the PiCCO for each 
intervention. Each calibration involved administering 15ml of refrigerated saline into the 
central venous catheter and repeating the same process three times. The recorded temperature 
gradient at the abdominal aortic catheter site was used to estimate SV, thus calibrating the 
PiCCO system. 
Continuous SV data from the PiCCO system was exported in MS excel format at the end of 
each experiment. The excel array was converted for analysis using MATLAB. Time on the 
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PiCCO device and Notocord were matched at the beginning of the experiment, so that 
estimated SV from all methods can be analysed on the same time line.  
6.2.2 Nonlinear Three-Element Model by Wesseling 
6.2.2.1 Wesseling Model 
The electrical analogy of the three-element model for the Wesseling model is identical to 
Figure 4.1 without applying the reservoir-excess pressure hypothesis from Wang et al (Wang 
et al., 2003). The Wesseling model uses total systolic pressure minus end diastolic pressure 
level as a systolic area for computing aortic flow. This systolic area is defined: 




Where Pw represents the systolic pressure component used for the Wesseling model, td is the 
end systolic time, Ped is the end diastolic pressure, and Pao(t) is the measured abdominal aortic 
pressure waveform.  
The main difference between the Wesseling pressure contour method and the aortic model 
presented in Chapter 5 is in the method for determining beat-to-beat characteristic impedance. 
The value of aortic area used in the Wesseling model is identified by employing the nonlinear 
pressure dependent aortic area relationship developed by (Langewouters et al., 1984). The 
relationship is also known as the arctangent aortic model, defined: 
l() = lK,* 0.5 9 1
 arctan @ − 6Q D																																																																																		(6.2) 
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Where Aw(P) is the pressure dependent aortic area used in the Wesseling model, P is the 
pressure, and the parameters, Amax, P0 and P1 define the characteristics of the aortic area 
function, which is the shape of arctangent function. Amax is the maximum aortic cross-sectional 
area at very high pressure, P0 defines the position of the inflection point on the pressure axis, 
and P1 defines the width between the points at one-half and three-quarter amplitude. The 
parameters Amax, P0, and P1 are defined using patient age and gender. The values and linear 
equations for these relationships are summarized in Table 6.1. 
Table 6.1 – Summary of linear equations used for Amax, P0, and P1 in arctangent aortic model 
(Wesseling et al., 1993). 
Parameter F M 
Amax, cm2 4.12 5.62 
P0, mmHG 72 – 0.89.Age 76-0.89.Age 
P1, mmHG 57 – 0.44.Age 57 – 0.44.Age 
The compliance per unit length of aorta can be identified by differentiating Equation (6.2) with 
respect to pressure, (C = dA/dP). The equation for aortic compliance derived from Equation 
(6.2) is written:  
() = 	 lK,* 
Q⁄1 9  − 6Q E
																																																																																																																		(6.3) 
Where Cw(P) is the Wesseling model aortic compliance. The identified compliance and aortic 
area from Equation (6.2) and (6.3) can be used to calculate aortic characteristic impedance:  
+() = m (l(). ())⁄ 																																																																																																													(6.4) 
Where Zw(P) is the pressure dependent aortic characteristic impedance used in Wesseling 
model. In this analysis, mean systolic pressure value were used in Equations (6.2) and (6.3) to 
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calculate aortic characteristic impedance for the beat. The calculated aortic characteristic 
impedance is then used to estimate beat-to-beat SV using systolic area defined in Equation 
(6.1), yielding.  
G = +(K, )																																																																																																																															(6.5) 
Where SVw is the stroke volume estimated from Wesseling model.   
6.2.2.2 Parameter Identification for the Wesseling Model 
The information required for estimating SV using the Wesseling model are the arterial pressure 
measurements, gender, and age. However, the pressure dependent area relationships described 
in Table 6.1 were obtained using human aorta data (Langewouters et al., 1984), and thus, the 
relationship may not be suitable for use in pig data. There are similarities between human and 
porcine cardiovascular systems (Li et al., 2008), but the age and gender related cardiovascular 
changes are expected to be different. 
To overcome this unidentifiable condition for the Wesseling model when using pig data, Amax 
and age were optimized by minimizing squared error between ‘true’ aortic characteristic 
impedance calculated using measured SV and Zw, giving the best possible accuracy for the 
model in this work. The equation for P0 was modified to, P0=74-0.89*Age, taking the middle 
value of male and female. This optimization is described: 





Where Tbeat is the total number of heart beats analysed in an experiment, and Ztrue is the 
calculated aortic characteristic impedance using SV from the admittance catheter/flow probe.  
Grid searches were applied by varying Amax and age from 2cm2 to 8cm2 with 1mm2 resolution, 
and 1year to 125years with 1year resolution, respectively. The range for the grid search covers 
all of the physiological values observed in (Langewouters et al., 1984). The error surface 
obtained from grid searches are shown in Figure 6.1. The results are zoomed in to capture the 
surface around the minimum region.  
 
Figure 6.1 – Error surface produced from Amax and age grid search for each pig. Vertical axis 
on the plots represents sum of squared error between Ztrue and Zw for the entire experiment. 
The error surface for each pig showed multiple combinations of Amax and age could be chosen 
to provide similar total error in aortic characteristic impedance, as shown by blue area in Figure 
6.1. The calculated SV accuracy from any combinations of Amax and age within the blue area 
would be very similar. However, to give the best possible accuracy for the Wesseling model, 
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the Amax and age values giving the minimum error were chosen. Table 6.2 summarises the 
identified values of Amax and age for each pig. 
Table 6.2 – Identified values of Amax and age for each pig from grid search. 
Parameter Pig 5 Pig 6 Pig 7 Pig 8 
Amax,mm2 260 796 315 244 
Age,year 50 121 1 1 
The identified values in Table 6.2 were substituted in Equation (6.2) – (6.4) for beat-to-beat 
aortic characteristic impedance calculation. Using the identified aortic characteristic 
impedance with the systolic pressure area, SV was estimated from the Wesseling model using 
Equation (6.5). The estimated SV were then used for SV comparison. 
6.2.3 Data Analysis 
The estimated SV from the PiCCO system were only obtained every 12 seconds. Thus, SV 
estimated from the Wesseling model and from the aortic model of Chapter 5 were decimated 
to the same sampling frequency. For the decimation, the MATLAB function ‘decimate(fir)’ 
were used, which applies a 30th order Hamming window filter to the original waveform and 
reduces the sampling rate by a chosen factor. The decimated SV waveform from each method 
was then used to compare SV accuracy. 
6.3 Results 
The Bland-Altman plots comparing measured SV and estimated SV using the three methods 
are presented in Figure 6.2. The summary of bias, 95% interval, and the 95% range for each 
pig are shown in Table 6.3. In addition, time series showing decimated SV measurements from 
admittance catheter/flow probe and decimated SV estimated from the three different methods 
















































































































Figure 6.2 – Bland-Altman plots comparing agreement between SV from admittance 
catheter/flow probe and SV estimated from three pressure contour methods; 1) PiCCO (red 
cross), 2) Wesseling (green circle), and 3) the aortic model (blue triangle). The bias and 95th
percentile for each comparison are shown with dashed line and error distribution are shown on 
the right panel. 
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Table 6.3 – Summary of Bland-Altman analysis for each pig and each pressure contour method. 
Data are presented as bias and 95% interval, and precision are presented as 95% range divided 
by mean SV in percentage. 
The Aortic Model 
Pig No Bland-Altman results (ml) Precision (%) 
Pig 5 -5.0 [-11.9 – 1.0] +21, -25 
Pig 6 -2.4 [-11.3 – 1.5] +14, -31 
Pig 7 -8.1 [-23.1 – 11.4] +29, -22 
Pig 8 0.0 [-2.1 – 6.1] +30, -10 
PiCCO 
Pig No Bland-Altman results (ml) Precision (%) 
Pig 5 -0.5 [6.6 – 11.3] +17, -25 
Pig 6 1.8 [-1.5 – 10.8] +31, -11 
Pig 7 23.3 [10.5 – 44.4] +31, -19 
Pig 8 -1.3 [-4.5 – 2.3] +18, -16 
Wesseling Model 
Pig No Bland-Altman results (ml) Precision (%) 
Pig 5 0.2 [-6.8  – 8.7] +30, -25 
Pig 6 2.0 [-2.3 – 9.4] +26, -15 
Pig 7 1.3 [-20.7 – 17.0] +23, -32 




























































6.4.1 Accuracy of Each Method 
The Bland-Altman results from the three different pressure contour methods showed similar 
accuracy across all pigs, as shown in Figure 6.2 and Table 6.3. The accuracy calculated as the 
95% range divided by mean SV were all within ±31%, demonstrating clinically acceptable 
estimates of SV by each method (Critchley and Critchley, 1999). All of the methods were 
capable of capturing SV changes induced by the RMs. However, in some of the RM periods, 
accuracy was reduced, especially in the post-dobutamine periods. The time-series plots in 




















No Intervention Endotoxin Endotoxin + 800mlEndotoxin + 400mlFilling400
Figure 6.3 - Time series plots showing SV from admittance catheter/flow probe (measured) 
and estimated SV from three pressure contour methods 1)PiCCO (red line), 2)Wesseling (green 
line), and 3)the aortic model (blue line). Top panel shows decimated SV waveforms in RM 
period after each clinical interventions. Bottom panel shows airway pressure measured by the 
ventilator. PiCCO thermodilution calibration were made in between each clinical interventions 
(vertical black line). 
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SV estimated from the PiCCO and Wesseling model during the dobutamine RM period in Pig 
5 showed decreases in SV estimated with increasing PEEP, while the aortic model and 
admittance SV had minimal change induced by, increasing PEEP in this case, despite 
expectations. The PiCCO and Wesseling model estimate of SV suggest Pig 5 is preload 
responsive as SV variation is achieved with preload changes induced by the RM (Hofer et al., 
2008). On the other hand, SV estimated by the aortic model suggests a non/less-preload 
responsive case compared to pre-dobutamine period. This lack of response was also seen in the 
measured SV from the reference admittance catheter. In clinical situations, this error seen in 
the PiCCO and Wessling model could lead to overloading the patient with extra fluid when the 
patient is no longer fluid responsive (Monnet and Teboul, 2013). Hence, the ability to track the 
measured SV changes is important. 
SV estimated from the three pressure contour methods were different from each other during 
the dobutamine RM period in Pig 6. The PiCCO was able to capture the absolute SV trend 
induced from RM, but was offset by approximately -10ml. The error seen in the PiCCO outputs 
could be due to inaccurate thermodilution calibration made at the start of dobutamine 
administration. It can be seen that this error was removed at the start of the ‘dobutamine+180ml’ 
RM period as another thermodilution calibration was made between the two dobutamine RM.  
The Wesseling model and aortic model both overestimated the SV trends induced by the RM. 
In addition, SV estimated from the aortic model was overestimated by approximately +10ml at 
the beginning and the end of the RM. The overestimation in SV by the Wesseling model and 
the aortic model are due to fixed model parameters. Pig 6 had the most significant increase in 
measured aortic pressure, and consequently, the arctangent model in the Wesseling model and 
a fixed value of the aortic area in the aortic model were not able to capture the dramatic change 
in aortic dimension induced, in this period.  
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The PiCCO estimated SV in Pig 7 was significantly lower than the SV directly measured by 
the aortic flow probe. Thermodilution calibrations for PiCCO were made several times during 
the experiment, and the SV value obtained from the calibrations were consistently 20-30ml 
lower than the SV obtained from the integral of the aortic flow directly measured by the flow 
probe, unlike the case seen in Pig 6 where the thermodilution value deviated only once. With 
both flow probe and thermodilution SV measurements being equivalent to the research and 
clinical gold standard (Smartt, 2005, Yang et al., 2013), the justification of the ‘true’ SV value 
in such cases is very difficult. However, the SV trends measured by the flow probe are still 
useful as it captures decreases or increases in SV. The Wesseling model method captured the 
SV trends accurately, while the aortic model and PiCCO were less accurate in the endotoxin 
RM, for this pig. 
In Pig 8, all three methods displayed similar results with little to no bias compared with SV 
measurement from the flow probe, and all methods captured SV changes from the RM 
accurately throughout the entire experiment. There were minor underestimations made by the 
aortic model in the ‘Filling400’ section, but SV accuracy in the endotoxin periods was very 
high. In addition, the Wesseling model and PiCCO SV were overestimated in the last two RMs.  
Overall, the accuracy of SV estimated by each method was very similar. The only difference 
between each method was in the way the pressure contour was calibrated. The Wesseling 
method was calibrated using the entire SV waveform giving the optimal result. The PiCCO 
device was calibrated each time an intervention was made. The aortic model was calibrated 
only once at the beginning of the experiment and thus had the least amount of information 
available, and is thus potentially the most clinically realistic. The results showed 
models/algorithms used to estimate SV for each method computes acceptable SV with 




The accuracy of the PiCCO device has been investigated in a number of studies (Bajorat et al., 
2006, Rödig et al., 1999, Østergaard et al., 2006). However, some studies indicate inaccuracies 
for continuously estimating SV with this system under hemodynamic instability or during 
inotrope/vasoactive drug use (Halvorsen et al., 2006, Yamashita et al., 2008, Yamashita et al., 
2007), which is exactly when it is most clinically useful and necessary. In addition, due to these 
inaccuracies, re-calibration of the PiCCO system is recommended whenever cardiovascular 
properties are expected to change (Rödig et al., 1999, Bendjelid, 2009), which is a difficult 
proposition to predict and to act upon when it occurs.  
There are two main potential causes for the error produced in SV estimated by the PiCCO: 1) 
inability to correctly capture hemodynamic properties; and 2) error introduced from inaccurate 
thermodilution calibration measurement. The physiological model and algorithms used to 
estimate SV for the PiCCO are unknown. However, based on several studies done on the 
accuracy of PiCCO during hemodynamic instability (Boyle et al., 2007, Halvorsen et al., 2006, 
Rödig et al., 1999), it is clear that the model parameters used for pressure to flow conversion 
deviate from the true hemodynamic values as vascular properties change from the calibrated 
points. These results demonstrate the limited ability of obtaining changes in vascular properties, 
such as aortic characteristic impedance, compliance, and systemic resistance from pressure 
measurements alone.   
The second error introduced in PiCCO is from the reference/calibration measurement. This 
error is due to thermodilution measurements having an approximately ±20% error in estimating 
SV, even with an accurate method using a Pulmonary Artery Catheter (PAC) (Yang et al., 
2013). The PiCCO device uses transpulmonary thermodilution methods, and thus, could 
produce incorrect SV trends when the device is re-calibrated. This effect can be seen in the first 
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dobutmine RM period in Pig 6, where the PiCCO system showed significantly decreased SV, 
while the SV from the admittance catheter stayed constant. With the large error in the reference 
measurements, frequent model calibration could lead to incorrect SV trends.  
Calibration error is reduced in PiCCO as it uses three thermodilution measurements per 
calibration (Gondos et al., 2009). As a result, there were only one obvious error seen from 17 
calibrations performed across all pigs, as shown in Figure 6.3. With the PiCCO system 
calibration measurements being very close to the admittance/flow probe SV value, the PiCCO 
SV estimates obtained are considered to be at its optimum accuracy, and clinically such 
frequent calibration would not be expected, leading to reduced accuracy.   
6.4.3 Wesseling Model 
The Wessling model is used as the basis for several commercially available uncalibrated pulse 
contour devices (Truijen et al., 2012), and is a well-known model in the cardiovascular field. 
Wesseling et al introduced a method for identifying characteristic impedance by defining the 
pressure-area relationship in Equation (6.4). This relationship provides a method to compute 
aortic flow from pressure, thus making SV estimation possible. Moreover, the equation links 
aortic characteristic impedance and compliance, revealing interactions between changes in 
hemodynamics and vascular properties.  
The arctangent model developed by (Langewouters et al., 1984), were combined in a Wesseling 
model to develop a SV estimation method requiring no SV calibration. The arctangent model 
uses population derived aortic wall properties for describing the pressure-area relationship. The 
model requires the patient’s age and maximum cross-sectional area, Amax, as input parameters 
to determine subject-specific relationship. The relationship is used to calculate aortic 
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compliance and area, which is then used to identify aortic characteristic impedance using 
Equation (6.4). 
In this analysis, age and Amax were optimised for the pig experiments to give the best SV 
estimate. The identified pressure-area relationship from optimization provides the best subject-
specific representation of the aorta for the given SV data. In reality, such optimization is not 
possible, and the arctangent model would introduce larger errors, as a result, depending on the 
strength of population derived relationships used in the model for any given subject.  
The optimized Wesseling model correctly captured SV trends induced from PEEP changes, 
dobutamine, and endotoxin. The result demonstrates the ability of the nonlinear three-element 
Windkessel model combined with aortic characteristic impedance determined from the 
arctangent model and Equation (6.4). However, if age and Amax were changed from the optimal 
value, the model error could increase rapidly, as can be seen in Figure 6.1. 
6.4.4 Aortic Model 
The aortic model presented in Chapter 5 resulted in similar SV accuracy compared against the 
clinically accepted PiCCO system with multiple calibrations during the experiment, and the 
Wesseling model optimised for the SV data. The results show ability of the aortic model for 
continuous accurate estimation of Windkessel model parameters, and thus accurate estimation 
of SV in all conditions tested. The model requires only a single calibration, and minimises the 
possible error introduced from re-calibration with the reference measurement. 
The aortic characteristic impedance calculation using Equation (5.3) for the aortic model is 
similar to Equation (6.4) for the Wesseling model. However, the aortic model uses PWV 
measurement instead of the arctangent model for describing aortic pressure-area relationship. 
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The PWV captures aortic distensibility (Bramwell-Hill equation), and given a calibrated aortic 
area, pressure-area relationship is obtained. The use of PWV measurement removes the 
potential error associated with population derived relationships. Thus, the aortic model 
accurately estimates SV, even when vascular system is significantly altered/modified as 
vascular properties are continuously monitored through PWV measurement.  
6.5 Summary 
The accuracy of three pressure contour methods: 1) PiCCO; 2) Wesseling; and 3) the aortic 
model presented in Chapter 5 are compared in this chapter. The result showed all methods are 
capable of accurate continuous SV estimation, provided model parameters are adequately 
calibrated. The PiCCO device was calibrated multiple times during the experiment and 
Wesseling method was optimised to the SV data. In contrast, the aortic model required only a 
single calibration, demonstrating its ability to capture changes in cardiovascular parameters, 
and thus provide accurate continuous SV without the need for frequent re-calibration. 
The aortic model requires less calibration as information from both PWV and pressure 
measurements are used. The PWV measurement provides continuous information on aortic 
wall properties and removes the need for population approximation. The changing property of 
the aortic wall is measured instead of fixed or estimated, thus the aortic model is capable of 
accurate SV estimation even during significant hemodynamic modification induced by 
dobutamine, and endotoxin. 
The additional PWV measurement required by the aortic model can be seen as a disadvantage, 
as the PiCCO and Wesseling methods need only pressure waveform. However, reduced 
probability of misdiagnosis and incorrect treatment from accurate SV monitoring could 
outweigh the model disadvantage. In addition, the frequent calibration and/or subject-specific 
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optimisation required by the other methods is clinically impractical. The primary source of 
error during hemodynamic instability is the main time when SV estimation is most clinically 
necessary. Further investigation of the model using post-hoc human data would reveal the 
clinical applicability and usefulness in the critical care environment.
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Chapter 7: Estimation of Changes in 
Contractility and Mechanical Efficiency 
for Monitoring Inotrope Therapy  
Contractility and mechanical efficiency of the heart are essential for optimizing/titrating 
treatment involving inotropes. However, current methods of identifying these parameters 
involve highly invasive procedures and are not clinically feasible. Thus, this chapter 
investigates the relationship between contractility, mechanical efficiency and output 
parameters from the extended aortic pressure model presented in Chapter 5. The goal is to 
minimise invasive measurements, while enabling more optimal inotrope therapy. The strengths 
of these relationships for contractility, Ees - PWV, ventricular arterial coupling (1/EesCV) - 
aortic characteristic impedance, Zao, and mechanical efficiency - ratio of aortic compliance to 
impedance, (CV/Zao), are analysed using the data from the dobutamine experiments. 
7.1 Introduction 
Inotropes are used in the ICU for management of heart failure and administered if 
hemodynamic properties cannot be improved with “standard care”, such as fluid resuscitation 
(Felker and O’Connor, 2001). In such cases, the decompensating heart requires stimulation of 
adrenergic receptors to improve cardiovascular performance and oxygen delivery to restore 
adequate organ perfusion (Overgaard and Dzavik, 2008). Adrenergic agonists/blockers in the 
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inotrope stimulate/block adrenergic receptors, modifying cardiac function and/or vascular tone 
to change CO, blood pressure, and systemic resistance (Metra et al., 2011). 
The effects of inotropes can be broken down into three main physiologic changes: 1) 
chronotropic (rate); 2) Inotropic (strength); and 3) vasoconstriction/dilation. A given inotrope 
binds/blocks each of the alpha, α, and beta, β, adrenergic receptors (α1, α2, β1, β2, and β3) to a 
different degree, and thus, the overall effect varies depending on the specific drug (Francis et 
al., 2014). Selection of suitable drug type is often made with knowledge of the drug from past 
studies and/or types of agonists/blockers within the drug (Garg et al., 2012). However, 
pharmacokinetics and pharmacodynamics of the drug can be significantly different between 
individuals (Lehtonen et al., 2004), and thus, desirable outcomes may not be achieved unless 
the quantifiable patient-specific effects of inotropes can be monitored appropriately.  
To capture the patient-specific effects of inotropes, changes in Heart Rate (HR), myocardium 
contractility, and arterial compliance need to be monitored (chronotropy, inotropy, and 
vascular tone). HR is measured relatively easily from electrocardiography or 
photoplethysmography, and changes in arterial compliance can be measured from central 
pressure measurement combined with the aortic model described in Chapter 5. However, a 
method for measuring contractility requires information from the pressure-volume (PV) 
relationship within the ventricle at various levels of preload (Sagawa, 1978), and is highly 
invasive.  
For this reason, assessments of contractility are very rare in ICU despite their importance for 
capturing patient-specific inotrope response. In addition, many clinical trials of inotrope 
therapies do not include this parameter for the analysis due to the difficulty in obtaining the 
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parameter value (Lobo et al., 2006, Modine et al., 2005).  Hence, there is a clinical need for a 
non-additionally invasive assessment. 
Another important parameter to be monitored for inotrope therapy is the mechanical efficiency 
(ME) of the heart (Knaapen et al., 2007). ME is calculated as stroke work (SW) divided by 
pressure volume area (PVA) which is defined by the sum of total area under the end systolic 
pressure volume relationship (AESPVR) and SW.  
F = G>l																																																																																																																																										(7.1) 
l = G> 9	lW_Y																																																																																																																							(7.2) 
PVA represents the total mechanical energy generated by the heart per beat and the efficiency, 
ME, shows the amount of energy received by the arterial system per total energy produced by 
the heart (Westerhof, 2000).  
Inotropes increase contractility of the heart. However, if ME is altered with changes in 
ventricular-arterial (VA) coupling, which is the ratio of arterial elastance to contractility 
(Pittarello et al., 2004), it could have adverse effects in the failing heart as the added energy 
expenditure of the heart can be insufficiently transferred to the vascular system. Therefore, ME 
needs to be monitored along with the key metrics to properly capture and assess effectiveness 
of these drugs.  
In this chapter, clinically measurable metrics such as PWV and Windkessel model parameters 
of the vascular system are investigated to see whether changes in contractility and ME of the 
heart can be captured during inotrope therapy. Relationships between invasively measured 
contractility and ME from the admittance catheters with clinically measurable metrics from 
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aortic pressure measurements are analysed to assess the accuracy of these surrogates against 
highly invasive direct measurement. Identified relationships between these parameters would 
provide a basis for a less invasive method to capture drug response and efficacy, and could 
improve current inotrope therapy by offering better metrics with which to titrate inotropes to a 
more optimal level.      
7.2 Method 
7.2.1 Measurement of Contractility    
Contractility of the heart can be defined at any given time in systole as it is defined by the ratio 
of ventricular pressure to volume (Suga and Sagawa, 1972) or time-varying elastance, Event(t) 
of cardiac muscle; 
Event(t) = Pvent(t)/(Vvent(t) – Vd)                                      (7.3) 
Where Event, Pvent and Vvent are ventricular elastance, pressure, and volume, respectively, and Vd 
is the ventricular volume at zero pressure (Sagawa, 1981).  
The pressure within the ventricle during isovolumetric relaxation does not represent pressure 
resulting from the ventricular contraction. Consequently contractility calculated from Equation 
(7.3) can only be valid during systole. An example of a typical time-varying elastance profile 







Figure 7.1 - Left Panel: Ventricular PV loop showing various ratios of pressure and volume 
during one cardiac cycle and the slopes represents the contractility Event(t). Right Panel: Time-
varying elastance curve shown in the time domain. Ventricular elastance calculated using 
Equation 7.1 are shown, however, elastance from t2 to t3 does not represent the true value. 
Figure from (Stevenson, 2013). 
In this analysis, the maximum value of Event(t) during a cardiac cycle was chosen to represent 
contractility for a given heartbeat as maximum contractility is the value most commonly used 
for assessment of contractility in clinical settings (Kass, 1992). The maximum contractility of 
the heart is reached at end-systole, and is located at point t4 in Figure 7.1. Equation (7.3) can 
now be modified to give beat-to-beat end systolic contractility, defined: 
max(Event(t)) = Ees = Pvent(tes)/(Vvent(tes) – Vd)    (7.4) 
Where tes is the time at end-systole. To determine Pvent(tes), and Vvent(tes), end-systolic time, tes, 
was identified as the time when product of maximum Vvent(t) minus Vvent(t), and Pvent(t) reaches 
maximum, representing t4 in Figure 7.1. 
tes = t @ max((max(Vvent)-Vvent(t)) . Pvent(t))     (7.5) 
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Using the identified end-systolic point on the PV loop, Vd in Equation (7.3) was identified using 
the data from the first RM of the experiment. RMs provide sufficient preload variation to 
identify a linear relationship, Pvent(tes) = mVvent(tes) + b, and using this linear equation, Vd was 
determined for each pig. The example of multiple PV loops obtained from a RM and the 
identified linear relationship is shown in Figure 7.2. 
 
Figure 7.2 – End-systolic pressure volume relationship obtained from RM. Beat-to-beat 
identified end-systolic points are shown with blue dots. PV-loop obtained at PEEP 5, 10, 15, 
and 20 are shown with red line (thick to thin, respectively). Regression line representing 
ESPVR is shown with black line with corresponding linear equation at top left corner. 
As can be seen in Figure 7.2, Vd is a negative value and does not represent ‘true’ ventricular 
volume when pressure is zero. This outcome is due to ESPVR curve being nonlinear in the 
nonphysiologic range at low ventricular volume (Oommen et al., 2003). In reality, “dead space 
volume” or volume that exists within the ventricle at zero pressure is a positive value. However, 
it is assumed for this analysis that the ESPVR line can be treated as linear within the 
physiological range (Senzaki et al., 1996).  Negative values of Vd are non-physiological, but 
are a necessary assumption in obtaining beat-to-beat contractility within the physiological 














contractility can be calculated using Equation (7.3) with Pvent(tes) and Vvent(tes) identified from 
Equation (7.5) for each beat.  
7.2.2 Measurement of Mechanical Efficiency 
Total mechanical energy produced by the heart from contraction can be defined as the energy 
received by the arterial system plus the remaining elastic potential energy of the heart when 
the aortic valve closes. This elastic potential energy can be determined from the area under the 
ESPVR line on a PV plot, similar to determining potential energy stored in a spring on a force-
displacement plot. Figure 7.3 shows the two energy components on a ventricular PV diagram.  
 
Figure 7.3 – The total mechanical energy produced by the heart from contraction. Light grey 
area shows the energy received by the arterial system (external work) and dark grey area shows 
the remaining elastic potential energy of the heart at end systole. Figure from (Stevenson, 2013). 
 
 
The total energy produced by the heart, also known as PVA has been linearly correlated with 
oxygen consumption under various preload and afterload conditions (Suga et al., 1981). Thus, 
ME of the heart, which is the ratio of external work to PVA, also represents how well the heart 
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is utilizing oxygen to provide energy for the vascular system. To estimate the area of potential 
energy and external work done in Figure 7.3, these areas were simplified as a rectangle and a 
triangle.  
SW = (Pvent(tes) - Pvent(ted)).( Vvent(ted) - Vvent(tes))                  (7.6) 
PVA = (Pvent(tes) - Pvent(ted)).( Vvent(tes) - Vd)/2 + SW                  (7.7) 
ted = t @ min((max(Vvent)- Vvent(t)) . Pvent(t))                                                                        (7.8) 
where ted=t1 and ted=t4 in Figure 7.1 
For the calculation of PVA, “dead space volume”, Vd, was assumed to be zero, unlike the case 
for estimating contractility in Equation (7.3). This assumption is due to potential energy being 
the integral of the ESPVR curve, and thus, the true value of Vd, which is approximately zero, 
should be used. Using the obtained PVA, beat-to-beat ME was calculated using Equation (7.1). 
7.2.3 Alternative Indices  
7.2.3.1 Contractility 
Contractility of the heart alters the blood flow within aorta, as more forceful contraction has 
greater capacity to produce higher flow (de Wildt and Sangster, 1983). However, flow rate 
through aorta is not directly proportional to contractility, as there are two other factors that 
could influence its rate: 1) ability of the aorta to absorb contractile force; and 2) initial potential 
energy of the aorta. If the aorta is very stiff, and thus, difficult to absorb energy from the heart 
(Chirinos, 2013), low flow is expected even with higher contractility. The same phenomenon 
is expected if the initial potential energy of the aorta is high yielding a lower energy difference 
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between the ventricle and aorta. To approximate the contractility from aortic flow, these two 
influences must be considered. 
The output parameters of the aortic model presented in Chapter 5 can be used to measure these 
effects. Identified compliance, Cv, could assess the energy absorption potential/capacity of the 
aorta and the amount of excess pressure can reveal how easily the heart was able to overcome 
the potential energy of the aorta. Therefore, a parameter showing flow rate per unit compliance 
per unit of excess pressure can be hypothesised to provide an estimate of changes in 
contractility. PWV, as described by the water hammer relation in Equation (5.3), can be 
rearranged by substituting in Equation (4.4) to yield such a parameter.   
PWV = Qin/PexCA   (7.7) 
7.2.3.3 Mechanical Efficiency 
The mechanical efficiency of a single heartbeat captures the ratio of energy received by the 
aorta or external work done by the heart to that of the entire energy produced by contractility 
of the heart. For a given contractility and a given magnitude of aortic pressure, the energy 
received by aorta is determined by the values of aortic characteristic impedance and compliance. 
Higher compliance for a given reservoir pressure increases energy stored by the aorta during 
systole, and reduced impedance for a given excess pressure increases SV during systole. Thus, 
the values of these two parameters influence the external work and ME of a heartbeat. 
External work done can be explained by the sum of four energies within the aorta: 1) potential 
energy before ventricular ejection, PEao; 2) energy stored by aortic compliance during systole, 
Estored; which is also the energy released during diastole by the aorta, 3) energy expended by 
aortic compliance during systole, Eexpende; and 4) excess energy introduced by the ventricle to 
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accelerate flow, Eex. Potential energy of the aorta is the energy that the heart must first 
overcome to start ejecting blood from the ventricle to aorta, through increase in contractility of 
the heart during systole. Once contractility is increased above potential energy of the aorta, 
energy is transferred into aortic compartment, where this energy is divided into three energies 















Figure 7.4 – Diagram showing four energies in the aortic compartment during systole on 
ventricular PV loop. Top panel shows increase in time varying contractility during systole (red 
lines). At aortic valve opening time, ventricular energy exceeds aortic potential energy to start 
transferring energy in to aorta. Blue rectangle shows the total energy transferred from the 
ventricle to aorta. Bottom panel shows three energy components within the total energy 
transferred, which are Estored, Eexpend, and Eex 
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Relationships between impedance, compliance, SV, and each of these energy components are 
defined:  
F," 	= 	L 	G	 (7.8) 
F$"L 	= 	E −	L 	 (7.9) 
F*) L 	=  −	L%G −	F," (7.10) 
F*' 	= _\a~{|  (7.11) 
Where Ts is systolic time interval and the overbar represents the mean value for systole.  
These equations were derived from the definition of reservoir-excess pressure outlined by 
Wang et al. (2003), combined with aortic flow generated from each pressure component. The 
value of aortic characteristic impedance is determined from the water hammer relation in 
Equation (5.3), where changes in aortic compliance modify the value of PWV and impedance 
value. With increased aortic compliance, PWV is reduced and, consequently, aortic 
characteristic impedance is reduced. Equation (7.11) shows the increase in Eexcess with reduced 
aortic characteristic impedance as more flow would be expected from the excess pressure. 
From an increased amount of total aortic flow, the rest of the external work done, as shown in 
Equations (7.8) - (7.10), is also increased. Thus, ME of the heart increases with increased 
compliance and reduced impedance by producing higher external work done for a given 
pressure and contractility. Figure 7.5 shows how each energy components relates to aortic 





Figure 7.5  – Pressure-Volume diagram showing different components of external work done 
and its relations to impedance and compliance. Looking at the external work done enclosed by 
the black lines, rectangular section below Ped shows the initial potential energy of aorta PEao. 
Middle rectangles in between Ped and  shows the sum of Eabsorb and Eexpend separated by 
volume absorbed by the aorta ∆V. Top rectangle section between  and   shows the 
amount of Eex. Slopes inside Eabsorb and Eex as shown in the figure relates to the value of 
impedance and compliance. The dashed blue line represents increased external work from 
reduced slopes. 
Assuming that contractility is a function of aortic characteristic impedance and compliance 
multiplied together, so Ees = f(ZaoCV), or Ees α PWV, as can be derived from the relation 
described in Section 7.2.3.1, and that the values of each parameter, Zao and CV, determines the 
size of external work done, the ratio of compliance and impedance, CV/Zao, could potentially 
track the ME of the heart. For a given contractility, ZaoCV, a set of solutions that results in a 
higher value of CV/Zao indicates larger external work done. This result is similar to the 
definition of ME, which is a measure of the ability of aorta to absorb energy produced by 
contractility of the heart. 
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7.2.4 Data Analysis 
Data from the four dobutamine experiments described in Chapter 4 (Pigs 2, 3, 5, and 6) were 
used to analyse the relationship between contractility, ME, and output parameters of the aortic 
model in Chapter 5. Measured continuous ventricular volume and pressure waveforms were 
first split into individual heart beats for the beat-to-beat PV loop analysis. The start of a beat 
was identified as the location of maximum ventricular volume. Theoretical dead space volume, 
Vd, in Equation (7.3) was estimated using the first RM for each pig and beat-to-beat contractility 
of the heart was calculated for whole duration of the experiment with fixed Vd. ME of the heart 
was determined using measured SW and PVA from PV-loop using Equation (7.6) and (7.7), 
respectively.  
The values of PWV were obtained using the method described in Section 3.2.3. Windkessel 
model parameters of the aorta were identified using the aortic model in Chapter 5 with 
measured values of SV. Measured values of SV were used in this investigation to reveal the 
relationships between ‘true’ vascular properties and cardiac parameters. Moreover, it is 
important to provide correct evidence for clinical feasibility of the relationships, in the case 
where accurate Windkessel parameters could be identified using other methods and techniques 
(Cappello et al., 1995). To assess the accuracy of PWV and CV/Zao for capturing changes in 
contractility and ME, respectively, correlation coefficients and regression coefficients using 
least-squares were analysed for each data set. 
7.3 Results 
7.3.1 Hemodynamic Changes from Dobutamine 
To investigate the effectiveness of dobutamine for each pig, hemodynamic parameters for 10 
heartbeats before and after dobutamine administration (steady-state) were analysed. Table 7.1 
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summarises the changes in maximum elastance, Ees, end-diastolic/systolic ventricular volume, 
Ved and Ves, ventricular-arterial coupling (VAC), PVA, SW, ME, PWV, Zao, and CV resulting 
from the administration of dobutamine. The value of VAC is determined as aortic elastance, 
(1/CV), divided by contractility, Ees. The mean value of 10 heartbeats analysed are shown in 
Table 7.1, which eliminates any effect of beat-to-beat variability due to breathing cycle or other 
factors, so a direct change can be assessed due to dobutamine. 
Table 7.1 – Summary of hemodynamic changes made by dobutamine. Data are presented as 
the mean of 10 heartbeat analysed. 
10 Heartbeats Before Dobutamine 
Pig Ees  Ved  Ves VAC  PVA SW ME PWV Zao CV 
No (mmHg/ml) (ml) (ml)     (mmHg.ml)  (m/s) (mmHg.s/ml) (ml/mmHg) 
Pig 2 1.40 99 73 1.41 9318 3893 0.42 5.5 0.32 0.50 
Pig 3 0.76 58 43 5.8 3578 1519 0.42 6.4 0.28 0.23 
Pig 5 0.80 71 37 2.0 5700 3676 0.65 8.4 0.17 0.62 
Pig 6 1.44 73 46 0.78 2516 1349 0.53 3.9 0.25 0.91 
10 Heartbeats After Dobutamine 
Pig Ees  Ved  Ves VAC  PVA SW ME PWV Zao CV 
No (mmHg/ml) (ml) (ml)      (mmHg.ml)  (m/s) (mmHg.s/ml) (ml/mmHg) 
Pig 2 1.85 78 44 0.79 8791 5315 0.6 6.4 0.20 0.70 
Pig 3 0.83 51 29 3.2 3729 2209 0.59 6.8 0.16 0.37 
Pig 5 0.80 43 19 2.0 3524 2546 0.72 8.4 0.17 0.63 
Pig 6 1.86 66 41 0.61 2789 1552 0.55 4.5 0.22 0.87 
 
7.3.1 Correlation between Contractility and PWV 
Correlation plots between measured contractility and PWV for each pig are presented in Figure 
7.6. Correlation coefficient, linear regression line, and corresponding linear equation for 
individual pig are also shown in the plots. The correlation plots shows that contractility and 
PWV were more varied in the dobutamine RM period than the pre-dobutamine RM due to 
higher preload responsiveness achieved by higher inotropy of the heart. The variability around 
the regression line shows the level of intra-subject variability in each pig and each condition. 
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They also show that the regression line varies significantly for each pig, indicating significant 
inter-subject variability. 
 
7.3.2 Correlation between Ventricular-Arterial Coupling and Impedance 
As seen in Figure 7.6, contractility can adequately be expressed as a linear function of PWV. 
Using this linear relationship combined with compliance derived from the aortic model, 
impedance can be related to VA coupling. VA coupling is the ratio of aortic elastance and 
contractility, 1/EesC. Therefore, inverse of PWV divided by compliance, which is simply the 
impedance of aorta should also be correlated with VA coupling. In addition, past studies and 
results indicate the possibility of a relationship between these parameters (Bauernschmitt et al., 
1999, Eaton et al., 1993). To investigate the relationship between impedance and VA coupling, 
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y = 0.62x - 1.09
R = 0.93
y = 0.27x - 0.97
R = 0.94
y = 0.32x - 0.32
R = 0.84
y = 0.13x - 0.35
R = 0.76
Figure 7.6 – Correlation plots showing relationship between contractility, Ees, and PWV. 
Correlation coefficient and linear equation are shown at top left corner. Pre-dobutamine RM 
period are shown with blue dots and post-dobutamine RM period are shown with red dots. 
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correlation plots relating these two parameters are shown Figure 7.7, which again show 
significant inter-subject variability, but much less intra-subject variation. 
 
 
7.3.3 Correlation between Mechanical Efficiency and Ratio of Compliance 
and Impedance 
Correlation plots between ME and the ratio, CV/Zao, are presented in Figure 7.8. The analysis 
shows that the relationship between these parameters can be poor, for example in Pig 6. The 
relationship also showed that ME could plateau at certain level while there is still an increase 
in the ratio CV/Zao. 
 































y = 4.2x + 0.02
R = 0.98
y = 18.4x + 0.44
R = 0.98
y = 2.6x + 0.07
R = 0.83
y = 11.4x + 0.11
R = 0.96
Figure 7.7 – Correlation plots showing relationship between VA coupling and aortic 
characteristic impedance, Zao. Correlation coefficient and linear equation are shown at top left 
corner. Pre-dobutamine RM period are shown with blue dots and post-dobutamine RM period 





7.4.1 Effect of Dobutamine 
Dobutamine is a sympathomimetic drug with three main effects on the sympathetic nervous 
system. It is primarily a β1 agonist, with β2, and α1 effects. Stimulation of the β1 receptors 
increases contractility and heart rate, β2 increases arterial compliance by relaxing vascular 
muscle, and α1 has a vasoconstrictive effect (Garg et al., 2012). Patient response to each of 
these effect varies, , but dobutamine is a drug generally viewed as predominantly β1, weak β2, 
and minor α1 stimulation (Ruffolo Jr, 1987). From this information, the benefit of inotrope 
therapy by dobutamine can be summarised: 
• Increased SV by increasing contractility of the heart 
































y = 0.02x + 0.45
R = 0.69
y = 0.05x + 0.41
R = 0.88
y = 0.03x + 0.61
R = 0.80
y = -0.003x + 0.54
R = -0.18
Figure 7.8 – Correlation plots showing relationship between mechanical efficiency and ratio 
of compliance and impedance, CV/Zao. Correlation coefficient and linear equation are shown at 
top left corner. Pre-dobutamine RM period are shown with blue dots and post-dobutamine RM 
period are shown with red dots. 
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• Increased compliance of the blood vessels to minimise systemic hemodynamic 
changes due to increased contractility  
• Improved mechanical efficiency of the heart by modulating VA coupling  
The expected hemodynamic improvements from dobutamine are relatively simple. However, 
complex and patient-specific differences in pharmacokinetics and pharmacodynamics of the 
drug could produce sub-optimal and sometimes undesired outcomes.  As seen in Table 7.1, two 
out of four pigs (Pig 3 and 5) had minimal change in contractility and there was no change in 
compliance for Pig 5. The only change induced by dobutamine in Pig 5 was a reduction in SV, 
Ved, and Ves caused by a significant increase in HR (Weissler et al., 1961). This increased HR 
can be seen as an undesired effect with decreased SW, delivering less energy to the vascular 
system per beat, and increased HR is related to increase cardiovascular risks (Hori and 
Okamoto, 2012). For these reasons, it is important to monitor the effectiveness of inotrope 
therapy, as continuing dobutamine administration for a patient who responds in a similar 
manner to Pig 5 could only result in higher chance of mortality without any benefit.  
7.4.2 Relationships 
7.4.2.1 Contractility and PWV 
The results from Figure 7.6 demonstrate the ability of PWV for tracking changes made to 
contractility by dobutamine. Correlation coefficients between PWV and Ees were very high for 
all pigs, with the lowest coefficient value of R = 0.76 for Pig 5. The regression coefficients for 
each pig were different, showing estimation of changes in absolute value of Ees from PWV 
measurement alone is difficult, due to significant inter-subject variability. 
The difference in gradient of the relationship for each pig could be due to inaccurate 
measurements of PWV. As seen in Figure 7.6, the relationships had higher gradient when PWV 
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was in the lower range and had lower gradient when PWV was in a higher range. PWV was 
calculated using the approximate distance between the catheters (40cm as described in Section 
3.2.3), and the absolute value of PWV could be incorrect by a constant factor for each pig. If 
the approximated catheter distance were longer than the actual distance, calculated PWV values 
are higher with higher variability. In contrast, if the approximated catheter distance were 
shorter than the actual distance, the opposite would occur, potentially shifting the results to the 
left with a higher gradient on the correlation plots. Taking these inaccuracies into account, a 
population correlation between PWV and Ees may result in a similar gradient. To reveal the 
true population relationship between PWV and Ees, further investigations are necessary where 
exact catheter distance is known or can be measured accurately. 
Individual differences in the relationship prevents capturing the absolute changes in 
contractility from PWV. However, it can be seen from Pig 5 in Table 7.1 that both PWV and 
contractility were constant before and after dobutamine administration, showing the clinical 
feasibility of the relationship in an unaffected case. The identified relationship, combined with 
the value of compliance from the aortic model, has the potential to improve dobutamine therapy 
in the clinical settings.  
7.4.2.2 VA Coupling and Impedance 
The results from Figure 7.7 shows VA coupling and Zao are highly correlated, with a lowest 
correlation coefficient R = 0.83 for Pig 6. Zao were highly accurate in capturing the increase 
and decrease of VA coupling. However, the difference in regression coefficients between each 
pig shown in Figure 7.7 prevents use of this relationship to capture changes in absolute value 
of VA coupling from Zao. 
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The reservoir-excess aortic model separates systolic aortic pressure waveform into excess 
pressure. Excess pressure represents the force producing ejection of blood out of the ventricle 
into the aorta, and reservoir pressure, which represents force pushing against the aortic valve 
(Hametner et al., 2014). Thus, the excess pressure results from the interaction between the 
ventricle and aorta. Converting this force into measures of elastance by dividing it by volume 
would yield a parameter representing VA coupling. The aortic characteristic impedance 
derived from the reservoir-excess aortic model captures this interaction, and was highly 
correlated with VA coupling.  
The assessment of VA coupling is important for clinical diagnosis, selecting correct treatment, 
and optimizing cardiac energetics (Ky et al., 2013, Guarracino et al., 2013, Guarracino et al., 
2014). In acute heart failure, reductions in contractility of the heart decreases the vascular 
compliance as a result of the normal response of the autonomic nervous system from reduced 
SV. The outcome is significantly decreased VA coupling with an inefficient cardiovascular 
system (Chantler and Lakatta, 2012, Asanoi et al., 1989).  
For these conditions, inotrope therapy is necessary (Stevenson, 2003), and appropriate 
monitoring is required as inotropes may overcompensate and/or have adverse effects. Optimal 
VA coupling is achieved when 1/EesCV = 1 (Sunagawa et al., 1985), and the relationship 
between Zao and VA coupling could thus be used to guide inotrope therapy. The results of this 
study show that it is difficult to capture the absolute value of VA coupling from Zao alone. 
However, if the relationship can be calibrated using a PWV-Ees relationship and/or using 
intermittent echocardiographic measurements (Chen et al., 2001), monitoring continuous VA 
coupling becomes much easier in clinical settings, and can be used to guide/monitor therapy.  
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7.4.2.3 Mechanical Efficiency and Ratios CV /Zao 
The results from Figure 7.8 show linear relationships between ME and the ratio CV /Zao. 
However, in Pigs 3 and 5, there were regions where ME was unchanged while there were 
variations in CV /Zao. This plateauing of ME might be due to reaching the maximum absolute 
mechanical efficiency of the heart for a specific pig. Theoretically, an increase in the ratio, CV 
/Zao, increases the ME of the heart, as shown in Figure 7.5. However, such conditions can only 
be achieved if there is no limit for the end-diastolic volume, Ved. In reality, this volume 
restriction of the heart limits the increase in ME even when the ratio, CV /Zao, continues to 
increase. For this reason, the relationship between these parameters is only valid up to certain 
level of ME. 
The correlation coefficients for Pig 6 were very low, showing no relationship between ME and 
CV /Zao. The calculation of ME involves assuming Vd=0, as explained in Section 7.2.2. This 
assumption can alter the absolute value of ME, especially when Ves is close to Vd. If the real 
value of Vd for Pig 6 was higher than the other pigs, it can be seen that Pig 6 could have already 
reached the maximum ME of the heart. In addition, Pig 6 had an extremely low blood pressure 
with a normal level of contractility, as can be seen in Table 3.1 and Table 7.1, which would 
suggest that Pig 6 had a high ME to begin with. With maximum ME throughout the experiment, 
the linear part of the relationship between ME and CV/Zao was thus not observed in Pig 6. 
The gradient for Pigs 2, 3, and 5 were relatively close to each other suggesting a general ability 
to estimate an increase in ME from CV /Zao across the population. To confirm the validity of 
this result, further investigation is necessary, including larger sample size. It can be 
approximated that for a unit increase in CV /Zao, 2 ~ 5% increase in ME is expected, as shown 




One limitation of this analysis is similar to those described in Section 3.4.3.2, that measurement 
error/noise involved in PWV estimation and PV-loop data could alter the relationships 
identified in this chapter. However, high correlation coefficients identified from each 
relationship suggest that only regression coefficients would be affected from minor 
measurement inaccuracy. Thus, the identified linear relationship between PWV-Ees, VAC-Zao, 
and ME- CV / Zao in this chapter is still valid. 
Another limitation of this analysis is that all experiments were performed on otherwise healthy 
pigs and the hemodynamic response from dobutamine in heart failure may involve additional 
physiological influences/responses that were not considered in this analysis. The relationship 
identified and its accuracy described in this chapter requires further validation covering lager 
number of subjects with wider range of physiological conditions. 
7.5 Summary 
The relationships analysed in this chapter showed promising results for identifying the changes 
in contractility, VA coupling, and ME from the parameters that can be determined from central 
pressure measurements. PWV and Zao were highly correlated with contractility and VA 
coupling, respectively, demonstrating clinical capability for monitoring effectiveness of 
inotropic treatment. The relationship between the ratio, CV /Zao, and ME showed a linear 
relationship can only be drawn before reaching maximum ME of the heart, but these two 
parameters were highly correlated before reaching maximum ME. In the linear region, the 
relationship showed 2 ~ 5% increase in ME from a unit increase in CV /Zao.  
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The regression coefficients of the relationships for contractility and VA coupling showed 
different absolute effects are expected from changes in PWV and Zao, respectively. However, 
PWV and Zao were reliable in detecting the trends of contractility and VA coupling, showing 
its ability to separate affected/unaffected case for hemodynamic modification made from 
inotrope. The relationships identified in this chapter have great potential for estimating 
contractility, VA coupling, and ME in a minimally invasive fashion, and thus, could improve 




Chapter 8: Estimation of Pulse Wave 
Velocity using Single Aortic Pressure and 
Electrocardiogram Measurements 
This chapter investigates the clinical applicability of estimating PWV using ECG and a single 
aortic pressure measurement to reduce the need for specialised devices and/or additional 
invasive pressure measurements for estimating PWV. Beat-to-beat transit time is calculated 
using the time from the ECG R-peak to the foot of abdominal aortic pressure waveform. A 
method of estimating distance between the heart and the aortic pressure catheter site is also 
presented. The accuracy of SV estimation in Chapter 5 and relationship between contractility 
and PWV identified in Chapter 7 are re-analysed using PWV estimated from ECG and aortic 
pressure measurements to assess clinical and practical implications. Limitations and possible 
errors introduced using this approach are discussed.  
8.1 Introduction 
The clinical application of PWV measurement was expanded in Chapter 5 by improving the 
pressure contour method for estimating SV and in Chapter 7 by relating PWV to contractility. 
Despite its usefulness, the method of estimating PWV in these analyses uses pressure 
measurements at two separate locations within the aorta, which is not currently common in the 
ICU, but can be achieved with a dual-lumen catheter. For this reason, the clinical applicability 
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of the aortic pressure model in Chapter 5 and relationships identified in Chapter 7 are limited 
by the availability of PWV measurements, where their quality will also impact these estimates. 
PWV can be estimated non-invasively using specialised devices (Rajzer et al., 2008). However, 
PWV measurements from non-invasive methods produce regional average PWV values 
including stiffer peripheral arteries, and may not accurately reflect the changes in aortic PWV 
(Pereira et al., 2015). Another limitation of estimating PWV is that the estimated distance 
between two measurement sites can be inaccurate due to curvature of the vasculature (van der 
Meer et al., 2007). The straight-line distance between two points differ from the distance 
travelled by the pressure wave. Thus, these errors need to be minimized for accurate monitoring. 
ECG measurements are non-invasive and commonly available in the ICU for patients suffering 
from cardiovascular disease and its waveform could potentially be used to limit the 
invasiveness required for PWV measurement. The ECG signal shows the electrical activity due 
to depolarization/repolarization of the heart. The signal from a single heartbeat can be separated 
into three main characteristic waveforms, P-wave, QRS complex, and T-wave as shown in 
Figure 8.1.  
The P-wave represents atrial depolarization, the QRS complex represents ventricular 
depolarization, and the T wave represents repolarization of ventricular muscle (Becker, 2006). 
Within the QRS complex, the R-wave reflects depolarization of the main mass of the ventricle 
and indicates the starting time of heart contraction (Ashley and Niebauer, 2004). The timing of 
heart contraction can be used to approximate starting time of the travelling pressure wave, and 
thus, the ECG R-wave can be used instead of the foot of the pressure measurement closer to 
the heart. This approach would remove the necessity of additional pressure measurements 
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within the aorta, and nearby vasculature, and provides a method of estimating transit time using 
commonly available measurements in the ICU.  
The limitation of estimating distance between the heart and the pressure catheter site can be 
overcome using an accurate value of PWV. This accurate value of PWV can be obtained by 
moving the pressure catheter a known distance within the aorta and recording transit time using 
foot of the pressure waveform at two locations. Using this PWV value combined with transit 
time estimated from ECG to the pressure catheter site, the distance between the heart and the 
catheter site can be estimated. With this estimated distance, beat-to-beat PWV can be calculated 
from the measured transit time. 
This chapter investigates the accuracy and clinical applicability of PWV measurements using 
the ECG waveform and a single pressure measurement instead of the two pressure 
measurements in the method described in Chapter 3 Section 3.2.3. The value of PWV estimated 
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from the ECG R-wave and the two pressure method are compared. In addition, the accuracy of 
estimating SV, and the relationship between PWV and contractility are re-analysed using the 
PWV estimated from the ECG measurement, to assess its practical and clinical impact.  
8.2 Method 
ECG measurements were not taken in the endotoxin pig experiments as these were conducted 
with open chest to facilitate aortic flow measurement, and consequently, only the dobutamine 
experimental data are analysed for the estimation of PWV using the ECG measurement. A 
method of detecting ECG R-wave and estimation of transit time are described. Beat-to-beat 
PWV are then calculated from ECG and abdominal pressure waveforms without using the 
information from the aortic arch pressure waveform. 
The distance calibration procedure of moving the pressure catheter a known distance within 
aorta was only performed in Pig 7, and thus is presented here as another possible method that 
could be combined and implemented to estimate PWV using ECG measurement. Consequently, 
the distances used to calculate PWV for the dobutamine pigs were calibrated by matching the 
mean PWV values for the first 10 heartbeat of the experiment. This calibration method results 
in an optimal case for identifying absolute value of PWV. However, the error involved in using 
the ECG measurement could still be investigated as relative change in transit time may still 
differ from the two pressure measurements method. In normal clinical settings, distance 
calibration can be performed at any time, but, for a retrospective analysis using limited data, 
the distance calibration method was applied using different pigs in this chapter.  
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8.2.1 Transit Time Estimation from ECG and Single Pressure Waveforms 
To determine transit time using ECG and abdominal pressure measurements, the ECG R-wave 
and foot of the abdominal pressure waveform need to be identified. The foot of the abdominal 
pressure waveform was identified using the method described in Section 3.2.3. For detecting 
the R-wave, the minimum magnitude of the ECG signal was used to identify its position. The 
minimum magnitude of ECG signal per heartbeat was identified using the Matlab function 
‘findpeaks’. From the identified minimum location, seven previous sampled data were selected, 
and the maximum value within the selected region was identified as the ECG R-wave. The 
equations for R-wave detection are defined: 
v = [υn-7 υn-6  υn-5  υn-4  υn-3  υn-2  υn-1  υn] 
R wave = max(v)                     (8.1) 
Where υn = detected location of minimum magnitude within single beat. An example of a 
















Figure 8.2 – Example of detected R wave on a measured single beat ECG waveform. P wave, 
QRS complex, and T wave are shown on the ECG measurement (blue line). Detected location 
of minimum magnitude within a single beat ECG waveform is shown with red cross. The 
region selected for identifying the R wave are shown by black vertical lines, and detected R 
wave within the region are shown with red circle. 
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The uniqueness of peaks within QRS complex varies depending on the location of ECG leads. 
Patterns, signs and shapes of the ECG signal can be different if positions of the ECG leads are 
changed (Biel et al., 2001). Thus, the algorithms for detecting R-waves may need to be adjusted 
accordingly. In this analysis, the algorithm presented in Equation (8.1) was applied as the most 
unique points seen on the overall ECG measurements were the minimum magnitude or the S 
wave. The identified ECG R-wave was then used to determine transit time. Figure 8.3 shows 
an example of estimated transit time using the time between the foot of the abdominal pressure 
waveform and ECG R-wave identified. 
 
8.2.2 Distance Calibration 
The distance travelled by the pressure wave between the heart and the abdominal pressure 
measurement site can be determined if the value of PWV is known. Using the value of PWV 






















Figure 8.3 – Typical ECG (orange line) and abdominal pressure (blue line) measurements for 
a single heartbeat. Identified R wave and foot of abdominal pressure waveform are shown by 
black vertical lines. Transit time estimated from these two points are indicated by the width of 




3.5 can be rearranged to calculate the distance. To determine the value of PWV, the abdominal 
pressure catheter can be moved a known distance to obtain accurate information of both the 
transit time and the distance.  
During an endotoxin experiment (Pig 7), the abdominal pressure catheter was shifted towards 
the heart in increments of 7, 12, 17, and 22cm. The distance inserted was measured using a 
ruler on catheter cord. Transit times between aortic arch and abdominal pressure measurements 
were captured at each increment. In this analysis, aortic arch pressure was used for the value 
of transit time as ECG measurements were not recorded. However, the calibration process 
would be identical using the transit time determined using ECG R-wave. Approximately 5-10 
heartbeats worth of data were obtained at each catheter position within the aorta. Figure 8.4 















Figure 8.4 – Scatter plot showing recorded mean transit time (black cross) at inserted length 
of 0, 7, 12, 17, and 22 cm. The regression line represents negative inverse value of PWV in 
centimetres per second. Estimated distance between the heart and the pressure catheter site is 
shown as x-interception of the regression line. 
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As seen in Figure 8.4, the distance-time relationship can be obtained from the difference in 
transit time recorded between locations. The gradient of regression line represents negative 
inverse value of PWV along aorta, and the distance between two measurement points can be 
calculated using the identified linear coefficients. PWV is assumed to be constant during the 
calibration period (20-30 heartbeats), and thus, required to be performed when patient 
circulatory conditions are relatively stable. Once calibrated, this distance can be used to 
estimate beat-to-beat PWV for the entire duration of ICU stay. In addition, if the catheter is 
replaced or moved from the original position, the calibration method can be repeated without 
requiring additional devices.  
8.2.3 Data Analysis 
The data from dobutamine Pigs 2, 3, 5, and 6 were used to estimate transit time between the 
ECG R-wave and foot of abdominal pressure catheter. As the distance calibration method was 
developed after these experiments were conducted, the distance between the heart and the 
pressure catheter site were calculated using initial 10 beats of measured PWV from two 
pressure measurements method (Chapter 3 Section 3.2.3). The PWV calibration process using 
ECG data is defined: 
vIwhJ.,$/',$$ = 40H	.  ,¡]¡^¡{¢	£P	\{^a¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤d`\aa¥`\,¡]¡^¡{¢	£P	\{^a¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤       (8.2) 
>Z¦ =	§$, '¨\{`^©b{^¨\^\`          (8.3) 
Where TT is transit time and subscript ECG and pressure represents transit time estimated 
using the ECG R-wave and aortic arch pressure measurement, respectively. The 40cm in 
Equation (8.2) is the approximate distance used to calculate PWV with the two pressure 
measurements method (Chapter 3 Section 3.2.3).  
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To test its effectiveness, the beat-to-beat PWVECG using Equation (8.3) is used to re-analyse the 
accuracy of SV estimation described in Chapter 5 and the relationship identified between 
contractility and PWV in Chapter 7. Measured abdominal pressure waveforms with PWVECG 
were used to estimate beat-to-beat SV. Reservoir-excess pressure separation was performed 
using Equation (5.2) with the value of PWV replaced with PWVECG. The values of aortic length 
and area used are the same as those in Table 5.1, as the first 10 PWVECG values were calibrated 
to match PWVpressure. After the pressure separation, aortic characteristic impedance was 
calculated using Equation (5.5) with PWVECG, and SV was calculated using Equation (5.6). For 
the relationship between contractility and PWVECG, correlation and regression coefficients are 
analysed. 
8.3 Results 
8.3.1 Comparison of PWV Estimated from ECG and Two Pressure 
Measurements 
The correlation plots between PWV estimated from Equation (8.3), PWVECG, and two pressure 
method, PWVpressure, for each pig are presented in Figure 8.5. It is evident that identified 
PWVECG and PWVpressure were dissimilar except in Pig 6. In Pig 2, PWVECG and PWVpressure were 
linearly related, but the gradient was steeper than 1. Pig 3 showed underestimation of PWVECG 
in the pre-dobutamine period and overestimation in the post-dobutamine section. For Pig 5, 








8.3.2 Accuracy of SV Estimation using PWVECG 
Figure 8.6 shows Bland-Altman plots between estimated SV from PWVECG and measured SV 
from the admittance catheter. The summary of bias, 95% interval, and precision accuracy 
calculated as the 95% range divided by mean SV for each pig are shown in Table 8.1. To 
compare the accuracy of estimated SV between PWVECG and PWVpressure, Table 8.1 also 









Figure 8.5 – Correlation plots comparing PWV estimated from ECG measurement, PWVECG, 
and two pressure measurements, PWVpressure. The identity line is also drawn on the plot to show 
any deviation in PWVECG from PWVpressure. Pre-dobutamine period is shown with blue dots and 
post-dobutamine period are shown with red dots. Correlation coefficients are shown on the top 
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Figure 8.6 - Bland Altman plots showing agreements between measured and estimated SV for 
each pig. Pre-dobutamine periods are shown with black dots, and post-dobutamine periods are 
shown with blue dots. The red dashed line shows the bias and 95% interval. Right panel shows 
the error distribution between measured and estimated SV values. 
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Table 8.1 – Summary of Bland-Altman analysis for SV estimated using PWVECG and 
PWVpressure. Data are presented as bias [2.5th – 97.5th percentiles] and precision as 95% range 
divided by mean SV value. 
 PWVECG PWVpressure 
Pig No Bland-Altman 
results (ml) 
Precision (%) Bland-Altman 
results (ml) 
Precision (%) 
Pig 2 -7.2 [-28.7 – 1.7] +28, -66 -6.8 [-17.7 – 2.2] +27, -34 
Pig 3 0.0 [-4.3 – 6.1] +30, -23 1.7 [-1.3 – 4.9] +21, -18 
Pig 5 -9.8 [-16.8 – -1.8] +27, -23 -3.3 [-9.2 – 2.2]  +22, -23 
Pig 6 -3.7 [-13.7 – 4.3] +28, -35 -2.7 [-11.4 – 3.9] +22, -31 
 
8.3.3 Correlation between Contractility and PWVECG 
The relationships identified in Section 7.3.2 are re-analysed using PWVECG. Figure 8.7 shows 
correlation plots between beat-to-beat contractility estimated using the ventricular pressure-
volume loop and PWVECG. The correlation and regression coefficients calculated for each pig 
are summarised in Table 8.2. 






























Figure 8.7 – Correlation plots showing relationship between contractility and PWVECG. Pre-




Table 8.2 – Summary of correlation and regression coefficients for the relationships identified 
between PWVECG, PWVpressure, and contractility estimated from ventricular PV-loop. 
Regression coefficients are presented as m and c, where Contractility = mPWV+c. 
 PWVECG PWVpressure 
Pig No. Correlation 
Coefficient (r) 
Regression 




Coefficients (m, c) 
Pig 2 0.84 0.16, 0.61 0.84 0.32, -0.32 
Pig 3 0.17 0.27, 0.58 0.94 0.27, -0.97 
Pig 5 0.37 0.13, 0.79 0.76 0.13, -0.35 
Pig 6 0.87 0.62, -0.34 0.93 0.62, -1.09 
8.4 Discussion 
8.4.1 Clinical feasibility of PWVECG 
The correlation plots in Figure 8.5 show PWV estimated using the transit time from the ECG 
R-wave to the foot of the abdominal pressure waveform can be different from PWV estimated 
using the two pressure measurements method. The relationship between PWVECG and 
PWVpressure in Pig 6 were on the identity line showing PWVECG can be used to accurately capture 
PWVpressure. However, the relationship diverged from the identity line for Pigs 2, 3, and 5 
revealing the error associated using the ECG measurements and the inter-subject variability in 
applying this method. There were positive linear relationships in all pigs suggesting that 
relative/trend changes in PWVpressure are captured by PWVECG, but with low linear correlation 
coefficients in Pig 3 and Pig 5, particularly the overall accuracy is decreased.   
The correlation coefficients between PWVECG and contractility showed lower values than the 
relationship between PWVpressure and contractility. Despite lower coefficient values, Pig 2 and 
Pig 6 showed good linear correlation, indicating the potential clinical usefulness of the 
relationship. The result in Pig 3 shows dobutamine producing large errors in estimated PWV 
from ECG measurement. There were small increase in the measured PWVpressure from 
dobutamine administration (Table 7.1), but PWVECG were significantly increased during this 
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period as it can be seen in Figure 8.5. This error in PWVECG produced low correlation 
coefficients for Pig 3 seen in Figure 8.7 and Table 8.2. There are evidence that PWVECG could 
predict change in contractility, however, the potential error associated with use of inotrope 
needs to be further investigated. 
Table 8.1 shows the accuracy of SV estimated using PWVECG resulted in similar precision to 
SV estimated using PWVpressure, except for Pig 2. In Pigs 3 and 5, PWVpressure variation was 
small compared with PWVpressure variation in Pig 2 by approximately half as seen in Figure 8.5. 
Therefore, the SV error produced using PWVECG in these pigs were not as significant as for Pig 
2. In addition, variation of PWVECG for Pig 3 in the post-dobutamine period followed the 
identity line closely producing minimal difference in the estimated SV. Overall, the accuracy 
of estimating SV using PWVECG was within approximately ±30% for 3 out of 4 pigs, 
demonstrating good initial outcomes for clinical feasibility of PWVECG. However, taking into 
account the potential error which can be seen in Pig2, the accuracy of PWVECG for estimating 
aortic PWV needs to be improved. 
8.4.2 Transit Time Estimated from ECG R-wave  
8.4.2.1 Phases of Systole 
The time interval between the ECG R-wave and the dicrotic notch on the aortic pressure 
waveform is known as the total mechanical systolic interval (Lewis et al., 1977). The total 
mechanical systolic interval consists of two phases of ventricular contraction which are: 1) 
Isovolumetric Contraction Time (ICT); and 2) Ventricular Ejection Time (VET) (Weissler et 
al., 1968). The VET can be further divided into two sections on the pressure waveform: 1) 
transit time from aortic valve to pressure catheter site; and 2) the time from the foot of the 
pressure waveform to the dicrotic notch.  
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The transit time recorded using two pressure measurements contains only the time taken for 
the pressure wave to travel between two points, and thus, the ‘true’ value of aortic PWV can 
be estimated. In contrast, the transit time recorded using ECG measurement contains the ICT, 
which introduces error in calculating aortic PWV. Disagreement between PWVECG and 
PWVpressure seen in Figure 8.5 can be explained by variability of ICT due to changes in 
cardiovascular parameters (Payne et al., 2006). The accuracy of PWVECG would be improved 
if the ICT could be subtracted from the transit time measured from ECG R wave to foot of 
abdominal pressure waveform. 
8.4.2.1 Factors Affecting ICT 
ICT can be influenced by contractility (Harris et al., 1967). Contractility of the heart is related 
to the velocity of myocardium fibre shortening (Glick et al., 1965), and ICT will be reduced if 
contractility is increased and vice versa (Talley et al., 1971). This effect can likely be seen in 
Pig 2 from Figure 8.5. The relationship between PWVECG and PWVpressure produced a higher 
gradient than the identity line indicating a shortening of ICT at higher contractility or higher 
PWVpressure. Another example of this phenomena can likely be seen in Pig 3, as there were 
significant increase in PWVECG due to reduced ICT in the post-dobutamine period. 
Other factors determining the duration of ICT are preload and afterload. Preload changes 
contractility of the heart by the Frank-Starling mechanism, and thus, increased preload 
decreases ICT and vice versa. Afterload changes the ICT by changing the load on the aortic 
valve resisting opening (Wallace et al., 1963). Increased afterload prolongs ICT as longer time 
would be taken for ventricular pressure to rise above increased aortic pressure. However, some 
studies suggest that ICT variability due to change in afterload are minimal or insignificant 
(Obrist et al., 1979, Cousineau et al., 1978).  
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In Pig 6, contractility was increased by dobutamine (Table 7.1), while ICT remained relatively 
constant. A combination of changes in cardiovascular parameters could have produced this 
outcome. Further investigations are required to quantify the effect of each of the cardiovascular 
parameters with the time of ICT. In addition, if a model could be developed for identifying 
ICT, it could be combined to give an accurate value of aortic PWV from ECG and a single 
pressure measurement. 
8.4.3 Potential Error Related to Detecting R-Wave 
The ECG waveform recorded during the experiment showed clear R-waves within the QRS 
complex for approximately 90 percent of the data. The rest of the data showed clear S-waves 
without a uniquely located R-wave and/or T-wave amplitude higher than R-wave. This type of 
ECG waveform was often recorded in the post-dobutamine period. The adrenergic stimulation 
from dobutamine may have introduced changes in the characteristics of the ECG waveforms 
(Yates and F Manini, 2012). An example of such an ECG waveform is shown in Figure 8.8. 
 
Figure 8.8 – Example of ECG waveform having non-distinctive R wave. Location of R wave 
detected using algorithm in section 8.2.1 are shown with red circle. Estimated regions of P 













Figure 8.8 shows that the width of QRS complex can be uncertain, as there were no distinctive 
Q-wave and R-wave in the ECG waveform. The algorithm in Section 8.2.1 estimated the 
location of the R-wave peaks, while the ‘true’ location of R wave could have been closer to the 
P-wave with the R-wave hidden/covered by the Q-wave. The calculated PWVECG includes 
errors due to R-wave detection. However, unique R-waves were present in approximately 90 
percent of the data, and thus, the result from this chapter is still valid. 
The problem of identifying the R-wave peak could be solved in the ICU environment, if ECG 
leads could be relocated to a position where a clear R-wave can be seen within the QRS 
complex. If patients have 6 or 12 leads ECG measurement, signal with the greatest R-wave 
magnitude could be used to ensure accurate detection. With a clear R-wave present on the ECG 
signal, the error associated with incorrect estimation of transit time can thus be minimised. 
8.4.4 Distance Calibration limitation 
The distance calibration method presented in section 8.2.2 assumes constant PWV through the 
aorta. In reality, PWV in the lower abdominal region will be higher than PWV near the aortic 
valve (Westerhof et al., 2015a). This space variation of PWV through the aorta produces a 
small error in the calculated distance. The accuracy of distance calibration can be improved 
with increased catheter movement distance. However, this approach may increase the risk of 
catheter related problems (Scheer et al., 2002). Further investigation are required to identify 
optimal catheter movement distance and related error produced from this method.  
8.5 Summary 
Estimation of PWV using transit time between the ECG R-wave and a single aortic pressure 
measurement were investigated in this chapter to improve clinical applicability of the aortic 
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model presented in Chapter 5 and the relationship identified in Chapter 7. Transit time 
estimated using ECG R-wave consists duration of ICT, and thus, did not accurately reflect 
values of aortic PWV when contractility, preload, and afterload are significantly altered. 
Dobutamine induced changes in these cardiovascular parameters showed the potential error 
associated with this approach. 
The accuracy of estimating SV using PWVECG was within the clinically acceptable range 
(±30%) if changes in aortic PWV were relatively small, however, when aortic PWV was 
significantly changed, SV estimation using PWVECG was unreliable as it was seen in Pig 2. The 
relationship between PWVECG and contractility had lower correlation coefficients than those 
identified in Chapter 7. It was observed that when changes in ICT are positively proportional 
to changes in aortic PWV, PWVECG is still clinically useful in predicting the changes in 
contractility. 
The use of the ECG R-wave for determining transit time can be improved if variability in ICT 
can be identified from changes in factors affecting ICT. Subtracting the value of ICT from 
transit time between ECG R-wave to a pressure measurement within aorta would provide an 
accurate value of aortic transit time. This method combined with the distance calibration 
technique presented would remove the necessity of additional pressure measurements or 
specialised devices for measuring aortic PWV. The methods presented have the potential to 
enhance efficiency of available data in the ICU, and increase clinical practicality of the aortic 
model presented in Chapter 5 and the relationship between PWV and contractility.
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Chapter 9: Conclusions 
Diagnosis and treatment of patients suffering from cardiovascular dysfunctions is very difficult 
due to regularly changing physiological state and complex interactions between the 
physiological responses to both dysfunction and treatment. These patients require 
hemodynamic monitoring that provides a full and clear picture of their cardiovascular state, 
where current approaches do not allow clear differentiation of dysfunction and thus make 
proper treatment selection difficult. This approach would enable optimal and patient-specific 
treatment, leading to better patient outcomes. 
The key hemodynamic parameters to monitor are SV and the circulatory factors influencing 
SV, such as vascular resistance and compliance. This information allows clinicians to 
differentiate dysfunction types, which in turn can guide them to correct diagnosis of evolving 
patient condition. Moreover, cardiovascular treatment involves modification of these 
parameters, and thus, providing quantifiable ‘direct’ response enables patient-specific titration 
of fluid and drug therapies in a way not currently possible. 
Currently, several methods are available for estimating SV. However, these methods are either 
accurate, but highly invasive, or less invasive, but only provide intermittent SV and/or are less 
accurate during hemodynamic instability, which is the point at which they are most needed. 
Because hemodynamic monitors are typically used for patients suffering from dysfunctions 
and requiring modification of hemodynamic parameters via treatment, hemodynamic 
instability in this cohort is inevitable. The more accurate, highly invasive methods may not be 
clinically or ethically feasible considering benefit-to-risk ratio.   
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Thus, the main aim of this research was to investigate, develop, and validate methods for 
continuous, accurate beat-to-beat estimation of SV using non-additionally invasive and/or 
typical ICU measurements. This goal was achieved by incorporating PWV measurements, 
traditionally used as a measure of vascular stiffness, into pressure contour analysis using a 
reservoir-excess pressure method. The developed method was validated using 
dobutamine/endotoxin porcine experimental data, and showed good accuracy compared with 
the direct, invasive measurements of SV.  
9.1 Novel SV Estimation Method 
In Chapter 3, the relationship between PWV and SV was investigated. The analysis revealed a 
linear relationship between these two parameters, but only when preload is the dominant 
influence for changes in SV. The relationship was much weaker when effects from dobutamine 
and endotoxin were involved. This new knowledge can be useful for monitoring fluid treatment, 
where the main hemodynamic changes arise from preload changes. However, continuous SV 
estimation from PWV measurements alone are unreliable, as both preload and afterload 
changes are not only expected from patients with cardiovascular dysfunction, but can define 
and differentiate these dysfunctions. 
Chapter 4 investigated a pressure contour method combining the three element Windkessel 
model and reservoir-excess method proposed by Wang et al. (2003). The aortic model 
developed utilizing these two methods provided relationships between the shapes of the aortic 
pressure waveform, Windkessel model parameters, and aortic blood flow. However, the model 
was structurally non-identifiable with the information from pressure measurements alone. 
Consequently, the model had to be calibrated with reference SV measurement, and assuming 
constant Windkessel model parameter for continuous estimation of SV. This choice was clearly 
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not ideal as hemodynamic instability indicates changes in Windkessel model parameters. The 
result showed larger errors in the estimated SV due to modification in Windkessel model 
parameters made by dobutamine and endotoxin. 
In Chapter 5, the aortic model developed in Chapter 4 was extended by combining the 
information from PWV and aortic pressure waveform, to overcome the limitations of fixing 
Windkessel model parameters for continuous SV estimation. This goal was achieved utilizing 
the water-hammer equation to identify aortic characteristic impedance from excess pressure 
and PWV, both of which were measured beat-to-beat. Thus, all the Windkessel model 
parameters were dynamically captured, enabling accurate SV estimation during significant 
hemodynamic changes. The result from the extended model showed significant improvement 
in estimated SV over previous methods. In particular, the estimation error caused by 
dobutamine/endotoxin changes was significantly reduced. Estimated SV accuracy from the 
extended model compared to direct measurement of SV was within approximately ±30%, 
demonstrating clinically acceptable accuracy according to clinical criteria from Critchely and 
Critchely (1999).  
Chapter 6 compared the accuracy of the novel SV estimation method developed in Chapter 5 
with the PiCCO system from PULSION and a nonlinear three-element model developed by 
Wesseling et al. (1993), both of which are widely known, but very different, pressure contour 
methods. The PiCCO system was calibrated before and after the administration of dobutamine 
and endotoxin to minimize error from hemodynamic changes, representing a best case scenario. 
The Wesseling model was optimized to the direct SV measurement, retrospectively. These 
calibrations and optimizations gave the best possible accuracy for these two methods. However, 
a method requiring multiple calibrations, particularly to minimizing error in unpredictable 
instability, suggests that patient SV trends between the calibration times could be unreliable, 
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thus minimizing the clinical utility. In addition, optimization of a model using SV data is thus 
clinically impossible. However, these issues do not affect the proposed method, highlighting 
its clinical advantages. 
The comparison between the aortic model, the PiCCO system, and the Wesseling model 
showed similar SV accuracy. This result demonstrates the ability of the proposed aortic model 
to capture relative changes in SV without calibration. Thus, estimated SV trends are reliable 
and patient progression from treatment can be correctly assessed, again, without requiring 
calibration or foreknowledge of when instability might occur.  
In summary, combined information from PWV and pressure contours enabled improved SV 
estimation from pressure measurements, even when significant homonymic instabilities are 
present. Furthermore, continuous arterial pressure measurements are often available in the ICU. 
Thus, the developed method is continuous, accurate, and potentially non-additionally invasive. 
9.2 Extending Clinical Functionality  
In Chapter 7, the relationship between contractility of the heart, ME, VAC, and outputs of the 
aortic model in Chapter 5 were investigated. Specifically, the strength of relationships between 
contractility and PWV, VAC and aortic characteristic impedance, and ME and the ratio of 
aortic compliance to impedance (CV/Zao) were analysed. This analysis was performed as 
knowledge of ME and contractility of the heart in addition to SV provides greater insight into 
the mechanics of the heart, as well as delineating the effects from the inotropes dosing to 
enhance contractility. Relationships identified can be used in a non-additionally invasive 
fashion, as required measurements are already obtained for estimation of SV.  
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The analysis revealed strong linear correlation between contractility and PWV, VAC and aortic 
characteristic impedance. These results add to the value of obtaining PWV and aortic 
characteristic impedance, as contractility and VAC trends can be monitored utilizing the 
identified relationships. However, inter-subject variability in the identified linearity limited 
identification of absolute changes. The relationship between ME and the ratio CV/Zao was 
weaker, but showed less inter-subject variability with 2 ~ 5% expected increase in ME from a 
unit increase to CV/Zao in s-1.  
In Chapter 8, accuracy of estimating aortic PWV using ECG R-wave and a single pressure 
measurement was investigated. Currently, two spatially separated pressure measurements 
within the aorta is uncommon in the ICU, thus the accuracy of PWV values obtained utilizing 
ECG signal was analysed as a way to obtain PWV with no additional equipment. The result 
revealed potential errors associated with this approach as transit time estimated includes 
isovolumetric contraction time and did not represent true wave transit time. It was found that 
variability of ICT must be identified to accurately capture PWV using the ECG R-wave. 
9.3 Overall Outcome 
A final major conclusion of this work is that a model-based approach can elucidate existing 
clinical data, turning them into physiologically relevant metrics. The output values from 
physiological models can then be used to assess patient-specific “direct” response from 
treatments. Such an approach is essential for developing effective patient-specific treatment 
protocols without adding new devices, sensors, or cost. The overall results thus provides an 




Specifically and more broadly, patient condition in cardiac or circulatory failure may appear 
essentially the same despite having different underlying physiological conditions. In such cases, 
a “standard” management is sub-optimal and can potentially be harmful. The model developed 
in this work allow clinicians to identify the exact cause of modulation in the blood pressure 
measurement, which is crucial for patient-specific diagnosis and treatment, and has not 
previously been possible. A treatment protocol based on unambiguous clinical measurement 
will significantly improve quality of patient care in the ICU. 
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Chapter 10: Future Work 
This chapter outlines the possible future avenues to expand, improve, and further validate the 
models/concepts presented in this thesis.   
10.1 Relationship between Ejection Time and Aortic Area  
The aortic model developed in Chapter 5 uses linear relationship identified between ejection 
time and aortic area calculated using direct SV measurement, as shown in Figure 5.3. The 
population relationship obtained between these two variables were employed to minimize the 
error in the estimation of aortic characteristic impedance using water-hammer equation. 
However, true aortic area was not measured in the porcine experiment, and thus, further 
investigation is required to confirm the validity of this relationship. 
Parameters identified based on population data could introduce additional error in the estimated 
SV, depending on the strength of the relationship. The identified relationship between ejection 
time and aortic area presented may weaken as future data including wider cardiovascular states 
are added. Therefore, the exact rationale behind this relationship needs to be clarified with 
measured aortic area. 
A possible explanation of this relationship could be the viscoelastic behaviour of aorta. The 
energy loss due to hysteresis of the aorta may change according to the speed of expansion, 
which is related to ejection time. The water-hammer equation does not take these variabilities 
into account, and when the amount of energy absorbed by the aorta is altered, calculated aortic 
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characteristic impedance deviates from the true value, where this effect is corrected by 
‘dynamic aortic area’ in this study. In such cases, changes in aortic area can be assumed 
negligible and relationship between energy loss and ejection time must be investigated. 
Continuous measurement of aortic cross sectional area is possible using sonomicrometry or 
using echo devices. With measured cross sectional area and aortic pressure value, beat-to-beat 
stress-strain loops can be produced revealing the time-dependent mechanisms of the aortic wall. 
Such data would clarify the relationship identified in Figure 5.3, potentially making the model 
entirely data-driven and the accuracy can be further improved. 
10.2 Validation with Human Data  
The aortic model presented in Chapter 5 has only been validated using porcine experimental 
data. Although human and porcine cardiovascular systems are very similar, human SV is 
approximately 3-4 times larger than pig and the total circulatory length is much longer. These 
physiological/anatomical differences may introduce new errors and limitations, which are not 
seen with the porcine data. In addition, the dobutamine experiment was performed on healthy 
pigs without any cardiovascular dysfunction. In reality, more complex cardiovascular 
interactions from various diseases and treatments are expected. Thus, further analysis and 
validation must be done with human data covering wider range of dysfunction states and 
inotropes/vasoactive drugs to confirm the clinical utility of these results. 
At the Christchurch Hospital ICU, PAC is used to monitor SV and pulmonary circulation, after 
mitral valve replacement or repair surgery. The data set for these patients would include 
intermittent SV from thermodilution, ECG, and continuous pulmonary arterial pressure 
waveform. These measurements would enable right ventricular SV to be estimated using the 
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model in Chapter 5. Furthermore, estimated SV can be validated against intermittent SV 
obtained from the PAC. 
The reservoir-excess separation can be performed on the pulmonary arterial pressure waveform 
as the pressure contour is similar to aortic pressure waveform. PWV can be estimated using the 
method presented in Chapter 8. The error introduced from ICT is thought to be reduced in the 
pulmonary circulation as PWV is much slower, taking up more time of the transit time 
estimated from the ECG R-peak to the foot of pulmonary arterial pressure. Using the 
determined excess pulmonary arterial pressure with PWV, pulmonary arterial impedance can 
be calculated. The continuous right ventricular SV can then be estimated from the excess 
pressure and the arterial impedance. 
All of the hemodynamic measurements required are taken as part of normal care for patients 
recovering from post mitral valve surgery. Hence, no additional interventions/measurements 
are required for this analysis, and thus, they provide the perfect starting point for human 
validation. In addition, past patient data can be retrospectively collected from the ICU data 
base, making larger data set.    
10.3 Integrating Aortic Model with Treatment Protocols 
Hemodynamic monitoring can only provide benefit to the patient when coupled with a defined 
and effective treatment protocol. For the aortic model developed in Chapter 5 to be clinically 
useful, the estimated hemodynamic parameters must influence treatment decisions, forming a 
feedback loop between the cause and the effect. Thus, allowing patient-specific titration of 
fluid/dosage in an attempt to achieve desired outcomes.  
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The aortic model is capable of continuously estimating SV as well as aortic characteristic 
impedance, aortic compliance, and systemic resistance. Utilizing these physiological 
parameters, an example of a treatment protocol in sepsis can be: administer/increase 
vasopressors until systemic resistance reaches a desired level, and once reached, titrate 
vasopressors, so that systemic resistance is maintained within a certain band. Similar approach 
can be applied for SV with fluid and inotropes. In addition, aortic characteristic impedance and 
compliance could be used for level of maldistribution, which are often present with hyper-





Abel, F. L. (1981). Maximal negative dP/dt as an indicator of end of systole. American Journal 
of Physiology - Heart and Circulatory Physiology, volume 240, H676-H679. 
Ackermann, U. (2004). Regulation of arterial blood pressure. Surgery (Oxford), volume 22, 
120a-120f. 
Alberts, B. (2012). Table 22-1 Blood cells. Molecular Biology of the cell. NCBI Bookshelf, 
volume 1. 
Alhashemi, J. A., Cecconi, M. and Hofer, C. K. (2011). Cardiac output monitoring: an 
integrative perspective. Critical Care, volume 15. 
Anavekar, N. S. and Oh, J. K. (2009). Doppler echocardiography: A contemporary review. 
Journal of cardiology, volume 54, 347-358. 
Antonelli, M., Levy, M., Andrews, P. J., Chastre, J., Hudson, L. D., Manthous, C., Meduri, G. 
U., Moreno, R. P., Putensen, C. and Stewart, T. (2007). Hemodynamic monitoring in 
shock and implications for management. Intensive care medicine, volume 33, 575-590. 
Anzics (2015). Centre for outcome and resource evaluation annual report 2014–2015. 
Australian and New Zealand Intensive Care Society, Melbourne, volume 1. 
Asanoi, H., Sasayama, S. and Kameyama, T. (1989). Ventriculoarterial coupling in normal and 
failing heart in humans. Circulation Research, volume 65, 483-493. 
Asfar, P., Meziani, F., Hamel, J.-F., Grelon, F., Megarbane, B., Anguel, N., Mira, J.-P., Dequin, 
P.-F., Gergaud, S. and Weiss, N. (2014). High versus low blood-pressure target in 
patients with septic shock. New England Journal of Medicine, volume 370, 1583-1593. 
Ashley, E. A. and Niebauer, J. (2004). Cardiology explained, Remedica. 
Awad, H. H., Anderson, F. A., Gore, J. M., Goodman, S. G. and Goldberg, R. J. (2012). 
Cardiogenic shock complicating acute coronary syndromes: insights from the Global 
Registry of Acute Coronary Events. American heart journal, volume 163, 963-971. 
Bajorat, J., Hofmockel, R., Vagts, D., Janda, M., Pohl, B., Beck, C. and Noeldge-Schomburg, 
G. (2006). Comparison of invasive and less-invasive techniques of cardiac output 
measurement under different haemodynamic conditions in a pig model. European 
journal of anaesthesiology, volume 23, 23-30. 
172 
 
Bangash, M. N., Kong, M. L. and Pearse, R. M. (2012). Use of inotropes and vasopressor 
agents in critically ill patients. British Journal of Pharmacology, volume 165, 2015-
2033. 
Bauernschmitt, R., Mehmanesh, H., Schulz, S., Vahl, C., Lange, R., Hanfler, M., Müller, A. 
and Hagl, S. (1999). Aortic Input impedance and ventriculoarterial coupling following 
cardioversion/defibrillation. Pacing and clinical electrophysiology, volume 22, 1047-
1053. 
Becker, D. E. (2006). Fundamentals of electrocardiography interpretation. Anesthesia progress, 
volume 53, 53-64. 
Bein, B., Meybohm, P., Cavus, E., Renner, J., Tonner, P. H., Steinfath, M., Scholz, J. and 
Doerges, V. (2007). The reliability of pulse contour-derived cardiac output during 
hemorrhage and after vasopressor administration. The Journal of the American Society 
of Anesthesiologists, volume 107, 107-113. 
Bein, B., Worthmann, F., Tonner, P. H., Paris, A., Steinfath, M., Hedderich, J. and Scholz, J. 
(2004). Comparison of esophageal Doppler, pulse contour analysis, and real-time 
pulmonary artery thermodilution for the continuous measurement of cardiac output. 
Journal of cardiothoracic and vascular anesthesia, volume 18, 185-189. 
Bellomo, R. and Uchino, S. (2003). Cardiovascular monitoring tools: use and misuse. Current 
opinion in critical care, volume 9, 225-229. 
Ben-Shlomo, Y., Spears, M., Boustred, C., May, M., Anderson, S. G., Benjamin, E. J., 
Boutouyrie, P., Cameron, J., Chen, C.-H. and Cruickshank, J. K. (2014). Aortic pulse 
wave velocity improves cardiovascular event prediction: an individual participant 
meta-analysis of prospective observational data from 17,635 subjects. Journal of the 
American College of Cardiology, volume 63, 636-646. 
Bendjelid, K. (2009). When to recalibrate the PiCCO™? From a physiological point of view, 
the answer is simple. Acta Anaesthesiologica Scandinavica, volume 53, 689-690. 
Biel, L., Pettersson, O., Philipson, L. and Wide, P. (2001). ECG analysis: a new approach in 
human identification. IEEE Transactions on Instrumentation and Measurement, 
volume 50, 808-812. 
Blacher, J., Asmar, R., Djane, S., London, G. M. and Safar, M. E. (1999). Aortic pulse wave 
velocity as a marker of cardiovascular risk in hypertensive patients. Hypertension, 
volume 33, 1111-1117. 
Bonate, P. L. and Steimer, J.-L. (2006). Pharmacokinetic-pharmacodynamic modeling and 
simulation, Springer. 
Boyd, J. H., Forbes, J., Nakada, T.-A., Walley, K. R. and Russell, J. A. (2011). Fluid 
resuscitation in septic shock: A positive fluid balance and elevated central venous 
173 
 
pressure are associated with increased mortality*. Critical care medicine, volume 39, 
259-265. 
Boyle, M., Lawrence, J., Belessis, A., Murgo, M. and Shehabi, Y. (2007). Comparison of 
dynamic measurements of pulse contour with pulsed heat continuous cardiac output in 
postoperative cardiac surgical patients. Australian Critical Care, volume 20, 27-32. 
Brace, R. A. (1977). Fitting straight lines to experimental data. American Journal of 
Physiology-Regulatory, Integrative and Comparative Physiology, volume 233, R94-
R99. 
Bramwell, J. C. and Hill, A. V. (1922). The velocity of the pulse wave in man. Proceedings of 
the Royal Society of London. Series B, Containing Papers of a Biological Character, 
volume 93, 298-306. 
Brun-Buisson, C. (2000). The epidemiology of the systemic inflammatory response. Intensive 
Care Medicine, volume 26, S64-S74. 
Burkoff, D. (2002). Mechanical properties of the heart and its interaction with the vascular 
system. Cardiac Physiology, volume, 1-23. 
Butlin, M. (2008). Structural and functional effects on large artery stiffness: an in-vivo 
experimental investigation. volume. 
Button, D., Weibel, L., Reuthebuch, O., Genoni, M., Zollinger, A. and Hofer, C. (2007). 
Clinical evaluation of the FloTrac/VigileoTM system and two established continuous 
cardiac output monitoring devices in patients undergoing cardiac surgery†‡. British 
journal of anaesthesia, volume 99, 329-336. 
Camporota, L. and Beale, R. (2010). Pitfalls in haemodynamic monitoring based on the arterial 
pressure waveform. Crit Care, volume 14, 124. 
Cappello, A., Gnudi, G. and Lamberti, C. (1995). Identification of the three-element 
windkessel model incorporating a pressure-dependent compliance. Ann Biomed Eng, 
volume 23, 164 - 177. 
Cavazzoni, S. L. Z. and Dellinger, R. P. (2006). Hemodynamic optimization of sepsis-induced 
tissue hypoperfusion. Critical Care, volume 10, 1. 
Cecconi, M., De Backer, D., Antonelli, M., Beale, R., Bakker, J., Hofer, C., Jaeschke, R., 
Mebazaa, A., Pinsky, M. R. and Teboul, J. L. (2014). Consensus on circulatory shock 
and hemodynamic monitoring. Task force of the European Society of Intensive Care 
Medicine. Intensive care medicine, volume 40, 1795-1815. 
Cecconi, M. and Rhodes, A. (2010). Pulse pressure analysis: to make a long story short. Critical 
Care, volume 14, 1. 
174 
 
Cecelja, M. and Chowienczyk, P. (2012). Role of arterial stiffness in cardiovascular disease. 
JRSM cardiovascular disease, volume 1, 11. 
Chantler, P. D. and Lakatta, E. (2012). Arterial–ventricular coupling with aging and disease. 
Frontiers in physiology, volume 3, 90. 
Cheatham, M. L., Block, E. F., Promes, J., Smith, H., Dent, D. and Mueller, D. (2008). Shock: 
an overview. Irwin RS si Rippe JM (editori)“Intensive care medicine”. Lippincott 
Williams & Wilkins, Philadelphia, volume, 1831-1842. 
Chen, C.-H., Fetics, B., Nevo, E., Rochitte, C. E., Chiou, K.-R., Ding, P.-A., Kawaguchi, M. 
and Kass, D. A. (2001). Noninvasive single-beat determination of left ventricular end-
systolic elastance in humans. Journal of the American College of Cardiology, volume 
38, 2028-2034. 
Cheryl, H. (1999). Reflexes that control cardiovascular function. volume. 
Chirinos, J. A. (2013). Ventricular–arterial coupling: invasive and non-invasive assessment. 
Artery research, volume 7, 2-14. 
Collaboration, R. V. F. a. S. (2010). Determinants of pulse wave velocity in healthy people and 
in the presence of cardiovascular risk factors:‘establishing normal and reference values’. 
European heart journal, volume 31, 2338-2350. 
Cousineau, D., Lapointe, L. and De Champlain, J. (1978). Circulating catecholamines and 
systolic time intervals in normotensive and hypertensive patients with and without left 
ventricular hypertrophy. American heart journal, volume 96, 227-234. 
Cousins, T. R. and O'donnell, J. M. (2004). Arterial cannulation: a critical review. AANA 
journal, volume 72. 
Critchley, L. A. and Critchley, J. A. (1999). A meta-analysis of studies using bias and precision 
statistics to compare cardiac output measurement techniques. Journal of clinical 
monitoring and computing, volume 15, 85-91. 
Dart, A. M. and Kingwell, B. A. (2001). Pulse pressure—a review of mechanisms and clinical 
relevance. Journal of the American College of Cardiology, volume 37, 975-984. 
De Wilde, R., Schreuder, J., Van Den Berg, P. and Jansen, J. (2007). An evaluation of cardiac 
output by five arterial pulse contour techniques during cardiac surgery. Anaesthesia, 
volume 62, 760-768. 
De Wilde, R., Van Den Berg, P. and Jansen, J. (2008). Review of the PiCCO device; our 
experience in the ICU. Netherlands J Crit Care, volume 12, 177-179. 
175 
 
De Wildt, D. J. and Sangster, B. (1983). An evaluation of derived aortic flow parameters as 
indices of myocardial contractility in rats. Journal of pharmacological methods, 
volume 10, 55-64. 
Dean, D. A., Jia, C.-X., Cabreriza, S. E., D‘Alessandro, D. A., Dickstein, M. L., Sardo, M. J., 
Chalik, N. and Spotnitz, H. M. (1996). Validation study of a new transit time ultrasonic 
flow probe for continuous great vessel measurements. ASAIO Journal, volume 42, 
M671-676. 
Della Rocca, G., Costa, M. G., Coccia, C., Pompei, L., Di Marco, P., Vilardi, V. and Pietropaoli, 
P. (2003). Cardiac output monitoring: aortic transpulmonary thermodilution and pulse 
contour analysis agree with standard thermodilution methods in patients undergoing 
lung transplantation. Canadian journal of anaesthesia, volume 50, 707-711. 
Dellinger, R. P. (2003). Cardiovascular management of septic shock. Critical care medicine, 
volume 31, 946-955. 
Dubin, A., Pozo, M. O., Casabella, C. A., Pálizas, F., Murias, G., Moseinco, M. C., Edul, V. S. 
K., Estenssoro, E. and Ince, C. (2009). Increasing arterial blood pressure with 
norepinephrine does not improve microcirculatory blood flow: a prospective study. 
Critical Care, volume 13, 1. 
Eaton, G. M., Cody, R. J. and Binkley, P. (1993). Increased aortic impedance precedes 
peripheral vasoconstriction at the early stage of ventricular failure in the paced canine 
model. Circulation, volume 88, 2714-2721. 
Eisenberg, P. R., Jaffe, A. S. and Schuster, D. P. (1984). Clinical evaluation compared to 
pulmonary artery catheterization in the hemodynamic assessment of critically ill 
patients. Critical care medicine, volume 12, 549-553. 
Elbers, P. W. and Ince, C. (2006). Bench-to-bedside review: Mechanisms of critical illness–
classifying microcirculatory flow abnormalities in distributive shock. Critical care, 
volume 10, 1. 
Ellender, T. J. and Skinner, J. C. (2008). The use of vasopressors and inotropes in the 
emergency medical treatment of shock. Emergency Medicine Clinics of North America, 
volume 26, 759-86. 
Eren, H. Year. Accuracy in real time ultrasonic applications and transit-time flow meters. In:  
Instrumentation and Measurement Technology Conference, 1998. IMTC/98. 
Conference Proceedings. IEEE, 1998. IEEE, 568-572. 
Esper, S. A. and Pinsky, M. R. (2014). Arterial waveform analysis. Best Practice & Research 
Clinical Anaesthesiology, volume 28, 363-380. 
Evans, D., Doraiswamy, V., Prosciak, M., Silviera, M., Seamon, M., Funes, V. R., Cipolla, J., 
Wang, C., Kavuturu, S. and Torigian, D. (2009). Complications associated with 
176 
 
pulmonary artery catheters: a comprehensive clinical review. Scandinavian Journal of 
Surgery, volume 98, 199-208. 
Felker, G. M. and O’connor, C. (2001). Rational use of inotropic therapy in heart failure. 
Current Cardiology Reports, volume 3, 108-113. 
Francis, G. S., Bartos, J. A. and Adatya, S. (2014). Inotropes. Journal of the American College 
of Cardiology, volume 63, 2069-2078. 
Frank, O. (1895). Zur Dynamik des Herzmuskels, Druck v. R. Oldenbourg. 
Franklin, C. and Mathew, J. (1994). Developing Strategies to Prevent Inhospital Cardiac-Arrest 
- Analyzing Responses of Physicians and Nurses in the Hours before the Event. Critical 
Care Medicine, volume 22, 244-247. 
Fukuda, N., Terui, T., Ohtsuki, I., Ishiwata, S. I. and Kurihara, S. (2009). Titin and troponin: 
central players in the Frank-Starling mechanism of the heart. Current cardiology 
reviews, volume 5, 119-124. 
Ganz, W., Donoso, R., Marcus, H. S., Forrester, J. S. and Swan, H. J. (1971). A new technique 
for measurement of cardiac output by thermodilution in man. The American journal of 
cardiology, volume 27, 392-396. 
Garg, S., Singhal, S., Sharma, P. and Jha, A. (2012). Inotropes and vasopressors review of 
physiology and clinical use. J Pulmon Resp Med, volume 2, 128. 
Glick, G., Sonnenblick, E. H. and Braunwald, E. (1965). Myocardial force-velocity relations 
studied in intact unanesthetized man. Journal of Clinical Investigation, volume 44, 978. 
Gödje, O., Höke, K., Goetz, A. E., Felbinger, T. W., Reuter, D. A., Reichart, B., Friedl, R., 
Hannekum, A. and Pfeiffer, U. J. (2002). Reliability of a new algorithm for continuous 
cardiac output determination by pulse-contour analysis during hemodynamic instability. 
Critical care medicine, volume 30, 52-58. 
Goldhaber, S. Z. and Elliott, C. G. (2003a). Acute pulmonary embolism: Part I Epidemiology, 
pathophysiology, and diagnosis. Circulation, volume 108, 2726-2729. 
Goldhaber, S. Z. and Elliott, C. G. (2003b). Acute Pulmonary Embolism: Part II Risk 
Stratification, Treatment, and Prevention. Circulation, volume 108, 2834-2838. 
Gomez, C. and Palazzo, M. (1998). Pulmonary artery catheterization in anaesthesia and 
intensive care. British journal of anaesthesia, volume 81, 945-956. 
Gondos, T., Marjanek, Z., Kisvarga, Z. and Halász, G. (2009). Precision of transpulmonary 
thermodilution: how many measurements are necessary? European Journal of 
Anaesthesiology (EJA), volume 26, 508-512. 
177 
 
Gowda, R. M., Fox, J. T. and Khan, I. A. (2008). Cardiogenic shock: basics and clinical 
considerations. International journal of cardiology, volume 123, 221-228. 
Graham, C. and Parke, T. (2005). Critical care in the emergency department: shock and 
circulatory support. Emergency Medicine Journal, volume 22, 17-21. 
Grodins, F. S. (1962). Basic concepts in the determination of vascular volumes by indicator-
dilution methods. Circulation research, volume 10, 429-446. 
Gruenewald, M., Meybohm, P., Renner, J., Broch, O., Caliebe, A., Weiler, N., Steinfath, M., 
Scholz, J. and Bein, B. (2011). Effect of norepinephrine dosage and calibration 
frequency on accuracy of pulse contour-derived cardiac output. Critical Care, volume 
15, 1. 
Guarracino, F., Baldassarri, R. and Pinsky, M. R. (2013). Ventriculo-arterial decoupling in 
acutely altered hemodynamic states. Critical Care, volume 17, 1. 
Guarracino, F., Ferro, B., Morelli, A., Bertini, P., Baldassarri, R. and Pinsky, M. R. (2014). 
Ventriculoarterial decoupling in human septic shock. Critical Care, volume 18, 1. 
Hadian, M., Kim, H. K., Severyn, D. A. and Pinsky, M. R. (2010). Cross-comparison of cardiac 
output trending accuracy of LiDCO, PiCCO, FloTrac and pulmonary artery catheters. 
Critical Care, volume 14, 1. 
Hall, J. E. (2011). Guyton and Hall textbook of medical physiology. Philadelphia, PA: 
Saunders/Elsevier, volume. 
Halvorsen, P., Espinoza, A., Lundblad, R., Cvancarova, M., Hol, P., Fosse, E. and Tønnessen, 
T. (2006). Agreement between PiCCO pulse‐ contour analysis, pulmonal artery 
thermodilution and transthoracic thermodilution during off‐pump coronary artery 
by‐pass surgery. Acta anaesthesiologica scandinavica, volume 50, 1050-1057. 
Hametner, B., Wassertheurer, S., Hughes, A. D., Parker, K. H., Weber, T. and Eber, B. (2014). 
Reservoir and excess pressures predict cardiovascular events in high-risk patients. 
International journal of cardiology, volume 171, 31-36. 
Harley, A., Starmer, C. F. and Greenfield Jr, J. C. (1969). Pressure-flow studies in man. An 
evaluation of the duration of the phases of systole. Journal of Clinical Investigation, 
volume 48, 895. 
Harms, M. P., Wesseling, K. H., Frank, P., Jenstrup, M., Van Goudoever, J., Secher, N. H. and 
Van Lieshout, J. J. (1999). Continuous stroke volume monitoring by modelling flow 
from non-invasive measurement of arterial pressure in humans under orthostatic stress. 
Clinical Science, volume 97, 291-301. 
178 
 
Harris, W. S., Schoenfeld, C. D. and Weissler, A. M. (1967). Effects of adrenergic receptor 
activation and blockade on the systolic preejection period, heart rate, and arterial 
pressure in man. Journal of Clinical Investigation, volume 46, 1704. 
Hayes, M. A., Timmins, A. C., Yau, E., Palazzo, M., Hinds, C. J. and Watson, D. (1994). 
Elevation of systemic oxygen delivery in the treatment of critically ill patients. New 
England Journal of Medicine, volume 330, 1717-1722. 
Hirata, K., Kawakami, M. and O'rourke, M. F. (2006). Pulse wave analysis and pulse wave 
velocity: a review of blood pressure interpretation 100 years after Korotkov. 
Circulation journal: official journal of the Japanese Circulation Society, volume 70, 
1231-1239. 
Hofer, C. K., Senn, A., Weibel, L. and Zollinger, A. (2008). Assessment of stroke volume 
variation for prediction of fluid responsiveness using the modified FloTrac™ and 
PiCCOplus™ system. Critical Care, volume 12, 1. 
Hollenberg, S. M., Kavinsky, C. J. and Parrillo, J. E. (1999). Cardiogenic shock. Annals of 
internal medicine, volume 131, 47-59. 
Hori, M. and Okamoto, H. (2012). Heart rate as a target of treatment of chronic heart failure. 
Journal of cardiology, volume 60, 86-90. 
Horvath, I. G., Nemeth, A., Lenkey, Z., Alessandri, N., Tufano, F., Kis, P., Gaszner, B. and 
Cziraki, A. (2010). Invasive validation of a new oscillometric device (Arteriograph) for 
measuring augmentation index, central blood pressure and aortic pulse wave velocity. 
Journal of hypertension, volume 28, 2068-2075. 
Hughes, A., Wang, J.-J., Bouwmeester, C., Davies, J., Shrive, N., Tyberg, J. and Parker, K. 
(2012). The reservoir-wave paradigm. Journal of hypertension, volume 30, 1880-1881. 
Hughes, A. D. and Parker, K. H. (2009). Forward and backward waves in the arterial system: 
impedance or wave intensity analysis? Medical & biological engineering & computing, 
volume 47, 207-210. 
Ince, C. (2005). The microcirculation is the motor of sepsis. Critical care, volume 9, 1. 
Jansen, J., Schreuder, J., Mulier, J. P., Smith, N., Settels, J. and Wesseling, K. (2001). A 
comparison of cardiac output derived from the arterial pressure wave against 
thermodilution in cardiac surgery patients. British journal of anaesthesia, volume 87, 
212-222. 
Jansen, J., Wesseling, K., Settels, J. and Schreuder, J. (1990). Continuous cardiac output 




Jawad, I., Lukšić, I. and Rafnsson, S. B. (2012). Assessing available information on the burden 
of sepsis: global estimates of incidence, prevalence and mortality. population, volume 
2, 4. 
Jellema, W. T., Wesseling, K. H., Groeneveld, J. A., Stoutenbeek, C. P., Thijs, L. G. and Van 
Lieshout, J. J. (1999). Continuous Cardiac Output in Septic Shock by Simulating a 
Model of the Aortic Input Impedance A Comparison with Bolus Injection 
Thermodilution. The Journal of the American Society of Anesthesiologists, volume 90, 
1317-1328. 
Kamoi, S., Pretty, C., Docherty, P., Squire, D., Revie, J., Chiew, Y. S., Desaive, T., Shaw, G. 
M. and Chase, J. G. (2014). Continuous stroke volume estimation from aortic pressure 
using zero dimensional cardiovascular model: proof of concept study from porcine 
experiments. PloS one, volume 9, e102476. 
Kass, D. (1992). Clinical evaluation of left heart function by conductance catheter technique. 
European heart journal, volume 13, 57-64. 
Kelley, D. M. (2005). Hypovolemic shock: an overview. Critical care nursing quarterly, 
volume 28, 2-19. 
Khir, A., O'brien, A., Gibbs, J. and Parker, K. (2001). Determination of wave speed and wave 
separation in the arteries. Journal of biomechanics, volume 34, 1145-1155. 
Kinsman, J. M., Moore, J. W. and Hamilton, W. (1929). Studies on the circulation. American 
Journal of Physiology--Legacy Content, volume 89, 322-330. 
Knaapen, P., Germans, T., Knuuti, J., Paulus, W. J., Dijkmans, P. A., Allaart, C. P., 
Lammertsma, A. A. and Visser, F. C. (2007). Myocardial energetics and efficiency 
current status of the noninvasive approach. Circulation, volume 115, 918-927. 
Kougias, P., Weakley, S. M., Yao, Q., Lin, P. H. and Chen, C. (2010). Arterial baroreceptors 
in the management of systemic hypertension. Medical science monitor: international 
medical journal of experimental and clinical research, volume 16, RA1. 
Kutty, S., Kottam, A. T., Padiyath, A., Bidasee, K. R., Li, L., Gao, S., Wu, J., Lof, J., Danford, 
D. A. and Kuehne, T. (2013). Validation of admittance computed left ventricular 
volumes against real‐time three‐dimensional echocardiography in the porcine heart. 
Experimental physiology, volume 98, 1092-1101. 
Ky, B., French, B., Khan, A. M., Plappert, T., Wang, A., Chirinos, J. A., Fang, J. C., Sweitzer, 
N. K., Borlaug, B. A. and Kass, D. A. (2013). Ventricular-arterial coupling, remodeling, 
and prognosis in chronic heart failure. Journal of the American College of Cardiology, 
volume 62, 1165-1172. 
180 
 
La Rovere, M. T., Pinna, G. D. and Raczak, G. (2008). Baroreflex sensitivity: measurement 
and clinical implications. Annals of Noninvasive Electrocardiology, volume 13, 191-
207. 
Lamia, B., Chemla, D., Richard, C. and Teboul, J.-L. (2005). Clinical review: interpretation of 
arterial pressure wave in shock states. Critical Care, volume 9, 1. 
Landgarten, M. J., Kumar, A. and Parrillo, J. E. (2000). Cardiovascular dysfunction in sepsis 
and septic shock. Current treatment options in cardiovascular medicine, volume 2, 
451-459. 
Langewouters, G., Wesseling, K. and Goedhard, W. (1984). The static elastic properties of 45 
human thoracic and 20 abdominal aortas in vitro and the parameters of a new model. 
Journal of biomechanics, volume 17, 425-435. 
Lantelme, P., Mestre, C., Lievre, M., Gressard, A. and Milon, H. (2002). Heart rate an 
important confounder of pulse wave velocity assessment. Hypertension, volume 39, 
1083-1087. 
Laurent, S., Cockcroft, J., Van Bortel, L., Boutouyrie, P., Giannattasio, C., Hayoz, D., Pannier, 
B., Vlachopoulos, C., Wilkinson, I. and Struijker-Boudier, H. (2006). Expert consensus 
document on arterial stiffness: methodological issues and clinical applications. 
European heart journal, volume 27, 2588-2605. 
Lavdaniti, M. (2008). Invasive and non-invasive methods for cardiac output measurement. 
International Journal of Caring Sciences, volume 1, 112. 
Ledoux, D., Astiz, M. E., Carpati, C. M. and Rackow, E. C. (2000). Effects of perfusion 
pressure on tissue perfusion in septic shock. CRITICAL CARE MEDICINE-
BALTIMORE-, volume 28, 2729-2732. 
Lefrant, J., Bruelle, P., Aya, A., Saissi, G., Dauzat, M., De La Coussaye, J. and Eledjam, J. 
(1998). Training is required to improve the reliability of esophageal Doppler to measure 
cardiac output in critically ill patients. Intensive care medicine, volume 24, 347-352. 
Lehtonen, L. A., Antila, S. and Pentikäinen, P. J. (2004). Pharmacokinetics and 
pharmacodynamics of intravenous inotropic agents. Clinical pharmacokinetics, volume 
43, 187-203. 
Lewis, R. P., Rittogers, S., Froester, W. and Boudoulas, H. (1977). A critical review of the 
systolic time intervals. Circulation, volume 56, 146-158. 
Li, W. C., Yu, M. H., Zhang, H. M., Wang, H. Q., Xi, G. M., Yao, B. C., Deng, Z. H. and Zeng, 
Y. J. (2008). Biomechanical properties of ascending aorta and pulmonary trunk in pigs 
and humans. Xenotransplantation, volume 15, 384-389. 
181 
 
Lobo, S. M., Lobo, F. R., Polachini, C. A., Patini, D. S., Yamamoto, A. E., De Oliveira, N. E., 
Serrano, P., Sanches, H. S., Spegiorin, M. A. and Queiroz, M. M. (2006). Prospective, 
randomized trial comparing fluids and dobutamine optimization of oxygen delivery in 
high-risk surgical patients [ISRCTN42445141]. Critical care, volume 10, 1. 
Loukogeorgakis, S., Dawson, R., Phillips, N., Martyn, C. N. and Greenwald, S. E. (2002). 
Validation of a device to measure arterial pulse wave velocity by a 
photoplethysmographic method. Physiological measurement, volume 23, 581. 
Luecke, T. and Pelosi, P. (2005). Clinical review: Positive end-expiratory pressure and cardiac 
output. Critical Care, volume 9, 607-21. 
Mackenzie, I., Wilkinson, I. and Cockcroft, J. (2002). Assessment of arterial stiffness in clinical 
practice. Qjm, volume 95, 67-74. 
Marik, P. E. (2013). Noninvasive cardiac output monitors: a state-of the-art review. J 
Cardiothorac Vasc Anesth, volume 27, 121-34. 
Marik, P. E., Cavallazzi, R., Vasu, T. and Hirani, A. (2009). Dynamic changes in arterial 
waveform derived variables and fluid responsiveness in mechanically ventilated 
patients: a systematic review of the literature*. Critical care medicine, volume 37, 
2642-2647. 
Marik, P. E., Monnet, X. and Teboul, J.-L. (2010). Hemodynamic parameters to guide fluid 
therapy. Transfusion Alternatives in Transfusion Medicine, volume 11, 102-112. 
Mayer, J., Boldt, J., Poland, R., Peterson, A. and Manecke, G. R. (2009). Continuous arterial 
pressure waveform–based cardiac output using the FloTrac/Vigileo: a review and meta-
analysis. Journal of cardiothoracic and vascular anesthesia, volume 23, 401-406. 
Mckinley, M. and O'loughlin, V. 2007. Human Anatomy. McGraw-Hill  
Mehta, Y. and Arora, D. (2014). Newer methods of cardiac output monitoring. World journal 
of cardiology, volume 6, 1022. 
Merx, M. and Weber, C. (2007). Cardiovascular Involvement in General Medical Conditions. 
infection, volume 793, 802. 
Metafratzi, Z. M., Efremidis, S. C., Skopelitou, A. S. and De Roos, A. (2002). The clinical 
significance of aortic compliance and its assessment with magnetic resonance imaging. 
Journal of Cardiovascular Magnetic Resonance, volume 4, 481-491. 
Metra, M., Bettari, L., Carubelli, V., Bugatti, S., Dei Cas, A., Del Magro, F., Lazzarini, V., 
Lombardi, C. and Dei Cas, L. (2011). Use of inotropic agents in patients with advanced 
heart failure. Drugs, volume 71, 515-525. 
182 
 
Michard, F. and Teboul, J. L. (2002). Predicting fluid responsiveness in ICU patients - A 
critical analysis of the evidence. Chest, volume 121, 2000-2008. 
Millasseau, S. C., Stewart, A. D., Patel, S. J., Redwood, S. R. and Chowienczyk, P. J. (2005). 
Evaluation of carotid-femoral pulse wave velocity influence of timing algorithm and 
heart rate. Hypertension, volume 45, 222-226. 
Milnor, W. R. (1975). Arterial impedance as ventricular afterload. Circulation research, 
volume 36, 565-570. 
Modine, T., Decoene, C., Al-Ruzzeh, S., Athanasiou, T., Poivre, P., Pol, A. and Fayad, G. 
(2005). Dobutamine improves thoracic aortic blood flow during off-pump coronary 
artery bypass surgery: results of a prospective randomised controlled trial. European 
journal of cardio-thoracic surgery, volume 27, 289-295. 
Mohsenin, V. (2015). Assessment of preload and fluid responsiveness in intensive care unit. 
How good are we? Journal of critical care, volume 30, 567-573. 
Monnet, X., Anguel, N., Naudin, B., Jabot, J., Richard, C. and Teboul, J.-L. (2010). Arterial 
pressure-based cardiac output in septic patients: different accuracy of pulse contour and 
uncalibrated pressure waveform devices. Critical Care, volume 14, 1. 
Monnet, X. and Teboul, J.-L. (2013). Assessment of volume responsiveness during mechanical 
ventilation: recent advances. Crit Care, volume 17, 217. 
Montenij, L. J., De Waal, E. E. C. and Buhre, W. F. (2011). Arterial waveform analysis in 
anesthesia and critical care. Current Opinion in Anesthesiology, volume 24, 651-656. 
Morgan, C. and Wheeler, D. S. (2013). Obstructive Shock. Open Pediatric Medicine Journal, 
volume 7, 35-37. 
Mozaffarian, D., Benjamin, E. J., Go, A. S., Arnett, D. K., Blaha, M. J., Cushman, M., De 
Ferranti, S., Després, J.-P., Fullerton, H. J., Howard, V. J., Huffman, M. D., Judd, S. E., 
Kissela, B. M., Lackland, D. T., Lichtman, J. H., Lisabeth, L. D., Liu, S., Mackey, R. 
H., Matchar, D. B., Mcguire, D. K., Mohler, E. R., Moy, C. S., Muntner, P., Mussolino, 
M. E., Nasir, K., Neumar, R. W., Nichol, G., Palaniappan, L., Pandey, D. K., Reeves, 
M. J., Rodriguez, C. J., Sorlie, P. D., Stein, J., Towfighi, A., Turan, T. N., Virani, S. S., 
Willey, J. Z., Woo, D., Yeh, R. W. and Turner, M. B. (2015). Heart Disease and Stroke 
Statistics—2015 Update. A Report From the American Heart Association, volume 131, 
e29-e322. 
Murgo, J. P., Westerhof, N., Giolma, J. P. and Altobelli, S. A. (1980). Aortic input impedance 
in normal man: relationship to pressure wave forms. Circulation, volume 62, 105-116. 
Nahouraii, R. A. and Rowell, S. E. (2010). Static measures of preload assessment. Critical care 
clinics, volume 26, 295-305. 
183 
 
Nieminen, M. S. and Harjola, V.-P. (2005). Definition and epidemiology of acute heart failure 
syndromes. The American journal of cardiology, volume 96, 5-10. 
Norton, J. M. (2001). Toward consistent definitions for preload and afterload. Advances in 
Physiology Education, volume 25, 53-61. 
Obrist, P. A., Light, K. C., Mccubbin, J. A., Hutcheson, J. and Hoffer, J. L. (1979). Pulse transit 
time: Relationship to blood pressure and myocardial performance. Psychophysiology, 
volume 16, 292-301. 
Oommen, B., Karamanoglu, M. and Kovács, S. J. (2003). Modeling time varying elastance: 
the meaning of “load-independence”. Cardiovascular Engineering: An International 
Journal, volume 3, 123-130. 
Oren-Grinberg, A. (2010). The PiCCO monitor. International anesthesiology clinics, volume 
48, 57-85. 
Oren-Grinberg, A., Talmor, D. and Brown, S. M. (2013). Concise definitive review: focused 
critical care echocardiography in the ICU. Critical care medicine, volume 41, 2618. 
Østergaard, M., Nielsen, J., Rasmussen, J. and Berthelsen, P. (2006). Cardiac output–pulse 
contour analysis vs. pulmonary artery thermodilution. Acta anaesthesiologica 
scandinavica, volume 50, 1044-1049. 
Overgaard, C. B. and Dzavik, V. (2008). Inotropes and vasopressors - Review of physiology 
and clinical use in cardiovascular disease. Circulation, volume 118, 1047-1056. 
Parker, K., Alastruey, J. and Stan, G.-B. (2012). Arterial reservoir-excess pressure and 
ventricular work. Medical & Biological Engineering & Computing, volume 50, 419-
424. 
Payne, R., Symeonides, C., Webb, D. and Maxwell, S. (2006). Pulse transit time measured 
from the ECG: an unreliable marker of beat-to-beat blood pressure. Journal of Applied 
Physiology, volume 100, 136-141. 
Pearse, R. M. and Rhodes, A. (2004). Haemodynamic monitoring and management of the 
circulation in intensive care. Surgery (Oxford), volume 22, 88-93. 
Pereira, T., Correia, C. and Cardoso, J. (2015). Novel methods for pulse wave velocity 
measurement. Journal of medical and biological engineering, volume 35, 555-565. 
Perkins, G. D., Mcauley, D. F., Davies, S. and Gao, F. (2003). Discrepancies between clinical 
and postmortem diagnoses in critically ill patients: an observational study. Critical 
Care, volume 7, R129-R132. 
184 
 
Peyton, P. J. and Chong, S. W. (2010). Minimally Invasive Measurement of Cardiac Output 
during Surgery and Critical CareA Meta-analysis of Accuracy and Precision. The 
Journal of the American Society of Anesthesiologists, volume 113, 1220-1235. 
Phillips, R. and Brierley, J. (2015). Fluid responsiveness is about stroke volume, and not pulse 
pressure Yogi: the power of Doppler fluid management and cardiovascular monitoring. 
Journal of clinical monitoring and computing, volume 29, 197-200. 
Phillips, R. A., Hood, S. G., Jacobson, B. M., West, M. J., Wan, L. and May, C. N. (2012). 
Pulmonary artery catheter (PAC) accuracy and efficacy compared with flow probe and 
transcutaneous Doppler (USCOM): an ovine cardiac output validation. Critical care 
research and practice, volume 2012. 
Pinsky, M. R. (1984). Determinants of pulmonary arterial flow variation during respiration. 
Journal of Applied Physiology, volume 56, 1237-1245. 
Pironet, A., Dauby, P. C., Chase, J. G., Docherty, P. D., Revie, J. A. and Desaive, T. (2016). 
Structural identifiability analysis of a cardiovascular system model. Medical 
engineering & physics, volume 38, 433-441. 
Pittarello, D., Bonato, R., Marcassa, A., Pasini, L., Falasco, G. and Giron, G. (2004). 
Ventriculo‐arterial coupling and mechanical efficiency with remifentanil in patients 
with coronary artery disease. Acta anaesthesiologica scandinavica, volume 48, 61-68. 
Porhomayon, J., El-Solh, A., Papadakos, P. and Nader, N. D. (2012a). Cardiac output 
monitoring devices: an analytic review. Internal and emergency medicine, volume 7, 
163-171. 
Porhomayon, J., Zadeii, G., Congello, S. and Nader, N. D. (2012b). Applications of minimally 
invasive cardiac output monitors. International journal of emergency medicine, volume 
5, 1. 
Porterfield, J. E., Kottam, A. T., Raghavan, K., Escobedo, D., Jenkins, J. T., Larson, E. R., 
Treviño, R. J., Valvano, J. W., Pearce, J. A. and Feldman, M. D. (2009). Dynamic 
correction for parallel conductance, GP, and gain factor, α, in invasive murine left 
ventricular volume measurements. Journal of Applied Physiology, volume 107, 1693-
1703. 
Pugsley, J. and Lerner, A. B. Year. Cardiac output monitoring: is there a gold standard and 
how do the newer technologies compare? In:  Seminars in cardiothoracic and vascular 
anesthesia, 2010. SAGE Publications, 1089253210386386. 
Rajzer, M. W., Wojciechowska, W., Klocek, M., Palka, I., Brzozowska-Kiszka, M. and 
Kawecka-Jaszcz, K. (2008). Comparison of aortic pulse wave velocity measured by 
three techniques: Complior, SphygmoCor and Arteriograph. Journal of hypertension, 
volume 26, 2001-2007. 
185 
 
Revie, J. a. M. (2013). Model-based cardiovascular monitoring in critical care for improved 
diagnosis of cardiac dysfunction. volume. 
Reynolds, H. R. and Hochman, J. S. (2008). Cardiogenic shock current concepts and improving 
outcomes. Circulation, volume 117, 686-697. 
Rhodes, A. and Sunderland, R. 2005. Arterial Pulse Power Analysis: The LiDCOℳ plus 
System. Functional hemodynamic monitoring. Springer. 
Rivers, E., Nguyen, B., Havstad, S., Ressler, J., Muzzin, A., Knoblich, B., Peterson, E. and 
Tomlanovich, M. (2001). Early goal-directed therapy in the treatment of severe sepsis 
and septic shock. New England Journal of Medicine, volume 345, 1368-1377. 
Robson, S., Murray, A., Peart, I., Heads, A. and Hunter, S. (1988). Reproducibility of cardiac 
output measurement by cross sectional and Doppler echocardiography. British heart 
journal, volume 59, 680-684. 
Roch, A., Guervilly, C. and Papazian, L. (2011). Fluid management in acute lung injury and 
ards. Ann Intensive Care, volume 1, 16. 
Rödig, G., Prasser, C., Keyl, C., Liebold, A. and Hobbhahn, J. (1999). Continuous cardiac 
output measurement: pulse contour analysis vs thermodilution technique in cardiac 
surgical patients. British Journal of Anaesthesia, volume 82, 525-530. 
Romano, S. M. and Pistolesi, M. (2002). Assessment of cardiac output from systemic arterial 
pressure in humans. Critical care medicine, volume 30, 1834-1841. 
Ruffolo Jr, R. R. (1987). The pharmacology of dobutamine. The American journal of the 
medical sciences, volume 294, 244-248. 
Sagawa, K. (1978). The ventricular pressure-volume diagram revisited. Circulation Research, 
volume 43, 677-687. 
Sagawa, K. (1981). Editorial: the end-systolic pressure-volume relation of the ventricle: 
definition, modifications and clinical use. Circulation, volume 63. 
Sakka, S., Reinhart, K. and Meier-Hellmann, A. (1999). Comparison of pulmonary artery and 
arterial thermodilution cardiac output in critically ill patients. Intensive Care Med, 
volume 25, 843 - 846. 
Sakka, S. G., Reuter, D. A. and Perel, A. (2012). The transpulmonary thermodilution technique. 
Journal of clinical monitoring and computing, volume 26, 347-353. 
Sakr, Y., Reinhart, K., Vincent, J.-L., Sprung, C. L., Moreno, R., Ranieri, V. M., De Backer, 
D. and Payen, D. (2006). Does dopamine administration in shock influence outcome? 
186 
 
Results of the Sepsis Occurrence in Acutely Ill Patients (SOAP) Study. Critical care 
medicine, volume 34, 589-597. 
Salvi, P., Palombo, C., Salvi, G. M., Labat, C., Parati, G. and Benetos, A. (2013). Left 
ventricular ejection time, not heart rate, is an independent correlate of aortic pulse wave 
velocity. Journal of Applied Physiology, volume 115, 1610-1617. 
Scheer, B. V., Perel, A. and Pfeiffer, U. J. (2002). Clinical review: complications and risk 
factors of peripheral arterial catheters used for haemodynamic monitoring in 
anaesthesia and intensive care medicine. Critical Care, volume 6, 1. 
Schmid, E., Schmidlin, D., Tornic, M. and Seifert, B. (1999). Continuous thermodilution 
cardiac output: clinical validation against a reference technique of known accuracy. 
Intensive care medicine, volume 25, 166-172. 
Scholz, H. (1984). Inotropic drugs and their mechanisms of action. Journal of the American 
College of Cardiology, volume 4, 389-397. 
Senzaki, H., Chen, C.-H. and Kass, D. A. (1996). Single-beat estimation of end-systolic 
pressure-volume relation in humans a new method with the potential for noninvasive 
application. Circulation, volume 94, 2497-2506. 
Shekerdemian, L. and Bohn, D. (1999). Cardiovascular effects of mechanical ventilation. 
Archives of Disease in Childhood, volume 80, 475-480. 
Shi, Y., Lawford, P. and Hose, R. (2011). Review of Zero-D and 1-D Models of Blood Flow 
in the Cardiovascular System. BioMedical Engineering OnLine, volume 10, 33. 
Singer, M., Allen, M. J., Webb, A. R. and Bennett, E. D. (1991). Effects of alterations in left 
ventricular filling, contractility, and systemic vascular resistance on the ascending 
aortic blood velocity waveform of normal subjects. Critical care medicine, volume 19, 
1138-1145. 
Slifka, M. K. and Whitton, J. L. (2000). Clinical implications of dysregulated cytokine 
production. Journal of molecular medicine, volume 78, 74-80. 
Smartt, S. (2005). The pulmonary artery catheter: gold standard or redundant relic. Journal of 
PeriAnesthesia Nursing, volume 20, 373-379. 
Steinman, D. (2002). Image-based computational fluid dynamics modeling in realistic arterial 
geometries. Ann Biomed Eng, volume 30, 483 - 497. 




Stevenson, L. W. (2003). Clinical use of inotropic therapy for heart failure: looking backward 
or forward? Part I: inotropic infusions during hospitalization. Circulation, volume 108, 
367-372. 
Suga, H., Hayashi, T., Shirahata, M., Suehiro, S. and Hisano, R. (1981). Regression of cardiac 
oxygen consumption on ventricular pressure-volume area in dog. American Journal of 
Physiology-Heart and Circulatory Physiology, volume 240, H320-H325. 
Suga, H. and Sagawa, K. (1972). Mathematical interrelationship between instantaneous 
ventricular pressure-volume ratio and myocardial force-velocity relation. Annals of 
biomedical engineering, volume 1, 160-181. 
Sunagawa, K., Maughan, W. L. and Sagawa, K. (1985). Optimal arterial resistance for the 
maximal stroke work studied in isolated canine left ventricle. Circulation research, 
volume 56, 586-595. 
Sundar, S. and Panzica, P. (2010). LiDCO systems. International anesthesiology clinics, 
volume 48, 87-100. 
Talley, R. C., Meyer, J. F. and Mcnay, J. L. (1971). Evaluation of the pre-ejection period as an 
estimate of myocardial contractility in dogs. The American journal of cardiology, 
volume 27, 384-391. 
Taylor, S. (1966). Measurement of the cardiac output in man. Proceedings of the Royal Society 
of Medicine, volume 59, 35. 
Thames, M. D., Kinugawa, T., Smith, M. L. and Dibner-Dunlap, M. E. (1993). Abnormalities 
of baroreflex control in heart failure. Journal of the American College of Cardiology, 
volume 22, A56-A60. 
Thiele, R. H. and Durieux, M. E. (2011). Arterial Waveform Analysis for the Anesthesiologist: 
Past, Present, and Future Concepts. Anesthesia and Analgesia, volume 113, 766-776. 
Tibby, S. M. and Murdoch, I. A. (2003). Monitoring cardiac function in intensive care. 
Archives of Disease in Childhood, volume 88, 46-52. 
Tijsseling, A. and Anderson, A. (2012). CASA-Report 12-42 December 2012. volume. 
Tortora, G. J. and Derrickson, B. H. (2008). Principles of anatomy and physiology, Wiley. com. 
Transonic Science Inc. 2013. Theory of Operation [Online]. Available: 
http://www.transonic.com/resources/research/pressure-volume-theory-of-operation/ 
[Accessed 20th October 2016]. 
188 
 
Transonic Science Inc. 2015. Flow Matters News letters [Online]. Available: 
http://www.transonic.com/about-us/flowmatters-newsletters/spring-2015/ [Accessed 
20th October 2016]. 
Trudnowski, R. J. and Rico, R. C. (1974). Specific gravity of blood and plasma at 4 and 37 C. 
Clinical chemistry, volume 20, 615-616. 
Truijen, J., Van Lieshout, J. J., Wesselink, W. A. and Westerhof, B. E. (2012). Noninvasive 
continuous hemodynamic monitoring. Journal of clinical monitoring and computing, 
volume 26, 267-278. 
Tyberg, J. V., Bouwmeester, J. C., Parker, K. H., Shrive, N. G. and Wang, J.-J. (2014). The 
case for the reservoir-wave approach. International journal of cardiology, volume 172, 
299-306. 
Vadakel, H. and Rizzolo, D. (2013). Shock: Early recognition and resuscitation are key: 
Review common types of this life-threatening condition and how to respond 
appropriately. Journal of the American Academy of Physician Assistants, volume 26, 
21-24. 
Valentinuzzi, M., Geddes, L. and Baker, L. (1969). A simple mathematical derivation of the 
Stewart-Hamilton formula for the determination of cardiac output. Medical and 
biological engineering, volume 7, 277-282. 
Valtier, B., Cholley, B. P., Belot, J.-P., De La Coussaye, J.-E., Mateo, J. and Payen, D. M. 
(1998). Noninvasive monitoring of cardiac output in critically ill patients using 
transesophageal Doppler. American journal of respiratory and critical care medicine, 
volume 158, 77-83. 
Van Der Meer, R. W., Diamant, M., Westenberg, J. J., Doornbos, J., Bax, J. J., De Roos, A. 
and Lamb, H. J. (2007). Magnetic resonance assessment of aortic pulse wave velocity, 
aortic distensibility, and cardiac function in uncomplicated type 2 diabetes mellitus. 
Journal of Cardiovascular Magnetic Resonance, volume 9, 645-651. 
Vincent, J.-L. and De Backer, D. (2013). Circulatory shock. New England Journal of Medicine, 
volume 369, 1726-1734. 
Vincent, J.-L., Rhodes, A., Perel, A., Martin, G., Rocca, G., Vallet, B., Pinsky, M., Hofer, C., 
Teboul, J.-L., De Boode, W.-P., Scolletta, S., Vieillard-Baron, A., De Backer, D., 
Walley, K., Maggiorini, M. and Singer, M. (2011). Clinical review: Update on 
hemodynamic monitoring - a consensus of 16. Critical Care, volume 15, 229. 
Vincent, J., Sakr, Y., Sprung, C. L., Ranieri, V. M., Reinhart, K., Gerlach, H., Moreno, R., 
Carlet, J., Le Gall, J. and Payen, D. (2006). Sepsis in European intensive care units: 




Wallace, A. G., Mitchell, J. H., Skinner, N. S. and Sarnoff, S. J. (1963). Duration of the phases 
of left ventricular systole. Circulation Research, volume 12, 611-619. 
Wang, J.-J., O'brien, A. B., Shrive, N. G., Parker, K. H. and Tyberg, J. V. (2003). Time-domain 
representation of ventricular-arterial coupling as a windkessel and wave system. 
American Journal of Physiology - Heart and Circulatory Physiology, volume 284, 
H1358-H1368. 
Wei, A. E., Maslov, M. Y., Pezone, M. J., Edelman, E. R. and Lovich, M. A. (2014). Use of 
Pressure-volume Conductance Catheters in Real-time Cardiovascular Experimentation. 
Heart, Lung and Circulation, volume 23, 1059-1069. 
Wei, C.-L., Valvano, J. W., Feldman, M. D. and Pearce, J. A. (2005). Nonlinear conductance-
volume relationship for murine conductance catheter measurement system. IEEE 
Transactions on Biomedical Engineering, volume 52, 1654-1661. 
Weil, M. H. and Henning, R. J. (1979). New Concepts in the Diagnosis and Fluid Treatment 
of Circulatory Shock: Thirteenth Annual Becton, Dickinson and Company Oscar 
Schwidetsky Memorial Lecture. Anesthesia & Analgesia, volume 58, 124-132. 
Weissler, A. M., Harris, W. S. and Schoenfeld, C. D. (1968). Systolic time intervals in heart 
failure in man. Circulation, volume 37, 149-159. 
Weissler, A. M., Peeler, R. G. and Roehll, W. H. (1961). Relationships between left ventricular 
ejection time, stroke volume, and heart rate in normal individuals and patients with 
cardiovascular disease. American heart journal, volume 62, 367-378. 
Werdan, K. (2001). Pathophysiology of septic shock and multiple organ dysfunction syndrome 
and various therapeutic approaches with special emphasis on immunoglobulins. 
Therapeutic Apheresis, volume 5, 115-122. 
Wesseling, K., Jansen, J., Settels, J. and Schreuder, J. (1993). Computation of aortic flow from 
pressure in humans using a nonlinear, three-element model. J Appl Physiol, volume 74, 
2566 - 2573. 
Westerhof, N. (2000). Cardiac work and efficiency. Cardiovascular research, volume 48, 4-7. 
Westerhof, N., Lankhaar, J. and Westerhof, B. (2009). The arterial Windkessel. Medical & 
Biological Engineering & Computing, volume 47, 131 - 141. 
Westerhof, N., Segers, P. and Westerhof, B. E. (2015a). Wave Separation, Wave Intensity, the 
Reservoir-Wave Concept, and the Instantaneous Wave-Free Ratio Presumptions and 
Principles. Hypertension, volume 66, 93-98. 
190 
 
Westerhof, N., Segers, P. and Westerhof, B. E. (2015b). Wave Separation, Wave Intensity, the 
Reservoir-Wave Concept, and the Instantaneous Wave-Free RatioNovelty and 
Significance. Hypertension, volume 66, 93-98. 
Wetterslev, M., Møller-Sørensen, H., Johansen, R. R. and Perner, A. (2016). Systematic review 
of cardiac output measurements by echocardiography vs. thermodilution: the 
techniques are not interchangeable. Intensive care medicine, volume, 1-11. 
Yamashina, A., Tomiyama, H., Takeda, K., Tsuda, H., Arai, T., Hirose, K., Koji, Y., Hori, S. 
and Yamamoto, Y. (2002). Validity, reproducibility, and clinical significance of 
noninvasive brachial-ankle pulse wave velocity measurement. Hypertension Research, 
volume 25, 359-364. 
Yamashita, K., Nishiyama, T., Yokoyama, T., Abe, H. and Manabe, M. (2007). Effects of 
vasodilation on cardiac output measured by PulseCO™. Journal of clinical monitoring 
and computing, volume 21, 335-339. 
Yamashita, K., Nishiyama, T., Yokoyama, T., Abe, H. and Manabe, M. (2008). The effects of 
vasodilation on cardiac output measured by PiCCO. Journal of cardiothoracic and 
vascular anesthesia, volume 22, 688-692. 
Yang, X. X., Critchley, L. A., Rowlands, D. K., Fang, Z. and Huang, L. (2013). Systematic 
error of cardiac output measured by bolus thermodilution with a pulmonary artery 
catheter compared with that measured by an aortic flow probe in a pig model. Journal 
of cardiothoracic and vascular anesthesia, volume 27, 1133-1139. 
Yates, C. and F Manini, A. (2012). Utility of the electrocardiogram in drug overdose and 
poisoning: theoretical considerations and clinical implications. Current cardiology 
reviews, volume 8, 137-151. 
Zierler, K. L. (1962). Theoretical basis of indicator-dilution methods for measuring flow and 
volume. Circulation Research, volume 10, 393-407. 
 
